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ABSTRACT 
Dioxanones (1) are ketal- or acetal protected forms of 1,3-dihydroxyacetone (DHA). 
The thesis presents the stereoselective aldol transformations of dioxanones and 
applications to the synthesis of natural and higher carbohydrates listed in Scheme 1.  
(Note: The structural portion of dioxanone scaffold (1) incorporated into target compounds 
are highlighted in red color) 
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Scheme 1.0: Compounds synthesized from dioxanone scaffold 
The field of organocatalysis has recently gained much popularity among the chemical 
research community. In our group, a set of conditions are developed to perform 
stereoselective aldol reactions on dioxanone substrate. CS-symmetrical dioxanones have 
superior diasteroselectivities than C2V-symmetrical dioxanones (de up to 88% from 34%) 
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and presence of mild Lewis acid (LiCl) or Brønsted acid additives (PyPTS) enhance the 
enantioselectivity into synthetically useful ranges (from 60 up to 96 % ee).  
The first aldol addition of dioxanone (1) to desired aldehydes (possessing masked carbonyl 
functionality), followed by reduction of the corresponding aldol adduct and upon 
unmasking the aldehyde functionality (i.e dithiane or dimethoxy acetal hydrolysis) resulted 
in furanose (II) and pyranose (III) forms of D-ribose.  
A new protocol was developed for the synthesis of biologically important 
deoxyiminosugars such as L-1-deoxymannojirimycin (DMJ, IV), L-1-deoxyidonojirimycin 
(DIJ, V) and N-isopropyl DIJ (IV) from readily available dioxanone (1) precursor. The key 
steps include diastereoselective proline-catalyzed syn-aldol transformation and a reductive 
amination / cyclization. 
D-glycero-D-manno-2-octulose (VII), a higher-carbon sugar isolated from opium poppies 
has been synthesized in enantiomerically pure form.  The short synthetic sequence 
involved two proline-catalyzed aldol addition reactions of dioxanone (1) to appropriate 
aldehydes. Here, we developed a complete dioxanone methodology towards the higher 
monosaccharide in a stereocontrolled fashion. 
The enantioselective stereodivergent first total synthesis of DD- and LL-glycero-β-allo-
heptopyranose (IX, ent-IX) was accomplished from readily available non-chiral starting 
materials. The short synthetic sequence involves enamine and enolate mediated aldol 
reactions at α and α' positions of dioxanone (1) hence demonstrated the complementary 
nature of organocatalysis and organometallic methods.  
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Definitions and Conventions: (IUPAC recommendations 1999 & 1996) 
 
a) Scaffold: Core portion of a target molecule on which it is functionalized. 
b) Building Block: Only part of the structure will be incorporated into the final 
product 
Reference: IUPAC, Pure Appl. Chem., 1999, 71, 12, 2349-2365. 
 
Example: Dioxanone (1) is a scaffold, whereas dimethoxy acetaldehyde (2a), 1,3-dithiane 
carboxaldehyde (2b) and D-glyceraldehyde (2c) are building blocks 
O O
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Figure 1.1: Dioxanone scaffold and building blocks: selected examples 
 
 
 Nomenclature of carbohydrates: Pure & Appl. Chem., 1996, 68, (10), 1919-2008.    
Web link: http://www.chem.qmul.ac.uk/iupac/2carb/34.html 
 
a) The generic term “carbohydrate” includes monosaccharides, oligosaccharides and 
polysaccharides as well as substances derived from monosaccharides by reduction 
of the carbonyl group (alditols), by oxidation of one or more terminal groups to 
carboxylic acids or by replacement of one or more hydroxyl group (s) by hydrogen 
atom, an amino group, a thiol group or similar heteroatomic groups.  
 xix 
 
b) Sugars: The term “sugar” is frequently applied to monosaccharides and lower 
oligosaccharides. 
c) Monosaccharides: The generic term “monosaccharide” denotes a single unit, 
without glycosidic connection to other such unit. Parent monosaccharides are 
polyhydroxy aldehydes or polyhydroxy ketones with three or more carbon atoms. 
d) Aldoses and ketoses: Monosaccharides with an aldehydic carbonyl group are 
called as aldoses; those with a ketonic carbonyl group as ketoses. 
e) Deoxy sugars: Monosaccharides in which an alcoholic hydroxyl group has been 
replaced by a hydrogen atom are called deoxy sugars. 
f) Amino sugars: Monosaccharides in which an alcoholic hydroxyl group has been 
replaced by an amino group are called amino sugars. 
g) Imino sugar: The term 'imino sugar' may be used as a class name for cyclic sugar 
derivatives in which the ring oxygen atom has been replaced by nitrogen.  
h) Aza sugar: Use of the term 'aza sugar' should be restricted to structures where 
carbon, not oxygen, is replaced by a nitrogen atom.  
i) Higher monosaccharides: Higher monosaccharides also commonly known as 
higher-carbon sugars are carbohydrates having the backbone longer than the usual 
six carbon atoms.  
j) Nomenclature of higher monosaccharides: The monosaccharides with more than 
four stereogenic centres is named by adding two or more configurational prefixes 
to the stem name using the following criteria:  
i. The carbon chain is written vertically, with the lowest numbered carbon 
atom at the top. (In Fischer projection of the acyclic form) 
ii. Prefixes are assigned in order to the stereogenic centres in groups of four, 
beginning with the group proximal to C-1. 
iii. The configurational prefixes are printed in lower-case italic. E.g. glycero- or 
manno- etc. 
iv. The prefix relating to the group of carbon atom (s) farthest from C-1 (which 
may contain less than four atoms) is cited first. 
 xx 
 
v. Each configuration group has its own configurational symbol (D or L) 
according to the configuration at the highest-numbered stereogenic centre of 
the group. 
vi. Racemates or meso forms may be indicated by the prefix DL- 
vii. New stereogenic centre will be generated during the hemiacetal ring closure 
process. The two stereoisomers are reffered to as anomers, designated as α- 
or β- according to the configurational relationship between the anomeric 
stereogenic centre and the highest numbered stereogenic centre of the ring 
(next to ring heteroatom) 
  
Examples:  
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Figure 1.2: Nomenclature of higher monosaccharides: selected examples 
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1 INTRODUCTION 
 
1.1 Background and Significance 
The aldol reaction resembles nature's chemistry. As Sir John Cornforth states, 
“Nature, it seems, is an organic chemist having some predilection for the aldol and related 
condensations”.1 Nature employs enzymes in construction of new carbon-carbon bonds 
and, for example, in synthesis of D-glucose, plants use dihydroxyacetone phosphate (12a, 
DHAP) as the donor component and D-glyceraldehyde-3-phosphate (15a) as an acceptor 
component and the reaction is typically catalyzed by aldolase enzymes.
2 
Scheme 1.1a 
illustrates a “generic” retrosynthetic plan to complex higher carbohydrates starting from 
nonchiral dioxanone scaffolds (1) which has been a subject of our group‟s research for 
some time and is continued in this thesis.
10-15
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Scheme 1.1: a) Reterosynthetic plan to access polyoxygenated natural products and 
higher-monoscaaharides from dihydroxyacetone analogues. (b) Dihydroxyacetone and 
examples of its three-carbon synthetic equivalents. 
 2 
 
Although enzyme-catalyzed aldol reactions of dihydroxyacetone phosphate (12a, DHAP) 
are especially useful for stereoselective approach to keto sugars, nevertheless working with 
enzymes and DHAP (12a) is not straightforward and relatively expensive.
2b,2c
 Dioxanone 
scaffolds (1) are protected forms of dihydroxyacetone (12, DHA), a simple triose 
carbohydrate and an important three-carbon scaffold in synthesis of higher 
monosaccharides and various other polyoxygenated natural products (Scheme 1.1b). 
 
The work involved in this thesis primarily deals with aldol reactions of dioxanones (1). 
The aldol reaction has been one of the fundamental tools employed in stereoselective 
formation of C-C bonds in synthesis of numerous natural products as well as in synthetic 
versions of biologically active natural compounds.
3 
The aldol reaction finds its applications 
in synthesis of carbohydrates and other poly-oxygenated natural products, and also many 
other compounds of value in the field of pharmaceuticals and agrochemicals as well as 
playing an important role in medicinal chemistry.    
1.2 The Formose Reaction 
The total synthesis of carbohydrates and their analogs have engaged chemists ever 
since the discovery of the “formose reaction” by Aleksander Butlerow in 1861.4 The 
formose reaction generates a mixture of racemic aldoses and ketoses from a Ca(OH)2 
catalyzed oligomerization of formaldehyde (13, Scheme 1.2).
5
 The reaction begins with 
Benzoin-type condensation of two formaldehyde molecules (13) to form glycolaldehyde 
(14) which readily undergoes Ca(OH)2 mediated aldol reaction with another equivalent of 
formaldehyde (13) to produce glyceraldehyde (15).  Then an aldo-keto isomerization of 
glyceral (15) via Lobry de Bruyn-van Eckenstein rearrangement
6
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Scheme 1.2: Formose reaction cascade for C3 to C6 monosaccharides
5
  
results in the formation of dihydroxyacetone (12), a simplest form of triose 
monosaccharide and crucial intermediate in formose reaction pathway. The enolizable 
DHA (12) can undergo series of aldol transformations with formaldehyde (13), 
glycolaldehyde (14) and glyceraldehyde (15) to produce a complex mixture of keto and 
aldo- tetroses, pentoses and hexoses respectively. DHA (12) and its analogs are known to 
be key precursors in numerous biochemical processes including the synthesis of 
carbohydrates and photosynthesis.
2
 It is believed that the “classical formose reaction” 
 4 
 
might have played a significant role in the prebiotic synthesis of carbohydrates such as 
ribose, an important component of RNA.
7 
  
The synthesis of useful organic molecules from readily available monosaccharides such as, 
D-glucose, D-mannose, D-glucosamine, D- and L-arabinose are cheaper than from the 
laboratory total synthetic methods. However, to obtain the unnatural monosaccharides, 
“rare” enantiomers of useful organic compounds and their functional group manipulation 
would be much easier and more advantageous from total synthetic methods starting from 
the readily available precursors. A large number of natural products possess a “scaffold” 
structure that can be systematically explored in their total synthesis.  Dioxanones (1) are 
one such “scaffold” whose utility in asymmetric synthesis of bioactive natural products 
was illustrated in several publications, reviews and thesis.
8-12
 Most often, they are used as 
synthetic equivalents of 1,3-dihydroxyacetone phosphate (12a, DHAP). The objective of 
this review is to highlight their chemistry and synthetic utility in total synthesis of 
carbohydrates and polyoxygenated natural products. 
1.3  Dioxanone Chemistry 
2,2-Dialkyl substituted 1,3-dioxan-5-ones are commonly known as dioxanones 
(1).
10 
They are α-alkoxy heterocyclic ketones and ketal- or acetal protected forms of 1,3-
dihydroxyacetone (12, DHA). 
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Scheme 1.3. 
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The presence of the two alkoxy groups at the α- and α'-position in respect to the carbonyl 
makes the ketone electron-deficient and thus a much stronger electrophile, thereby 
exhibiting unusual aldehyde-like properties such as greater susceptibility to reduction via 
hydride transfer as well as to self-condensation upon treatment with lithium amide bases
 
(Scheme 1.3).
13 
The protected dendroketose (24) is often a minor product in reactions 
involving dioxanones including organocatalysis.
14
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Scheme 1.4. 
Over the past two decades, Majewski‟s group has been actively involved in exploring the 
chemistry on dioxanone substrates (1). Mark Gleave worked on developing the reaction 
conditions for synthesis of dioxanones (1).
10
 Later, Pawel Nowak employed employed 
dioxanones (1) as three carbon (C3) scaffolds in synthesis of protected forms of 
monosaccharides
11,15,16 
and in total synthesis of (+)-frontalin (81).
11,17
 Recently, Izabella 
Niewczas expanded dioxanone chemistry to include lithium and boron enolate-mediated 
 6 
 
double aldol reactions.
12,18
 Other research groups focused their efforts to capitalize on the 
synthetic utility of the dioxanone scaffold (1).
19-29
 Based on the literature data, the 
chemistry involving dioxanone scaffolds can be broadly divided into four different 
methodologies as illustrated in Scheme 1.4. 
I. Majewski‟s enantioselective deprotonation 
II. Enders‟ hydrazone methodology 
III. Funk‟s amidoacrolein methodology 
IV. Asymmetric organocatalysis 
 
1.4 Dioxanone Methodologies 
1.4.1 Majewski’s enantioselective deprotonation 
 
 
As Louis Pasteur stated “Most natural organic products, the essential products of 
life are asymmetric and possess such asymmetry that they are not superimposable on their 
images”.30 In this context, “asymmetric synthesis” is used as a tool in obtaining the 
enantiomerically enriched compounds which is especially important in medicinal 
chemistry and synthesis of pharmaceuticals.
31,32
  
In many carbon-carbon bond forming reactions, e.g aldol, Mannich, Michael, Robinson 
annulation, ketone alkylation or acylation reactions, the first step is the deprotonation of  a 
ketone to produce the corresponding enolate which is then trapped with an appropriate 
electrophile as required in total syntheses of the target.
33
 Enantioselective deprotonation of 
numerous ketones using chiral lithium amide bases represents an attractive and powerful 
 7 
 
method in asymmetric synthesis.
34  
Enantioselective deprotonation of dioxanones with 
chiral lithium amides was first investigated by Majewski‟s group in early 1990‟s. Initially, 
dioxanone substrates proved to be challenging cyclic ketone precursors for enolization but 
after extensive experimental work by Gleave,
10
 Nowak
11
 and later by Niewczas
12
 
conditions were developed that allowed the use of dioxanones in building carbohydrates 
and polyoxygenated natural products. 
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Scheme 1.5. 
11
 
The method is briefly summarized in Scheme 1.5.
11
 2-tert-Butyl-2-methyl-1,3-dioxan-5-
one (1b) is an achiral substrate having an internal plane of symmetry. This CS-symmetric 
dioxanone worked very well in enantioselective deprotonation If the dioxanone exists as a 
 8 
 
chair conformer, then the pair of axial protons at the C-4 and C-6 of the dioxanone ring are 
enantiotopic. The presence of the sterically bulky tert-butyl group at C-2 “locks” the ring 
conformation. Depending on the choice of the chiral lithium amide it was feasible to 
accomplish enantioselective deprotonation of one of the alpha protons HS or HR  of the 
ketone 1b to produce predominantly one of the corresponding enantiomers of the Li-
enolate 33 with good selectivity. 
The stereochemical information embedded in the chiral base was transferred to the 
enolates. The reactive chiral enolate 33 can react either at the oxygen center to produce the 
corresponding alkene 35 or at the enolate carbon center to form the  α-substituted 
dioxanone 34.  
The synthesis of several chiral lithium amides bases was reviewed by Nowak and 
Niewczas in their respective theses.
12
 The scope of this methodology was extended to a 
number of different cyclic ketones (36-38) having CS-symmetry as shown in Figure 1.3. 
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Figure 1.3: Symmetrical cyclic ketones for enantioselective deprotonation studies
34 
 
Gleave
10 
and Nowak
11
 demonstrated that aldol transformations involving the CS 
symmetrical 2-tert-butyl-2-methyl dioxanone 1b (Scheme 1.7) proceeded with higher 
 9 
 
stereoselectivities in comparison to similar transformations carried out the C2v symmetrical 
2,2-dimethyl-1,3-dioxa-5-one (1a, Scheme 1.6). The lithium enolate of dioxanone (1a) 
reacted with (R)-glyceraldehyde (2c) to produce two isomeric protected ketohexoses (40 
and 41) but the selectivity was rather low.   
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40 41
+
1.7 1:
Y: 70%
 
Scheme 1.6. 
In contrast, enantioselective deprotonation of the CS-symmetrical dioxanone (1b) gave one 
of the two chiral lithium enolates 43 in high ee. The reaction with the chiral aldehyde (R)-
2C gave derivatives of D-psicose (44) or D-tagatose (45) in fairly high diastereoselectivity. 
The ketone reduction followed by acid-catalyzed ketal hydrolysis of aldol adducts (44 and 
45) provided the known corresponding reduced ketohexoses (46-49) thus establishing the 
relative and absolute configuration of the products by the chemical correlation method.
11,16
 
This particular study eventually became a standard for comparison of stereochemical 
outcome of aldol reaction of dioxanones. 
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1.4.2 Enders’ hydrazone methodology 
 
As discussed in the previous section, dioxanones (1) under standard alkylation 
reaction conditions (e.g., lithium diisopropylamide, LDA, -78 °C or lithium 
hexamethyldisilazide, LHMDS) tend to undergo reduction of the carbonyl group, self-
condensation and decomposition.
35 
O O
O
1a
O O
N
N
OMe
*
O O
O
R
*
SAMP (or) RAMP
benzene, reflux
27
1). t -BuLi, THF, -78 °C;
3). O3, CH2Cl2, -78 °C
2). RX, THF, -100 °C to r.t.
28
 
Scheme 1.8.  
 
To date dioxanones (1) have been challenging alkylation substrates and the only available 
method for alkylation of dioxanones relies on using Enders‟ SAMP/RAMP-hydrazone (27) 
methodology (Scheme 1.8). In 1989 Enders and co-workers developed a method for 
stereoselective α-alkylation of dioxanones (28) that relies on “chirality transfer” of (+)-S-1-
amino-2-methoxymethylpyrrolidine (SAMP) or its enantiomer (RAMP) to the α reactive 
site of the dioxanone ring. This methodology was applied in asymmetric synthesis of 
different classes of natural products.
36 
1.4.3 Funk’s amidoacrolein methodology 
 
 Funk and coworkers have reported total syntheses of several polycyclic alkaloids 
using a trifunctional 2-amidoacrolein component derived from 2,2-dimethyl-1,3-dioxan-5-
one (1a).
37 
The general procedure involves the formation of an amidodioxin motif (29) 
 12 
 
starting from dioxanone (1a) which under simple heating produces the corresponding 
amidoacrolein (30, Scheme 1.9).   
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Scheme 1.9.  
 
In a quick sequence of Diels-Alder and aldol reactions the three-carbon assembly can be 
incorporated into the desired natural product ring system.  In the past decade Funk‟s 
research group employed the dioxanone-amidoacrolein methodology to realize the total 
synthesis of numerous natural products.
38-40
As an example, In the year 2001, Funk and 
Maeng applied amidoacrolein methodology in total synthesis of FR901483 (52, Scheme 
1.10).
41 
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Scheme 1.10.  
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1.4.4  Asymmetric organocatalysis 
The field of organocatalysis has received much attention in the field of asymmetric 
synthesis of chiral organic molecules. Organocatalysis is the process of acceleration of 
chemical reactions using substoichiometric amounts of a metal-free organic compound.
42
 
In early 1970‟s, Hajos and Parrish (at Hoffmann-La Roche Inc, USA)43,44 and Eder, Sauer 
and Wiechert (at Schering, Germany)
45
 independently reported the first enantioselective 
synthesis of bicyclic diketone 57, that was later named the Hajos-Parrish Ketone (HPK). 
The two-step procedure consisting of an acid-catalyzed Michael addition of methyl vinyl 
ketone (53) with methyl cyclopentanedione 54 gave the intermediate triketone 55, that, 
under organocatalytic conditions afforded the enantiomerically enriched hydrindane dione 
57 (Scheme 1.11).  
O
O
Me
O
+
O
OMe
OH
O
OMe
O O
OMe
ee: 97%
(+)-5753 54 55 56
a b c
Reagents and cond it ions: (a) aq.AcOH, 70 ºC, Yield 100%;(b) (S)-proline (3 mol%), DMF,
16 ºC, 3 days; (c) p-TsOH (cat.,), PhMe, reflux, yield 71% (two steps).  
Scheme 1.11. 
Although the first asymmetric organocatalytic recations were reported several decades ago, 
only in the past decade the field of enantioselective organocatalysis has become an area of 
active interest.
46
 The tremendous work and results obtained in this area are documented in  
a number of articles, reviews
47-52 
and books.
53
 My project primarily deals with the proline 
catalyzed aldol reactions on dioxanone scaffolds. The following section focuses on the 
concepts relevant to the ongoing project.    
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1.4.4.1 Proline-catalyzed enantioselective aldol reaction 
As described above, proline was first investigated as a small molecule catalyst in 
what became later known as the Hajos-Parrish reaction
43,44
 in 1974. Described by 
Jacobsen
54
 as the “simplest enzyme”, L-proline can catalyze a wide array of chemical 
reactions with moderate to high diastereo- and enantioselectivities. What are the main 
features that make proline such a good catalyst? In a review
49
 on organocatalysis, Dalko 
points out that: “Proline is the only natural amino acid with secondary amine functionality 
and thus has a higher pKa value and enhanced nucleophilicity relative to other amino 
acids. Proline can therefore react as a nucleophile with carbonyl groups or Michael 
acceptors to form iminium ions or enamines. As the carboxylic acid functionality of the 
amino acid acts as a Brønsted acid in these reactions, proline can be regarded as a 
bifunctional catalyst.” 
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Figure 1.4: Catalytic mechanism of class I aldolases 
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In the past decade, the field of organocatalysis has gained much popularity among the 
chemical research community. The proline-catalyzed aldol reaction involving formation of 
the donor enamine as shown in Figure 1.5, shows a striking similarity to the complex 
machinery of natural enzymatic catalysis that is shown in an abbreviated form in Figure 
1.4.
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Figure 1.5: Catalytic cycle for L-proline catalyzed asymmetric aldol reaction of dioxanone 
The catalytic cycle for the (S)-proline-catalyzed asymmetric aldol reaction of dioxanone 
(1) as illustrated in Figure 1.3 is an extrapolation of the concepts available in the 
literature.
55-57
 Dioxanone (1) reacts with the secondary amine group of (S)-proline (63) to 
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form the corresponding hemiaminal (64), which further results in the formation of the 
iminium intermediate (31), which can either form an enamine (65) or an oxazolidinone 
(69). Formation of the oxazolidinone (69) leads to a decrease in the turnover of the 
catalyst.
58,55 
Similarly, when an aldehyde reacts with the chiral enamine (65) this results in 
the formation of the new carbon-carbon bond and gives the iminium intermediate (66), 
which can also form the corresponding oxazolidinone (70). Hydrolysis of the iminium 
intermediate (66) yields an enantiomerically enriched aldol product (68) and releases (S)-
proline (63) back into the catalytic cycle.
 
 
 
 
1.4.4.2 Dioxanones as a scaffolds in synthesis of carbohydrates 
 
Majewski‟s group11,16 was one of the first to realize the potential of dioxanones in 
synthesis of pentoses and hexoses using C3 + Cn strategy where three-carbons are coming 
from the dioxanone scaffold and Cn-carbons from suitable electrophiles.  As discussed in 
Section 1.4.1, lithium-enolates of dioxanone substrates (1) were functionalized via 
enantioselective aldol reactions to synthesize naturally occurring D-psicose (44) and D-
tagatose (45) which established both the absolute and relative stereochemical outcome of 
deprotonation and aldol addition. Organocatalysis offered a simpler way of synthesis of 
monosccharides. 
 MacMillan et al. in a series of articles demonstrated the power of organocatalytic aldol 
reactions in synthesis of lower monosaccharides (hexoses) in high setereoselectivities on 
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par with natural processes,
 
as well as to alkyl, thio and amino derivatives of those 
monosaccharides.
27
 The scope of proline-catalyzed asymmetric transformations on 
dioxanones was explored by various research groups,
8
 in particular, the research groups of 
Enders,
20,23,25,27
 Barbas
21
 and Cordova
22,28
 explored the scope of organocatalytic aldol 
reactions of dioxanones (1) in syntheses of carbohydrates. This topic was covered by 
Niewczas
12
 in her thesis and also been reviewed by Mahrwald
8
 and Enders.
9 
Hence without 
going into details of the chemistry, the following section is intended to condense the 
literature information on dioxanone-based methodology towards the synthesis of 
carbohydrates.   
During the past decade, Enders, Barbas, and Cordova research groups independently 
functionalized dioxanone (1a) via organocatalytic aldol reactions to givesynthetically 
useful protected forms of various pentoses and hexoses shown in Scheme 1.12. 
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Scheme 1.12. 
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After extensive screening of reaction conditions, proline proved to be a superior catalyst 
and structural features of the electrophiles were shown to play an important role in overall 
yields and selectivity of this transformation. Enders et al confirmed the stereochemistry of 
the major aldol adduct to be the protected D-tagatose 73d. This was based on the 
correlation with literature data provided by Nowak.
11,16
 It seems that all subsequent 
publications relied their stereochemical assignments on Enders‟ work and thus, indirectly, 
on Nowaks work. 
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Scheme 1.13. 
 
List and coworkers first developed and explored the proline-catalyzed three-component 
diastereo- and enantioselective Mannich reaction on dioxanone 1a. The reaction, as 
illustrated in Scheme 1.13, involves an interaction between the si-face of the dioxanone 
enamine and the si-face of the aldehyde-derived imine to produce preferentially the syn-
configured Mannich products 76.
55
 The reversal of selectivity from the anti in the aldol 
reaction to the syn in the Mannich case can be explained based on the change in facial 
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selectivity between aldehyde (re-face) in aldol and imine (si-face) of Mannich with the 
same si-face of dioxanone enamine (1) 
Cordova‟s group reported the first proline-catalyzed Michael addition to 
phenylnitrostyrene (77) involving a dioxanone substrate (1a) to produce the Michael 
adduct 78 in low selectivity (Scheme 1.14).
56
 The compound 79 was readily hydrogenated 
to the corresponding dihydroxy pyrrolidine derivative 80, thereby developing a new route 
to access iminosugars. 
 
O O
O
+
1a
(S)-proline (30 mol%)
aq. DMSO, r.t. 8 days
Y= 40%
de = 6 :1 &ee = 11%
77
O O
O
78
NO2NO2
Ph
Ph
H
NO
O
79
H
NHO
HO
80
Pd(OH)2
H2
 
Scheme 1.14. 
Using the above methodologies, the synthetic utility of dioxanone scaffolds (1) was 
demonstrated in several target-oriented syntheses of natural products. Most of the 
compounds listed in Figure 1.6 were reviewed by Enders
9
 in 2005 and by Niewczas
12
 in 
her thesis in 2008. The following section of the thesis will focus on reviewing the recent 
literature related to applications of dioxanone-based methodology in natural product 
syntheses with prime attention on the reports published after 2006. 
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1.5 Dioxanone Scaffolds in Total Synthesis of Natural Products:   
Review of Recent Literature 
The literature untill 2006 includes numerous references where dioxanones (1) were 
used as dihydroxyacetone equivalents (DHA) in asymmetric total synthesis of complex 
natural products most of which were polyoxygenated compounds.
9-29
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Figure 1.6: Natural products synthesized from dioxanone building blocks until 2006 
(Note: The structural portion that came from the dioxanone (1) is highlighted in red color). 
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In the following section of the thesis, I will review the reports on syntheses involving the 
dioxanone methodology which are not covered in the previous reviews.
9,12 
 
1.5.1 Synthesis of methylenomycin furans (MMFs) 
                  Methylenomycin furans (MMFs) are derivatives of 2-alkyl-4-
hydroxymethylfuran-3-carboxylic acid (89) that were a recently discovered class of 
bacterial signaling compounds produced by Streptomyces coelicolor bacteria.
59
 About two-
thirds of the clinically used antibiotics are produced by these soil-dwelling bacteria.
60 
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Scheme 1.15: Synthesis of Methylenomycin Furans (MMFs) 
Recently, Sello et al. reported a two-step synthesis of MMFs starting from dioxanone 1a 
(Scheme 1.15).
61
 The optimal reaction conditions involved a scandium triflate-catalyzed 
domino reaction of β-ketoesters 87 and dioxanone 1a involving three steps: aldol addition, 
in situ trans-ketalization followed by the final dehydrative aromatization and produced the 
desired target MMFs 1-5 (89) in 45 to 66% overall yields 
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1.5.2 Enantioselective synthesis of L-Cladinose 
L-Cladinose (96) is a natural sugar found in erythromycins A, B, F and G, as well 
as in the azithromycins.
62
 Kang‟s protocol63 began with addition of propenyllithium to the 
ketone moiety of the dioxanone (1a) followed by an acid-catalyzed acetal hydrolysis to 
afford the glycerol substrate 90.
 
The desymmetrization of 90 was achieved by benzoylation 
that was catalyzed by a chiral imine CuCl2 catalyst to furnish the enantiomerically enriched 
monobenzoate (R)-91 in 98% yield (Scheme 1.16.). 
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Scheme1.16: Enantioselective desymmetrization of dioxanone scaffold to L-cladinose 
Subsequently, the benzoate was mesylated, followed by a DBU-mediated cyclization to 
produce the epoxide intermediate which, upon treatment with Red-Al, underwent 
debenzoylation to give the corresponding allylic alcohol 92. A one-pot sequence of 
mesylation-cyclization of 92 to epoxide followed by treatment with a vinyl Grignard 
reagent afforded the tertiary alcohol diene 93. The diene was then subjected to chemo- and 
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stereoselective Sharpless epoxidation followed by methylation of tertiary hydroxyl group 
to produce the epoxymethyl ether 94. The ruthenium-catalyzed oxidative cleavage of the 
double bond followed by Lewis acid mediated cyclization resulted in butyrolactone 95. 
The final DIBAL reduction of lactone proceded with a spontaneous rearrangement from 
furanose to pyranose and afford the target L-cladinose (96).  Thus, Kang and co-workers 
successfully functionalized the dioxanone scaffold (1a) into L-cladinose (96) in twelve 
steps with 12.5% overall yield.
63
 
1.5.3 Total synthesis of Azithromycin 
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Scheme 1.17: Total synthesis of Azithromycin 
 
Azithromycin (97) is a commercially available antibiotic with wide beneficial 
properties over popular erythromycins.
64
 Azithromycin possesses a 15-membered 
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macrolide structure with complex stereochemical architecture.
65 
Last year, Kang et al. 
demonstarted a highly stereoselective total synthesis of azithromycin in 18 linear steps 
with 5.2% overall yield starting from dioxanone 1a (Scheme 1.17).
66
 
1.5.4 Synthesis of (±)-β-Erythroidine 
β-Erythroidine alkaloids such as compound 100 exhibit interesting pharmacological 
properties such as sedative, hypotensive, neuromuscular blocking and CNS activity.
67
 
Recently, Funk and He demonstrated the usefulness of dioxanone methodology to access 
the tetracyclic (±)-β-erythroidine (100) in 13 steps with 13% overall yield (Scheme 1.18).68  
The key steps in their accomplishment include intramolecular amidoacrolein Diels-Alder 
cycloaddition followed by a subsequent Heck reaction and an electrocyclic ring closure to 
realize the polycyclic ring system of the target natural product. 
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Scheme 1.18: Retrosynthetic plan to (±)-β-erythroidine 
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1.5.5 Asymmetric synthesis of (+)-Altholactone 
(+)-Altholactone (111) has a tetrahydrofurano-2-pyrone structural motif and is a 
member of styryllactone family of natural products occuring in Polyalthia species.
69 
(+)-
Altholactone is (111) known to display cytotoxic and antitumor activities. In 2008, Enders 
and Barbion succeeded in the first asymmetric synthesis of (+)-altholactone using 
dioxanone-hydrazone methodology.
70
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Scheme 1.19: Synthesis of (+)-altholactone 
 
Readily available 2,2-dimethyl-1,3-dioxan-5-one (1a) was first transformed into the 
respective RAMP-hydrazone via the standard protocol developed in Ender‟s research 
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laboratory (Scheme 1.19). Then, at low temperature, the aza-enolate of the hydrazone was 
trapped with 3-benzyloxy-1-bromo-propane followed by hydrolysis of the hydrazone 
moiety to produce the α-alkylated dioxanone (R)-105 in good yield and selectivity. The 
second nucleophilic site of the dioxanone ring was subjected to boron-mediated aldol 
reaction with benzaldehyde to produce the anti-trans aldol adduct, and simple silyl 
protection of thehydroxyl functional group resulted in compound 106.  Further, the 
carbonyl reduction followed by functional group manipulation resulted in dibenzylated 
alcohol 107. The sequence involving a trans-acetonide formation, silylation followed by 
double debenzylation gave the corresponding diol 108. The γ-lactone 109 was then 
obtained from the diol 108 using an IBX mediated oxidation and in situ cyclization 
followed by a TPAP/NMO oxidation sequence. Next, the α,β-double bond was introduced 
into the lactone ring through α-selenylation/elimination and a subsequent TBS deprotection 
and tosylation gave compound 110. The last step was carried out under acidic conditions 
using the Amberlyst resin which induced the acetal deprotection resulting in spontaneous 
ring-closure with complete inversion of configuration to produce the desired (+)-
altholactone (111) in eighteen steps starting from dioxanone scaffold(1a) with 13.7% 
overall yield.
70
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1.5.6  Synthesis of an N-nucleoside derivative 
 
Nucleoside-type natural products and their analogues are known to be useful 
compounds in medicinal chemistry and for a broad range of disease targets.
71
 A variety of 
biologically useful nucleoside analogues have been synthesized to date.
72 
Enders and co-
workers reported the first asymmetric route to access 4'-quaternary 2'-deoxy-3'/4'-epi-
nucleosides using dioxanone-hydrazone methodology.
73
 The synthesis started with α-
alkylation of 2,2-dimethyldioxan-5-one (1a)  to produce the corresponding tert-butyl keto 
ester (R)-113. The subsequent diastereoselective Grignard addition to the ketone resulted in 
a moderate yield of the syn-diastereomer of the ester-alcohol 114. 
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Scheme 1.20: Synthesis of 4'-quaternary 2'-deoxy-3'-epi-β-N-nucleosides 
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Acid-catalyzed deketalization of 114 resulted in the triol intermediate which readily 
underwent trans-esterification to a five-membered lactone that was isolated as the 
disilylated lactone 115. Now, depending on the reaction conditions, the lactone 115 could 
be converted into either C- or N-nucleosides. The bioactive thymidine-N-nucleoside 117 
was synthesized via a sequence of DIBAL-mediated lactone reduction, and acetylation 
followed by NBS mediated silyl-Hilbert-Johnson reaction (Scheme 1.20).
73
 
1.5.7  Synthesis of 4'-epi-Trachycladines A and B 
 
In similar fashion as described above, Enders realized the synthesis of two 
nucleosides 4'-epi-trachycladines A and B (118 and 119), using dioxanone methodology as 
illustrated in the reterosynthetic scheme below (Scheme 1.21). The formal synthesis was 
accomplished in 14 linear steps starting from the dioxanone scaffold with 20% overall 
yield.
 74 
 
O O
O
dioxanone
O O
OH
Me
Me OBn
Me
OH OH
O Me OH
Me
OAc OAc
O Me OAc
Me
OH OH
O Me
N
NN
N
NH2
Cl
Me
OH OH
O Me
N
NHN
N
O
4'-epi-Trachycladines A
4'-epi-Trachycladines B
1a
118
119
120 121
122
 
Scheme 1.21: Retrosynthetic route to 4'-epi-trachycladines A and B 
 29 
 
1.5.8 Towards the Synthesis of (–)-Quinic acid and (–)-Dragmacidin F 
Stoltz envisaged that the structure of the dioxanone scaffold (1a) can be embedded 
into carbocyclic (–)-quinic acid (128) and further into more complex molecules as (–)-
dragmacidin F (129, Scheme 1.22).
75
 As a part of the “proof of concept” Stoltz‟s group 
performed alkylation on dioxanone (1a) via Enders‟ SAMP-hydrazone methodology to 
obtain 1-butenyl dioxanone (123). 
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Scheme 1.22: Synthetic route towards the (–)-quinic acid and (–)-dragmacidin F 
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The corresponding silyl enol ether 124 was subjected to palladium-catalyzed 
enantioselective allylation conditions to deliver the demanding tetrasubstituted ketone 
diene 125 in high yields and selectivity.  The α,ω-diene 125 was neatly transformed into 
spiroalkene 126 via ring-closing metathesis using Grubbs second generation catalyst 131. 
Finally, cyclohexene compound 126 under acetonide hydrolysis followed by periodic 
oxidation produced the hydroxyacid 127 a crucial component in the formal syntheses of   
(–)-quinic acid (128)76 and (–)-dragmacidin F (129).77 
 
1.5.9 Synthesis of (+)-Polyoxamic acid 
 
The Polyoxins 133 are a group of unusual peptidyl nucleosidic antibiotics isolated 
from the culture broths of Streptomyces cacoi var. asoensis.
78
 (+)-Polyoxamic acid (132, 
Figure 1.7) is one of the chief structural components of the polyoxin compounds with 
carbamoylated polyoxamic acid linked to the sugar moiety by an amide bond.  
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Figure 1.7: Structures of polyoxins and (+)-polyoxamic acid 
Polyoxins are known to exhibit antifungal activity against Candida albicans, a fungal 
pathogen that affects humans.
79
 The application in the field of medicinal chemistry have 
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led to the development of new synthetic methodologies towards polyoxamic acid and 
derivatives.
80 
 
Enders and Vrettou accomplished an elegant synthesis of (+)-polyoxamic acid (131) using 
an organocatalytic stereoselective Mannich methodology on the dioxanone scaffold (1a, 
Scheme 1.23).
81
 The desired syn configurational Mannich base (135) was obtained from 
the (S)-proline catalyzed reaction of dioxanone with N-BOC furfural imine (134) in 
excellent selectivity and yields. L-Selectride-mediated diastereoselective reduction of the 
ketone in the Mannich base 135 resulted in the desired syn isomer of the corresponding 
aminoalcohol 136. Subsequent oxidation of the furyl functionality was achieved by 
standard ozonolysis followed by aqueous TFA-mediated BOC and acetal groups removal 
to afford (+)-polyoxamic acid (131) in four steps in 46% overall yield. 
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Scheme 1.23: Enders‟ synthesis of (+)-polyoxamic acid 
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1.5.10 Synthesis of Jaspine B (Pachatrissamine) 
 
Jaspine B, also known as pachatrissamine (141) is a naturally occurring cyclic 
anhydrophytosphingosine derivative isolated from the Okinawan marine sponge 
Pachastrissa sp. as well as from Jaspis sp.
82,83
 Jaspine B (141) exhibits significant 
cytotoxic activity against numerous tumor cell lines.
82
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Scheme 1.24: Ender‟s synthesis of (+)-Jaspine B 
Enders‟ envisaged a proline-catalyzed aldol approach to access jaspine B (141) starting 
from the dioxanone scaffold (1a).
84
 As shown in Scheme 1.24, the anti-aldol adduct 137 
was obtained from (R)-proline-catalyzed aldol reaction of 2,2-dimethyldioxan-5-one (1a) 
with 1-pentadecanal (142). Next, standard silyl protection of the hydroxyl group followed 
by diastereoselective reduction of ketone with L-selectride gave the Syn-anti-configurated 
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alcohol (138) in good yields and selectivities. The free hydroxyl group of alcohol 138 was 
subjected to mesylation followed by treatment with sodium azide producing the azide, 
which, upon desilylation with TBAF afforded the syn-1,3-azidoalcohol compound 139. 
Next, formation of the tosyl intermediate followed by Amberlyst 15 catalyzed 
deketalization triggered the intramolecular nucleophilic displacement reaction producing 
the azido tetrahydrofuran intermediate 140. As the final step, reduction of the azide 
produced the target jaspine B (141) in 24% overall yield, after nine steps starting from the 
commercially available dioxanone scaffold (1a).
 84
 
1.6 Iminosugars 
1.6.1 A short overview 
 
        Iminosugars are low molecular-weight polyhydroxylated alkaloidal monosaccharides 
with nitrogen atom in the place of the ring oxygen of the corresponding carbohydrates.
85
 
Nojirimycin (144, NJ) is a glucose analogue and naturally occurring iminosugar which was 
first described as an antibiotic compound produced from the bacterial cultures of 
Steptomyces rosechromogenes R-468 and Streptomyces nojiriensis SF-426 by Inouye and 
coworkers in 1966.
86 
 Since then hundreds of polyhydroxylated alkaloidal iminosugars  
have been isolated from plants and microorganisms. The natural and unnatural iminosugars 
are known to mimic the natural sugar moieties in biochemical processes and thereby are 
believed to modulate and block enzyme-mediated catalytic glycosylation processes.
87
 For 
this reason, iminosugars are considered to have a high potential therapeutic value as 
antidiabetic drug candidates,
 
antiviral and anti-infective agents or in lysosomal storage 
disease treatment.
88
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Based on the core structural skeleton, polyhydroxylated alkaloidal iminosugars are broadly 
classified into five classes: polyhydroxylated pyrrolidines, piperidines, indolizidines, 
pyrrolizidines and nortropanes.
89
 Some of the examples of these structural classes of 
iminosugars are listed in Figure 1.8.  
OH
OH
N
H
OH
HO
1-Deoxynojirimycin
DNJ (146)
OH
OH
N
H
OH
HO
Nojirimycin
NJ (144)
N
H
OH
OH
CYB3
HO
N
HO
H OH
OHN
HO H OH
OH
OH
OH
NH OH
HO
SwainsonineAlexine
149
Calystegine A3
OH
OH
N
H
OH
HO
(+)-Adenophorine
148
OH
OH
N
H
OH
HO
- or-Homonojirimycin
145
HO
OH
OH
N
H
OH
Fagomine
 147
143
150 151  
Figure 1.8: Selected examples for imino sugars 
 
Nojirimycin (144), which is one of the best known representatives of iminosugars, was 
shown to be an inhibitor of  both α- and β-glycosidases of various origins.87 Another 
iminosugar, 1,4-imino-1,2,4-trideoxy-D-arabinitol (143, CYB 3), an analogue of  2-
deoxyribose, can be found in the leaves and seeds of Castanospermum austral,
90
 alexine 
(149) was isolated from Alexa leiopetala,
91a 
swainsonine (150) an indolizidine iminosugar 
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was isolated from Swainsona canescens,
91b 
calystegine A3 (151) is present in the roots of 
Lycium chinense.
91c 
1-Deoxynojirimycin (146, DNJ) is one of the important members of 
the nojirimycin family and the simplest natural carbohydrate mimic.  DNJ (146) is also 
known as 1,5-dideoxy-1,5-imino-D-glucitol or Moranoline.
92
 
In recent years, these iminosugars have attracted synthetic community‟s attention as this 
class of compounds comprises some potent glycosidase inhibitors as well as candidates 
with promising drug profiles and wide-ranging biological activities.
93
 DNJ (146), a 
glucosidase inhibitor, and N-butyl-deoxynojirimycin (153, Zavesca®) is an N-alkylated 
imino sugar  which is a prescription drug for a mild to moderate type 1 Gaucher disease; as 
well it has shown to inhibit human immunodeficiency virus (HIV).
94
 Compounds listed in 
Figure 1.9 represent a few of the many α- and β-glycosidase inhibitors, commercial drugs 
and candidates in clinical trials for treatment of diabetes, cancer, AIDS, viral infections and 
metabolic disorders.
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Figure 1.9: Commercial drugs and glycosidase inhibitors of iminosugar derivatives 
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1.6.2 Synthetic routes to iminosugars 
Due to these promising medicinal profiles, a large number of strategies have been 
developed for iminosugar synthesis. The general synthetic approaches to iminosugars and 
their derivatives can be broadly classified as follows:  
a) Strategies involving readily available furanose and pyranose carbohydrate 
precursors
91-96 
b) Enzymatic approach mimicking the natural processes97  
c) Strategies based on use of C2-symmetrical diols and readily available diethyl L-
tartrates to obtain the desired alkaloidal skeleton of the target iminosugars.
98 
 
1.6.2.1 Carbohydrate- based approach to iminosugars 
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Scheme 1.25: Lopes approach to 1-DNJ and n-Bu-1-DNJ 
As an example of the type-1 strategy, Lopes realized the synthesis of 1-
deoxynojirimycin (146) and N-butyl-1-deoxynojirimycin (153) starting from inexpensive 
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2,3,4,6-tetra-O-benzyl-α-glucopyranose (157) via 1,5-dicarbonyl intermediate (159) being 
eventually transformed into 1-DNJ (146) and N-Bu-1-DNJ (153) in 65% and 70% overall 
yields respectively (Scheme 1.25).
96 
1.6.2.2 Enzymatic approach to iminosugars 
Chi-Huey Wong and coworkers
97
 reported a general enzymatic approach to various 
iminosugars as shown in Scheme 1.26 starting from DHAP 12a (example for type-2 
stratergy). The scheme includes the combination of stereoselective enzymatic aldol 
reaction and reductive amination sequence to five- and six-membered iminocyclitols. 
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Scheme 1.26: Enzyme-catalyzed approach to iminosugars 
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1.6.2.3 Organocatalysis and tartrate approach 
In 2006, Fernández-Mayoralas reported a double asymmetric induction on proline-
catalyzed aldol reactions of dioxanone (1a) with α-azidoaldehyde 174 derived from diethyl 
tartrate (173) in the synthesis of homonojirimycin stereoisomers (Scheme 1.27).
99
 Reaction 
of dioxanone 1a with 174 under (S)-proline-catalyzed aldol addition reaction resulted in    
1 : 20 diastereomeric mixture of aldol adduct 175 with 70 % yield. On the other hand, the 
similar reaction with (R)-proline produced 177 in 60% yields and mediocre dr of 1:5. This 
particular example uncovered a new asymmetric route to biologically active 
homomannojirimycin iminosugars. 
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 Scheme 1.27: Double asymmetric induction and synthesis of homomannojirimycins 
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1.7 Higher Monosaccharides: A Short Review  
1.7.1 Background and significance 
Higher monosaccharides are commonly known as higher-carbon sugars. They are 
carbohydrate monosaccharides containing a backbone longer than the usual five or six 
carbon atoms.
100
 Some of the examples of these class are heptoses, octoses, nonoses, 
decoses and beyond. Higher-carbon sugars have been found in Nature. Recently, they have 
been receiving greater attention due to their potential applications as antibiotics, structural 
components with wide-ranging biological functions. There are several review articles 
written on this topic.
101,102
  
1.7.1.1 Heptoses and Octoses 
 
Figure 1.10: Schematic representation E. coli bacteria LPS with Kdo and heptoses
105
 
(Reproduced with permission of the publisher) 
Aldo- and ketoheptoses are important classes of higher monosaccharides.
103,104
 
Naturally occurring aldoheptoses, deoxy-aldoheptoses (Figure 1.10) along with 3-deoxy-D-
manno-oct-2-ulosonic acid (185, Kdo) are chief components of the antigenic endotoxins of 
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E. coli gram-negative bacteria lipopolysaccharides (LPS).
105 
 Aldoheptoses contain six 
consecutive stereogenic centers on the seven-carbon skeleton. From the 64 possible 
stereoisomers of aldoheptoses, only six have been found in LPS. L-glycero-D-manno-
heptose (179) was one of the first aldoheptoses isolated from Shigella flexneri 
polysaccharide by Slein and Schnell,
106
 but only meager amounts of these heptoses are 
available from natural sources. Low natural abundance and the immunological importance 
of the aldoheptose region of the LPS structure provoked considerable interest towards the 
development of new synthetic routes to obtain heptoses and their derivatives.
107,108 
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Figure 1.11: Heptoses and octoses compounds                    
Lincosamine (184), a eight carbon aminomonosaccharide and an important moiety of 
commercially available antibiotic lincomycin.
109 
3-Deoxy-D-manno-2-octulosonic acid 
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(Kdo, 185) is one more octose component found on the cell wall lipopolysaccharides of 
Gram-negative bacteria,
105, 110 
and octitol has been found in human eye lenses.
111  
The 
naturally occurring nucleoside octosyl acid A (186) is an unusual eight-carbon bicyclic 
sugar. Its adenine analogue, which can be obtained by transglycosylation, was shown 
inhibit cyclic-AMP phosphodiesterase.
112
 
 
1.7.1.2 Nine-carbon sugars and derivatives 
 
The nine-carbon sialic acid, 3-deoxy-D-gycero-D-galacto-non-2-ulopyranosonic 
acid (Kdn, 187, Figure 1.12) was isolated from polysialoglycoprotein of rainbow trout eggs 
and N-acetylneuraminic acid (188, NANA) plays an important role in the biological cell-
to-cell recognition phenomena.
113
 Calditol (189) is nonose structural component of 
complex lips of thermoacidophilic bacteria and amipurimycin (190) is a branched nine-
carbon moiety of glycosyl amino acid core of a complex nucleoside.
114
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Figure 1.12: Examples for nine-carbon monosaccharides
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1.7.1.3 Monosaccharides with ten or more carbon atoms in the skeleton 
Monosaccharide derivatives having ten and higher carbon atoms in the carbon 
skeleton are rare in nature (Figure 1.13). Hikosamine (192) is a C11 complex higher-sugar 
component of the nucleoside antibiotic hikizimycin (191) which was found to be active 
against Helminthosporium and other plant-pathogenic fungal species.
115
 An example of a 
eleven-carbon aminosugar is tunicamine (193), a chief component of antibiotic 
tunicamycin (193).
116
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Figure 1.13: Examples for ten or more carbon monosaccharides
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1.7.2 Synthetic methodologies for higher monosaccharides 
A number of articles, reviews
101
 and comprehensive chapters in books
102,103
 
addressed the biological significance and synthetic efforts towards higher monosaccharides 
and this section of the thesis aims to summarize briefly the synthetic methodologies 
prevalent in the literature.
100-119
 The general synthetic procedures for obtaining higher-
carbon sugars can be broadly classified into following strategies:     
a) Classical approaches 
b) Danishefsky's hetero-Diels-Alder approach 
c) Dondoni's thiazole route 
d) Jefford-Hanessian butenolide route 
e) Vogel's homologation of 7-oxanorbornenyl 
f) Jarosz‟s “Tail-to-Tail” Method 
 
1.7.2.1 Classical approaches 
The first of the classical approaches to higher monosaccharides is the well known 
Kiliani-Fischer homologation of lower monosaccharides. Scheme 1.28 illustrates the 
general protocol for Kiliani-Fischer homologation.
120 
The reaction proceeds via formation 
of a cyanohydrin intermediate 196; subsequent hydrolysis produces two epimers of the 
corresponding aldonic acid 197 resulting in one-carbon chain elongation with intact 
stereochemistry of the starting monosaccharide (195).   
Sug H
O
Sug CN
OH
Sug COOH
OHHCN H3O
+
195 196 197  
Scheme 1.28. 
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Another powerful elongation method to higher monsaccharides is by Wittig-Horner 
olefination reaction followed by stereoselective hydroxylation of the generated alkene 
bond.
101c
 The general protocol for this method is shown in Scheme 1.29. The carbonyl 
functionality of the lower sugar is treated with the phosphorane derivative of another sugar 
to generate the corresponding olefin, subsequent stereoselective manipulation of the double 
bond results in the desired higher sugar. 
Ph3P
Sug1 Sug2 Sug1
Sug2
+ Sug1
Sug2
198 199 200 201
O
H
HO
OH
Scheme 1.29. 
Kibayashi et al explored Wittig-Horner olefination methodology in the synthesis of the 
powerful glycosidase inhibitor (+)-α-homonojirimycin (176).121 Brimacombe and 
coworkers have used this approach to make some octoses, decoses and decitols.
101c
 Secrist 
and Barnes demonstrated the usefulness of this method in the synthesis of the eleven-
carbon hikosamine (192) core portion of  the nucleoside antibiotic hikizimycin (191).
122 
In 2000, Miljkovic and Habash-Marino
123
 expanded the Wittig-Horner olefination 
approach to the synthesis of a higher-carbon fragment 205 by coupling an aldose derivative 
203 with a glycopyranosyl phosphorane (202) to yield the alkene intermediate 204.  In a 
sequence of steps with a crucial “double activated lactonization” of the open-chain 
intermediate of 205, they produced the macrocyclic polyhydroxylated lactone 206 (Scheme 
1.30). 
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Scheme 1.30.  
 
Other well-precedented methodologies to access higher monosaccharides are by aldol or 
nitroaldol condensation of chiral aldehydes with chiral ketone enolates
124
 as well as 
nucleophilic additions using vinyl or allyltin reagents as “carbanion equivalents”.125 These 
methodologies are deliberately not covered in this section as they have been reviewed 
before.
101  
1.7.2.2 Danishefsky's hetero-Diels-Alder approach 
Danishefsky‟s group has developed the Lewis acid catalyzed hetero-Diels-Alder 
cycloaddition of highly activated and functionalized siloxydienes (207) with sugar 
aldehydes (208) to produce the pyranoid intermediate 210.
126
 Highly oxygenated pyran 
rings proved to be instrumental in synthesis of numerous higher monosaccharides. As 
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illustrated in Scheme 1.28, Danishefsky‟s method has been systematically  exploited  in 
realizing the total synthesis of octosylacid A (186), N-acetylneuraminic acid (188).   
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Scheme 1.31. 
 
1.7.2.3 Dondoni's thiazole route 
Dondoni and his colleagues
 
developed a methodology which parallels Kiliani-
Fischer
120
 homologation technology. The thiazole route to higher monosaccharides starts 
with the formation of D-erythro-thiazole derivative 211 by 2-(trimethylsilyl)thiazole (215) 
addition to D-glyceraldehyde acetonide (R)-3. A one-pot sequence comprising the standard 
benzyl protection of 211 and methylation of the resulting thiazole intermediate was 
followed by an in situ reduction to thazoline, which, upon hydrolysis produced the desired 
aldehyde 212. Further with repetition of this protocol produces heptoses, octoses, nanoses 
and higher monosacharides (Scheme 1.32). Dondoni‟s thiazole route has been used to 
synthesize various higher carbon sugars. 
127
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Scheme: 1.32. 
1.7.2.4 Jefford-Hanessian butenolide route 
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Scheme 1.33. 
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Butenolides are naturally occuring chiral γ-substituted α,β-unsaturated γ-
butyrolactone subunits (218). Hanessian
128
 and Jefford
129
 independently explored γ-
butyrolactone templates to higher carbohydrates via aldol-type condensation of 2-
(trimethylsiloxy)-furan (216) with sugar aldehyde 208 to produce the butenolide 
intermediate 217, which subsequently underwent hydroxylation to produce the 
butyrolactone template 218. Depending on the type of reaction conditions, compound 218 
could be rapidly converted into a higher monosaccharide architecture with a four carbon 
elongation to the starting sugar 208. This approach was used in the synthesis of the D-allo-
configuration of an 1-deoxynojirimycin homologue and several natural as well as unnatural 
higher monosaccharides. 
 
1.7.2.5 Jarosz’s “Tail-to-Tail” Method 
Jarosz is one of the pioneers in synthesis of higher monosaccharides.
101b,101d 
 The 
Scheme 1.34 illustrates Jarosz‟s methodology of “tail-to-tail” coupling of simple 
monosaccharides to build on the monosaccharide architecture in rapid fashion.  
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Sug1 Sug2 (C)nSug1
Sug2
(a)
(b)
O
OR
OR
OR
SS
2Li
OH
RO
RO
RO
OH
Sug
H
O
Sug S
S
223
208 224
 
Scheme 1.34. 
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Here, selectively protected forms of lower monosaccharides with activated “ends” i.e X 
and Y groups are connected via a Cn bridge sugar unit. For example, when activated 
carbanion 223 coupling with electrophile 208 results in corresponding skeleton of 
elongated higher carbon sugar 224. Jarosz and coworkers have extensively used this 
approach to construct medium size higher carbon sugars, i.e, C12 to C15 as well as for C19 
and C21 dialdose components. For complete review of “tail-to-tail” methodology, cf. 
references 101c and 101d.  
1.8 Scope of Methodology Development 
  An increasing number of rare unusual higher monosaccharides have been 
discovered in nature which show promising biological properties and are also used as leads 
in drug discovery.
117 
Their low natural abundance combined with potential biological 
activity has created a need for efficient synthetic methodologies to access these 
compounds. The multifunctional groups, presence of numerous stereogenic centers in 
addition to troublesome isolation of higher monosaccharides makes them interesting and 
challenging synthetic targets for organic chemists. 
The majority of synthetic methodologies for higher monosaccharides, as discussed in 
section 1.7.2 of the thesis, relies on coupling or sequential homologation of abundant lower 
monosaccharides such as pentoses and hexoses.
120-130 
Although these methods are 
straightforward they suffer from significant limitations such as side reactions and difficulty 
in isolation and purification of desired products from polar reaction mixtures.
118 
Stereocontrolled aldol reactions play a pivotal role in synthesis of these complex chiral 
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molecules. Thorough searches of the literature revealed that very few higher 
monosaccharides were described, especially above nonoses.  
 
 Figure 1.14  Number of SciFinder hits for different monosaccharides. 
 
The SciFinder search illustrates (Figure 1.14) that 92% of the “monosaccharide-related” 
references concern pentoses and hexoses.  The above picture showcases the need for 
developing simple but powerful synthetic methodologies to access these rare 
carbohydrates.    
Note: The SciFinder search results presented in Figure 1.14 are obtained with the research 
topics „monosaccharides and different classes of monosaccharides‟ as the root word search 
option. The above representation is an approximation of the number of references obtained 
through the SciFinder search carried out on 22
nd
 February 2010. The primary objective was 
to illustrate the research scope for development of new synthetic methodologies towards 
the higher monosaccharide class of compounds.  
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1.9 Concluding Remarks 
In the introduction chapter of the thesis, I have reviewed the concepts and 
chemistry related to the dioxanone scaffolds. Based on the literature information, the 
chemistry involving dioxanone scaffolds was broadly classified into four different 
methodologies as enantioselective deprotonation, hydrazone methodology, amidoacrolein 
methodology and asymmetric organocatalysis. The facts, limitations and synthetic 
applications of these approaches were summarized.  
Following that, I have updated the literature with the latest review on dioxanone scaffolds 
in total synthesis of polyoxygenated natural products.  
Recently, development of dioxanone based methodologies for the total synthesis of 
polyoxygenated natural products has been a growing area of research. Many different 
strategies have been developed; however, new methodologies applying more efficient and 
cost effective strategies are required. In particular, general methods that provides 
controlled access to any given stereoisomer. 
This thesis work mainly deals with the development of generic synthetic route to 
iminosugars and higher monosaccharides. In view of the objective, I have presented the 
background and the significance of these compounds. 
The question here was how can we envision dioxanone methodology towards the synthesis 
of higher monosaccharides and iminosugars?  The next two chapters of the thesis are 
aimed at presenting results and efforts towards the development of versatile dioxanone 
based Cm + C3 + Cn methodology to obtain polyoxygenated natural compounds of value. 
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2 RESULTS AND DISCUSSION 
As described in Chapter 1, dioxanones (1) were employed as scaffolds in synthesis 
of biologicaly important natural compounds. Our group has been one of the first to 
demonstrate the usefulness of dioxanones by developing a synthesis of (+)-frontalin (81) 
and lower monosaccharides.
11,15-17
 Recently, Niewczas developed a strategy to bis-
functionalized dioxanones generating four stereogenic centers in a sequence of two carbon-
carbon bond forming aldol reactions (Scheme 2.1.).
12,18 
The objectives of the current 
project included exploration of the complementary nature of organocatalytic, enamine-
mediated and “organometallic”, lithium-enolate mediated aldol reactions on dioxanone 
scaffolds, which is an ongoing research theme within the Majewski group.   
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Scheme 2.1. 
Scheme 2.1 illustrates a generic strategy towards polyoxygenated natural products based 
on combining three fragments: a dioxanone (three carbon fragment, C3), and two different 
aldehydes (e.g. a two-carbon and a three-carbon fragment).  Overall, this Cm + C3 + Cn 
dioxanone-based methodology was envisaged as a rapid entry into densely functionalized 
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chiral architectures (cf., 4 in Scheme 2.1) often found in polyoxygenated natural 
compounds such as carbohydrates. This approach parallels Nature‟s aldol approach to 
carbohydrates. The relative ease of preparation of dioxanones and various aldehyde 
electrophiles from the commercially available material provide an additional advantage. 
2.1 Research Objectives 
The primary goal of the project was to apply dioxanone methodology to the 
synthesis of higher carbon sugars, iminosugars and polyoxygenated natural products. This 
project mainly deals with enantioselective aldol reactions of 2, 2-disubstituted-1,3-dioxan-
5-ones , commonly known as dioxanones (1). Based on the available chemical information 
and limitations of dioxanone chemistry as discussed in Chapter 1, the following questions 
were asked at the initial stage of the project: 
 Do steric and / or electronic effects of the acetonide component of dioxanones have a 
role in directing the diastero- and enantioselectivities of proline-catalyzed aldol 
reactions? 
 Does the presence of mild-acid additives improve the stereoselectivity of proline-
catalyzed aldol reaction of Cs-symmetrical dioxanones (different substitution at 2
nd
 
position of dioxanone ring) as they do in C2-symmetrical dioxanones? 
 Can dioxanones be used as potential starting materials in the synthesis of higher 
carbon sugars and other poly-oxygenated natural products? 
 Limitations in available electrophiles to derivatize dioxanones. Could the scope be 
broadened by developing methods for alkylation, formylation or acylation of 
dioxanones?   
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To answer those questions, the following research objectives were set: 
 First, synthesize several Cs-symmetrical dioxanones with the desire to investigate 
stereoselectivity aspects of proline-catalyzed aldol reactions.  
 Study the influence of additives on the proline-catalyzed aldol reaction. 
 Investigate the stereocontrolled second aldol reactions on dioxanone scaffolds. 
 Apply dioxanone-methodology in synthesis of higher carbon sugars, iminosugars and 
polyoxygenated natural products of value. 
The project was initiated with methodological studies, primarily focusing on the 
proline-catalyzed aldol reaction. The broader outline of the project is shown in Figure 2.1. 
 
Figure 2.1 Project outline 
 
 
Project-IProject-II
Project-III
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2.2 Synthesis of 2,2-disubstituted-1,3-dioxan-5-ones 
 
Any synthetic project starts with the synthesis of starting materials, scaffolds, and 
needed precursors. A practical scaffold is one that can be synthesized from cost-effective, 
readily-available starting materials and it should be easily scalable to large quantities.  This 
project too began with synthesis of 2,2-disubstituted-1,3-dioxan-5-ones (1) based on the 
simple three-step procedure developed in our laboratory.
13
 The symmetrically substituted 
dioxanones belong to C2v point group of symmetry. The dioxanones which are 
differentially substituted at the 2
nd
 position are achiral molecules that belong to CS 
symmetry point group. Based on the mechanistic understanding the symmetry of 
dioxanone 1 might play a significant role in dictating the stereochemical outcome of 
asymmetric transformations on dioxanone substrate 1.  
To investigate the geometry, steric and / or electronic effects of the dioxanone ring on the 
diastero- and enantioselectivities of the corresponding proline-catalyzed direct aldol 
reactions, suitable starting materials are essential. The syntheses of dioxanones (1a-e) are 
carried out in accordance with the optimized synthetic procedures developed in our group 
by Mark Gleave
10
 and Pawel Nowak.
11
  
Scheme 2.1 illustrates the general synthetic protocol used with various dioxanone 
substrates. Standard ketalization of tris(hydroxymethyl)nitromethane (240)  with a desired 
ketone 241 resulted in formation of the corresponding nitro compound 242 which, upon 
reduction under catalytic hydrogenation conditions (85 ºC, 1400 psi), produced the 
corresponding amine 243. At this point, it was noticed that the same reaction could be 
carried out at ambient temperature and at reduced hydrogen pressure, i.e. from 1400 psi to 
50 psi, without compromising the yields.  
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Scheme 2.2. 
The final step in the sequence was sodium periodate oxidative cleavage of amine 243 that 
afforded the desired dioxanones (1a-e) in moderate yields. The ketone 241 with electron 
withdrawing groups (entry 1f; CF3) did not undergo initial ketal formation. A possible 
explanation for this observation could be that the reaction equilibrium lies towards the 
starting material due to strong electronic inductive effect of the CF3 group. The three step 
procedure proved simple, economical and easy to scale up.
 
The summary of yields of 
dioxanones (1a-e) is presented in Table 1.  
Table 1: Summary of three step approach to dioxanones  
Dioxanone R1 R2 
Dioxanone 
overall yield (%) 
1a Me Me 66 
1b t-Bu Me 76 
1c Ph Me 70 
1d Cyclohexanone 80 
1e p-CF3Ph Me 48 
1f Ph CF3 no reaction 
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2.3 Organocatalytic Aldol Reactions of C2 - and CS Symmetrical 
Dioxanones 
 
The scope of proline-mediated asymmetric transformations on dioxanones was 
explored by various research groups.
8,9 
In our group, Izabella Niewczas has screened a 
number of amino acids and esters as the catalysts for aldol reactions, but overall yields and 
selectivities were inferior compared to proline.
12
 Initially, her attempts to perform  proline-
catalyzed aldol reactions on a simple dioxanone substrate 1a met with difficulties such as 
formation of dimeric dendroketose (24) as shown in Scheme 1.3. Reactions carried out in 
dry solvents (DMSO or DMF) resulted in lower yields and inconsistent reproducibility.
132 
During the same time, Enders group published reaction conditions for the proline-
catalyzed aldol recation on dioxanone 1a with benzaldehyde (2f, Scheme 2.4).
20
 The 
reaction resulted in mediocre yields of aldol adduct 3 with low diastereo- and 
enantioselectivities (cf. entry 1, table 2). This particular example showcased the need for 
developing the methodologicaly to maneuver the reaction conditions to perform 
stereoselective aldol reactions on the dioxanone scaffold. It was decided to probe the 
influence of the geometry of dioxanone on the selectivity, as well as the influence of steric 
and electronic effects of the acetonide moiety on the diastero- and enantioselectivity of 
proline-catalyzed direct aldol reactions. 
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2.3.1 Hypothesis: Rationale to enhance selectivity from CS-dioxanones 
 
In 2000 our group reported that the diastereoselectivity of aldol addition of 
dioxanone lithium enolates to aldehydes was influenced by the size of the substituents R1 
and R2 at the C-2 position of the dioxanone ring.
16
 Here it was designed to explore the 
steric aspects of dioxanone run under organocatalytic conditions. An understanding of the 
mechanistic aspects of the proline-catalyzed aldol reaction involving dioxanones could be 
fundamental in development of the efficient aldol transformation. As discussed in Chapter 
1 (cf. Figure 1.5 and also Scheme 2.3 below), the proline moiety in the enamine 
intermediate 65 acts as the chiral auxiliary in dictating the stereochemistry of the 
corresponding aldol adduct (3). In general, the si-face of the enamine (65) reacts with the 
re-face of the aldehyde to produce the anti-aldol adduct as the major product.  
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Scheme 2.3. 
An interesting aspect of dioxanone chemistry is that the enamine 65 presumably exists in 
the half-chair conformation (71, Scheme 2.3). The presence of a bulky group (e.g. R1 = 
tert-butyl) at C-2 position “locks” the conformer, placing the bulky group in the equatorial 
position. It was speculated that, depending on the nature of R2 group in structure 71, there 
might be a high probability of blocking the re-face of the enamine. This would increase the 
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prospect for electrophilic addition from the bottom si-face of the enamine resulting in 
higher diastereoselectivity. 
2.3.2 Dioxanone structure and stereoselectivity of aldol reactions 
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Scheme 2.4. 
 
Table 2: Structural effects of dioxanone on proline-catalyzed aldol reactions 
  
Entry 
Dioxanone 
(1eq) 
Aldehyde 
(1.05 eq) 
Isolated 
yield (%) 
dr 
a
 
(anti:syn) 
er (anti) 
1 1a 2f 54 67 : 33 84 : 16
 b 
2 1b 2f 65 94 : 06 80 : 20
 b 
3 1c 2f 72 98 : 02 82 : 18 
b 
4 1a 2g 21 60 : 40 - 
5 1b 2g 30 95 : 05 84 : 16
c 
6 1a 2h 27 62 : 38 70 : 30 
7 1b 2h 61 85 : 15 77 : 23 
8 1a 2c 54 90 : 10 - 
9 1b 2c 46 84 : 16 - 
     
a
- Determined by 
1
H NMR of the crude product; 
b
- enantiomeric excess for the anti product using Eu(hfc)3 
as the shift reagent; 
c
- Determined by chiral-phase HPLC analysis on Chiralpak-IB column. 
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After initial screening for best solvent and other reaction conditions for proline-
catalyzed aldol reaction, running the reaction at 5 
o
C using DMSO as the solvent proved to 
be the superior choice. The summary of results obtained from the study of dioxanone 
symmetry on diastereoselectivity of the (S)-proline-catalyzed aldol reactions is shown in 
Scheme 2.4 and Table 2.   
In search for the best starting material four dioxanone substartes (1a-d, Scheme 2.4) were 
investigated. 2-tert-Butyl-2-methyl-1,3-dioxan-5-one (1b) has a plane of symmetry and 
belongs to the Cs symmetry point group. The (S)-proline catalyzed aldol reaction of achiral 
dioxanone 1b with benzaldehyde (2f) resulted in the corresponding β-hydroxy ketone in 
63% yield. During this transformation three new stereogenic centers were formed and eight 
stereoisomers were possible. Interestingly, this reaction proved to be highly 
diastereoselective in comparison with the similar reaction with a higher symmetry (C2v) 
dimethyl dioxanone 1a (cf. Table 2 entry 2 vs entry 1; de increased to 88% from 34%).  
Based on this initial result further screening was carried out on various dioxanone 
substrates (1a-d) and aldehydes (Table 2). The results from this study supported the initial 
hypothesis that the presence of a bulky group at C2 of the dioxanone indeed “locks” the 
conformation of the reactive enamine intermediate and the methyl group blocks the top 
face of the enamine thereby enhancing the stereoselectivities into synthetically useful 
range. Dioxanones 1c did not offer significant advantages over compounds 1a and 1b, 
moreover the spectral data of the aldol adducts of the former compounds were much 
simpler to analyze.  
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2.3.3 Dioxanones: Unusual chemistry 
 
Dixanones are deceptively simple heterocyclic ketones. As discussed in Section 
1.3, the unusual electrophilicity of dioxanones and their reactivity resembles the aldehydes 
rather than ketones. Another anomaly related to dioxanone chemistry is the equatorial 
addition of electrophiles to the reactive dioxanone enamine or enolate intermediate. This 
observation is contrary to the well known Evans‟ model for stereochemical considerations 
of similar transformations on enolates of cyclic ketones such as cyclohexanone.
133
 
Attempts to rationalize this unusual phenomenon are shown in Scheme 2.5: 
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Scheme 2.5. 
The tert-butyl group present in dioxanone 1b was employed as a reference group for the 
explanation of the unusual electrophilic addition. In the above reaction, if the electrophilic 
addition onto the enolate or enamine of dioxanone 1b occurs in cis-relation to the tert-
butyl group that result in compound 245 as the major product. This approach leads to the 
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higher energy twist-boat conformation 246, which then equilibrates to the chair conformar 
247. In contrast, Evans‟ analysis of similar reactions involving carbocyclic enolates 
requires that the electrophiles approaches from an “axial trajectory” which was explained 
by stereoelectronic effects thereby positioning the incoming electrophile and the tert-butyl 
group trans to each other as shown in structure 244. This approach leads directly into the 
chair conformer of the product.  
A plausible explanation for the “dioxanone anomaly” can be proposed based on analyzing 
the half-chair conformation of the reactive enolate or enamine intermediate 71.  The bulky 
tert-butyl at C-2 position locks the conformer placing methyl group in pseudoaxial 
position. If the electrophile approaches from the re-face of enamine (as commonly seen in 
simple cyclic enolates) then the half-chair enamine tends to evolve to a stable chair-like 
conformer 248.  If electrophilic addition occurs from the bottom si-face of the enamine, 
which eventually releases the half-chair conformer into a higher energy twist-boat 
conformation 246.   
   
O O
O OH
O
O
40
protected D-tagatose
 
Figure 2.2 Crystal structure for protected D-tagatose
14
 (Reproduced with permission of the 
publisher) 
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Examination of the literature for evidence of the existence of dioxanone derivatives in the 
twist-boat conformation revealed that Barbas and coworkers
14 
published a crystal structure 
data for D-tagatose derivative 40 obtained from the proline-catalyzed aldol reaction of 
dioxanone and protected D-glyceraldehyde (2c).
 
The crystal structure in Figure 2.2 clearly 
shows that the dioxanone moiety in this aldol adducts predominantly exists in the twist-
boat conformation.  
2.4 Effect of Additives on Organocatalytic Aldol Reactions of 
Dioxanones 
 
During the optimization of reaction conditions, Niewczas observed that the 
presence of mild additives such as lithium chloride (LiCl, a weak Lewis acid) and 
pyridinium-p-toluenesulfonate (PPTS, Brønsted acid) enhance the enantioselectivity of 
proline-catalyzed aldol reactions of C2-symmetrical dioxanones 1a.
12
 Based on this 
information, I started to investigate the question whether mild acid additives have a similar 
effect on aldol transformations involving CS-symmetrical dioxanone 1b. In this context, a 
study was initiated to evaluate the effect of additives such as lithium halides, and also 
CsCl, CeCl3, ZnCl3, and AlCl3 on proline-catalyzed aldol reactions.  
2.4.1 Hypothesis 
In 2004, List et al. reported the detection of oxazolidinone derivatives in the NMR 
based mechanistic studies on the proline-catalyzed aldol reaction of simpler ketones and 
aldehydes.
55
 In that study it was inferred that iminium ions, as well as enamine and 
oxazolidinone species are involved in the catalytic cycle in which all steps are reversible. 
The stabilities of oxazolidinones are superior in comparison to their iminium or enamine 
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carboxylic acid isomers; this factor shifts the equilibrium towards the oxazolidinones. List 
reported that the formation of oxazolidinones in the proline-catalyzed aldol reaction is a 
“parasitic process” and reasoned it to be the cause for long reaction times and low yields 
often observed in this type of reactions. Later Seebach, a pioneer in oxazolidinone 
chemistry
134
 expressed an alternative view on oxazolidinone species.
58
 In a review article, 
he evaluated the relative stability of oxazolidinones towards non-aqueous acids and bases. 
It was observed that the stable oxazolidinone ring can be opened by stirring these 
compounds with mild Lewis acid such as LiBr-saturated solution of deuterated THF.  
Upon extrapolation of these concepts to proline-catalyzed aldol reactions of dioxanones 
and based on initial observations made in our laboratory by Niewczas, the following 
rationale was proposed (Scheme 2.6):  
O O
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R1R2
CO2
H
O O
N
R1R2
H
O
O
iminium ion oxazolidinone
64 68
O O
N
R1R2
CO2
H
iminium ion
249
THF (D8)
LiBr
Li
Br
  
Scheme 2.6. 
The iminium intermediate 64 in the dioxanone-proline catalytic cycle can equilibrate to the 
corresponding enamine or to the more stable oxazolidinone 68. The reactions carried out in 
the presence of lithium halide salts are expected to have the equilibrium shifted towards 
double salt iminium intermediate 249 which can readily tautomerize to the corresponding 
chiral enamine, a reactive species in the catalytic cycle.  
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Pihko and his colleagues observed that water as an additive proved to be beneficial to 
stereoselectivities in numerous reactions,
135
 indicating that the deliberate addition of water 
has positive effect on the stereoselectivity of the proline-catalyzed aldol reactions.  
 
2.4.2 Effect of additives on the selectivity of proline-catalyzed aldol reactions 
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Scheme 2.7. 
 
 
The following section elaborates on the effect of additives on proline-catalyzed 
aldol reactions of dioxanone substrates. After securing the initial results from the previous 
project, I screened various aldehydes in proline catalyzed aldol reaction of 2,2-
disubstituted-1,3-dioxan-5-ones in the presence of different additives as shown in Scheme 
2.7. The summary of the results obtained in this study is shown in Table 3. 
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Table 3: 
 
Effect of additives on proline-catalyzed aldol reactions of dioxanones 
Entry 
Dioxanone Aldehyde 
(1eq) 
Additive 
(1eq) 
Isolated 
yield  
(%) 
dr 
a
  
(anti : syn) 
er  
(anti) R1 R2 
1 Me Me 2f - 54 67 : 33 84 : 16
 b 
2 t-Bu Me 2f - 63 94 : 06 80 : 20
 b 
3 t-Bu Me 2f LiCl 72 98 : 02 84 : 16
 b 
4 t-Bu t-Bu 2f PPTS (0.3eq) 71 95 : 05 92 : 08
 b
 
5 Me Me 2g - 21 60 : 40 - 
6 Me Me 2g LiCl 33 75 : 25 - 
7 t-Bu Me 2g - 30 95 : 05 84 : 16
 c
 
8 t-Bu Me 2g LiCl 37 97 : 03 88 : 12
 c
 
9* t-Bu Me 2g - 32 92 : 08 44 : 56
 c
 
10 Me Me 2i - 18 67 : 33 - 
11 Me Me 2i LiCl 28 88 : 12 - 
12 t-Bu Me 2i - 30 90 : 10 - 
13 t-Bu Me 2i LiCl 44 94 : 06 - 
14 t-Bu Me 2j - 65 98 : 02 88 : 12
 d 
15 t-Bu Me 2j LiCl 71 98 : 02 98 : 02
 d 
16 t-Bu Me 2j PPTS 61 98 : 02 96 : 04
 d 
17 t-Bu Me 2j ZnCl2 46 98 : 02 86 : 14
 d 
18* t-Bu Me 2j - 54 98 : 02 52 : 48
 d 
19 CHX 2b - 72 98 : 02 82 : 18
 b 
20 CHX 2b PPTS 85 98 : 02 91 : 09
 b 
21 CHX 2b PPTS (0.3 eq) 88 98 : 02 92 : 08
 b
 
22 CHX 2b LiCl 86 98 : 02 96 : 04
 b 
a
 Determined by 
1
H NMR of the crude product; 
b
 enantiomeric excess for the anti product using Eu(hfc)3 as 
the shift reagent: 
c
 Reaction time 72 hr & er determined by chiral-phase HPLC analysis on Chiralpak-IB 
column.  
d
 measured by HPLC using Chiralpak-AD column on the 3,5-dinitrobenzoate derivative. * aldol 
reaction using DL-Proline to get a racemic sample for comparison. CHX= cyclohexanone derivative 
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Reactions with out additives (Table 3, entry 2) proceeded with the diastereoselectivity (anti 
: syn) of 94 : 06 and the enantiomer ratio of 80 : 20 (absolute stereochemistry of the major 
product was as drawn in Scheme 2.7 for stereochemical assignments cf. page 120). Note 
that a similar transformation carried out by Niewczas, using the symmetrical 2,2-dimethyl-
1,3-dioxan-5-one (1a, entry 1) resulted in the aldol adduct having low d.r. (67 : 33) and 
similar ee. Thus, switching from dioxanone 1a to 1b substantially improved 
diastereoselectivity (de change of 34% to 88%). In most of the proline-catalyzed aldol 
reactions of dioxanones, addition of equimolar amounts of Brønsted acid p-
toluenesulphonate (PPTS) or lithium chloride proceeded with higher enantioselectivities 
and better yields in comparison with the reactions carried without those additives (cf. 
entries 2 vs 4; 14 vs 15; and 19 with 22). 
Although an array of additives was screened, I have limited to the experiments that showed 
some distinctive effect on the selectivity. In general, the selectivities of reactions involving 
aliphatic aldehydes proved to be higher than reactions involving the aromatic aldehydes, 
which is a general trend in organocatalysis. The enantiomeric excess values for aliphatic 
aldol products without any chromophores (entries 14 to 18), were measured by chiral-
phase HPLC analysis of the corresponding 3,5-dinitrobenzoate derivatives.
  
Based on the preliminary work carried out by Niewczas and through the focused 
methodological studies discussed in the previous sections, we were in possession of a set 
of reaction conditions for the proline-catalyzed „first aldol‟ (cf. Scheme 2.1) reactions on 
dioxanones that looked promising for use in synthesis of polyoxygenated natural products.  
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2.4.3 Enantiomeric excess measurement by HPLC and NMR methods 
O O
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S
S
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R2R1 R1 R2
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5 °C
Additive (1 eq)
S
S CHO
+
1 2b 250  
Scheme 2.8. 
Table 4:  Validation of enantiomeric excess by HPLC and NMR techniques 
a
- determined by chiral-phase HPLC analysis on Chiralpak-AD column.  *entry 12: Aldol reaction using DL-
proline to get the racemic sample. 
 
To have an insight into the accuracy of enantiomeric excess measurements by 
NMR using shift reagent the following brief study was carried out: The aldol adduct 250 
from dioxanone 1 and 1,3-dithiane-2-carboxaldehyde 2b was chosen as the model system 
(Scheme 2.8). The two enantiomers had good separation on the Chiralpak-AD column and 
also a well resolved 
1
H NMR spectrum of the enantiomeric aldol adducts 250 using 
Eu(hfc)3 as a shift reagent in C6D6 as solvent. The measurements of ee by both methods are 
summarized in Table 4. Based on the data obtained from this exercise it can be inferred 
that, although the NMR method is time consuming, with proper choice of shift reagent and 
S.No R1 R2 Additive 
Yield % 
(column 
purified) 
dr 
(1H NMR 
of crude) 
anti : syn 
er 
anti  product 
(using Eu(hfc)3 as 
a shift reagent) 
HPLC 
measurements 
RT 
(minutes) 
er
 a
 
1 Me Me - 96 98 : 02 77 : 23 ± 2 47.2 : 51.6 81 : 19 
2 Me Me LiCl 92 98 : 02 97 : 03 47.8 : 52.4 98 : 02 
3 t-Bu Me - 74 98 : 02 24 : 76 31.7 : 35.7 22 : 78 
4 t-Bu Me PPTs 81 98 : 02 11 : 89 31.5 : 35.6 15 : 85 
5 t-Bu Me LiCl 84 98 : 02 09 : 91 ± 1 31.7 : 35.9 11 : 89 
6 t-Bu Me LiF 68 98 : 02 17 : 83 32.0 : 36.2 18 : 82 
7 t-Bu Me LiBr 71 98 : 02 23 : 77 32.1 : 36.4 20 : 80 
8 t-Bu Me LiI 64 98 : 02 17 : 83 31.9 : 36.0 19 : 81 
9 t-Bu Me CsCl 78 98 : 02 19 :81 31.9 : 35.9 20 : 80 
10 t-Bu Me CeCl3 76 98 : 02 11 : 89 31.8 : 35.9 15 : 85 
11 t-Bu Me ZnCl2 53 98 : 02 23 : 77 31.3 : 35.6 21 : 79 
12* t-Bu Me - 73 98 : 02 52 : 48 30.8 : 34.9 51 : 49 
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solvent it is possible to get an accurate enantiomeric excess measurements as it is possible 
by chiral HPLC based analytical methods (Table 4). 
2.5 Organocatalytic syn-aldol reactions of dioxanones 
Another objective of the initial methodological studies was to investigate reaction 
conditions to obtain syn-aldol products preferentially on dioxanone substrates. This was an 
ambitious project, as the literature records no methodologies to obtain syn-selective aldols 
on dioxanones, despite significant progress made this area of chemistry (Scheme 2.9a). It 
should be noted, however, that Mannich and Michael addition on dioxanone yielded syn-
configuration in its products.
25,28,29
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Scheme 2.9. 
 
Be it a coincidence or intuition, as a part of ongoing efforts to come up with a set of 
conditions to perform syn-selective aldol reactions on dioxanone, I observed a “syn-like” 
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product in one of the proline-catalyzed aldol reaction of dioxanone with the hydrated form 
of aldehyde.
136
 The configuration across the newly formed carbon-carbon bond of the aldol 
adduct was assigned based on the observed small J-coupling constant between the two 
adjacent CH(O) protons. This led to a hypothesis that the „hydrated form of an aldehyde‟ 
might result in a syn-aldol adduct. In order to confirm this observation, dioxanone (1b) was 
subjected to proline-catalyzed aldol reaction with readily available chloral hydrate and 
bromoacetaldehyde hydrate (251, Scheme 2.9b). Both the reactions with hydrates resulted 
in respective syn-aldol adducts and especially the reaction with bromoacetaldehyde hydrate 
was perfectly clean and neat. The complete analysis of the major aldol product by 
1
H NMR 
and proton coupling constants (δ 5.9 ppm; J = 2.9 Hz for α-H) disclosed that the relative 
configuration of the newly formed bond was indeed syn and the major compound was 
found to be 252. Literature search revealed the existence of a precedent in a similar 
reaction involving cyclopentanone and chloral hydrate.
 
 
2.5.1.1  Syn-aldol with hydrates: stereochemical rationale 
The reversal of selectivity in proline-catalyzed aldol reactions of dioxanones with 
hydrated forms of aldehyde can be rationalized using Saito and Yamamoto‟s hypothesis of 
hydrogen-bond networking in the transition structures.
137,138  
Scheme 2.10 illustrates the 
possible hydrogen-bond networking between the hydrated form of aldehyde 253 and the 
proline moiety of the reactive dioxanone enamine 65. Upon sequential dehydration 
compound 253 releases the corresponding aldehyde with its si-face opened towards the si-
face of enamine. This type of facial selectivity might be the prime cause for the observed 
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syn-aldol products from the proline-catalyzed aldol reactions of dioxanone with aldehyde 
hydrates.  
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Scheme 2.10. 
 
2.6 Second Aldol Reactions on Dioxanones  
 
In the proposed approach to higher sugars and other polyoxygenated natural 
products double-aldol reactions at the α and α' carbons of the dioxanone scaffold play a 
pivotal role in constructing the densely oxygenated carbon chain architecture. Since 
performing the second part of the bis-aldol sequence using organocatalysis proved 
difficult,
139
 the second aldol was attempted with metal-mediated enolate chemistry. In our 
group, Izabella Niewczas hypothesized that starting materials having Lewis basic sites, 
such as oxygen atoms, should require excess amounts of LDA for enolization.
12,139
 She 
was able to develop reasonably efficient method for the second aldol reaction by using 
excess LDA.
139
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Scheme 2.11. 
 
Scheme 2.11 summarizes the “second aldol methodology”  starting from the protected 
aldol adduct 261 and using lithium or boron enolates with a variety of aldehydes, based on 
previous work from our group (Niewczas and Nowak). In the process, the reaction 
produces two new stereogenic centers from which four possible stereoisomers 262-265 can 
result. In summary, the experiments involving boron enolates, predominantly gave the 
anti-trans-anti isomer 263,
11,16
  whereas when excess amounts of the LDA base (3.3 eq) 
and of aldehydes (3 eq.) were used the anti-cis-anti isomer 262 and the anti-trans-anti 263 
isomer were obtained with variable selectivity (from ca 2:1 up tp 10:1 depending on the 
aldehyde).  
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2.6.1 Bis-aldol studies on CS-dioxanones  
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Scheme 2.12. 
As an extension of the bis-aldol approach, I decided to inspect whether the presence 
of the bulky tert-butyl substituent at the C-2 position of the dioxanone ring influences 
diastereoselectivity of the second aldol in a similar way to that observed and discussed 
during studies of the first aldol reaction. The study started from the standard silyl 
protection of the hydroxyl group in the aldol adduct 266 to give the silylated compound 
267, which was subjected to lithium base-mediated second-aldol reaction with 
benzaldehyde (2f) or 1,3-dithiane-2-carbaldehyde (2b) using excess base and excess 
aldehyde  to provide the crude aldol adduct 268. The TLC analysis showed three spots in 
each case and diastereoselectivity of the reaction was measured on the crude product. The 
major product in each case was separated by using flash chromatography, and was 
characterized and determined to be the anti-cis-anti aldol adduct 268a. The stereochemical 
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assignment of the configuration was based on the extracted coupling constants from the 
respective proton NMR spectra. The results are shown in Scheme 2.12 and Table 5. 
Table 5:
  
Double aldol reactions on dioxanone substrate 
Entry RCHO Yield (%) 
Product ratio 
a 
268a : 268b 
1* 2b 74 87 : 13 
2 2b 71 79 : 21 
3* 2f 99 84 : 16 
4 2f 57 75 : 25 
                      *
 similar reaction on 2,2-dimethyl dioxanone aldol adduct (Ref 12 ) 
                
a
 determined by 
1
H NMR of the crude product 
 
Depending on the C-2 substituent in the starting dioxanone, the diastereoslectivity of the 
second aldol reaction varied (cf. Table 5, entries 1 vs. 2; and 3 vs 4). As previously 
discussed in Section 2.32, the substitution at C-2 position of dioxanone has significant 
effect on diastereoselectivity of proline-catalyzed aldol reactions of dioxanones.  In 
contrast, the presence of a bulky substituent at C2 decreases diastereoselectivity of the 
second, lithium enolate-mediated aldol reaction. This observation seems to suggest a 
dissimilar nature of the transition states involved in the first and second aldol reactions. 
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2.7 Building Carbohydrates on Dioxanone Scaffold 
 
 Encouraged by the promising results from the initial methodological studies 
described above, my next objective was to use the dioxanone methodology to develop a 
stereo-controlled approach to interesting natural products: iminosugars and higher 
monosaccharides. Examination of the literature revealed only a few synthetic strategies to 
access the rare higher monosaccharides. The enormous research scope and the need for 
development of new synthetic methodologies to access these biologically important 
compounds have been discussed in section 1.8 of the thesis. The aim of this project was to 
develop the stereoselective and practical dioxanone-based protocol towards the synthesis 
of rare and biologically important monosaccharides. Here, I thought of applying 
organocatalysis and organometallic mediated Cm + C3 + Cn strategy on dioxanone scaffolds 
to obtain the complex chiral architecture often found in those target molecules. 
In early 2000, Majewski and Nowak published a milestone article on the dioxanone 
route to monosaccharide derivatives.
16
 Later in that decade, various researchers have 
followed up with numerous reports and reviews describing the usefulness of dioxanones as 
scaffolds for synthesis of lower monosaccharides.
8-28 
The following sections of this thesis 
are intended to portray the successful synthetic applications accomplished via the 
dioxanone methodology. 
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2.7.1 Dioxanone route of 1-deoxyiminosugars 
 
The first synthetic target was to use the dioxanone scaffold towards synthesis of 
naturally occurring 1-deoxyiminosugar molecules. Iminosugars are natural piperidine 
amino sugars (i.e. 5-amino-5-deoxyaldohexoses) and their corresponding 1-deoxy 
derivatives, are a class of monosaccharide with the nitrogen atom in place of the ring 
oxygen of the corresponding carbohydrate. As discussed earlier (section 1.6), the chemistry 
of iminosugars have attracted the synthetic community‟s attention as this class of 
compounds comprises some potent glycosidase inhibitors as well shown promising drug 
profiles and wide-ranging biological activities.
93
 1-Deoxynojirimycin (DNJ, 146) is a 
glucosidase inhibitor and N-butyl-deoxynojirimycin (Zavesca® 153), is a prescription drug 
for treatment of mild type 1 Gaucher disease as well as a promising HIV inhibitor.
94
  Due 
to their promising medicinal profiles, a large number of strategies have been developed for 
their syntheses.
96-99
 Most recently, Mayoralas et al have reported an organocatalytic 
dioxanone route to homonojirimycin compounds.
 99
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Figure 2.3: Selected examples for piperidine aminosugars  
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Inspired by Nature‟s approach to 1-deoxyiminosugars, I proposed a simple synthetic 
protocol to access L-1-deoxyidonojirimycin (L-DIJ, 269) N-isopropyl-DIJ 270 and L-1-
deoxymannojirimycin (L-DMJ, 271) via proline-catalyzed aldol reactions of isoserinal (2e) 
with dioxanone 1 (Scheme 2.13).
136
 
 
2.7.1.1 Retrosynthetic analysis for iminosugars 
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Scheme 2.13. 
 
The 1-deoxyiminosugar has four consecutive stereogenic centres from which sixteen 
stereoisomers are possible of which eight are dextro- and another eight are levorotatory 
isomers. To till date, only four stereoisomers have been isolated from plants and 
microorganisms. Many synthetic methodologies were reported to access stereoisomers of 
1-deoxyiminosugars and more importantly many of them showed promising biological 
properties.
140,141
 
A generic retrosynthetic analysis
142 
(Scheme 2.13) shows that the monocyclic 1-
deoxyiminosugar 272 skeleton could be fragmented into simple and readily available 
starting materials such as dioxanone (1) and protected isoserinal (2e) using simple aldol 
reactions and intramolecular reductive amination retrons. Thinking in the forward 
direction, the four stereogenic centres of an iminosugar can be incorporated as follows: the 
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stereochemistry on carbon-2 can be translated from isoserinal (2e); the first-aldol reaction 
of dioxanone 1 with aldehyde 2e would result in aldol adduct 273 fixing two stereogenic 
centers at carbon-3 and carbon-4. It was envisaged that the stereochemistry of compound 
273 can be controlled by employing (S)- or (R)-proline catalyst thereby switching two 
stereogenic centres respectively. Finally, the positioning of hydroxyl groups on the 
piperidine frame dictates the stereochemistry on carbon-5 via palladium-catalyzed 
reductive amination. Upon optimization and refinement of reaction conditions in the above 
sequence, the method has the potential to obtain all sixteen stereoisomers of 1-
deoxyiminosugars.  
As previously described, the literature records a number of aldol reactions involving 
dioxanones and a variety of aldehydes either under organocatalytic conditions or mediated 
by lithium or boron enolates.  In all cases the relative stereochemistry of the major aldol 
product was anti, and the diastereoselectivity (anti/syn) was good or excellent.  The 
simplicity associated with high selectivity of proline-catalyzed first-aldol reactions on 
dioxanones makes this method the most preferred. I hoped that it would be possible to 
broaden the scope of this strategy by manipulating the reaction conditions to perform 
selectively either the anti or the syn aldol transformation. 
During the screening for various conditions to perform proline-catalyzed syn-aldol 
reactions on dioxanone, surprisingly, I observed organocatalytic reaction of dioxanone 1b 
with an aldehyde hydrate resulted in the formation of only one product that appeared to be 
of syn relative configuration (cf., section 2.5). Chloral hydrate gave a similar result.
136,137 
This was a welcome development, because it allowed us to plan the synthesis of some less 
common deoxynojirimycin isomers.   
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2.7.1.2 Synthesis of (S)-isoserinal hydrate 
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Scheme 2.14. 
 
The necessary chiral building block for construction of nojirimycins, the protected 
(S)-isoserinal hydrate (283) was synthesized from the commercially available (S)-malic 
acid (274) following published procedures with substantial modifications (Scheme 2.14). 
(S)-Malic acid (274) was converted into (S)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-
yl)acetic acid (275) by acid-catalyzed ketalization with 2,2-dimethoxypropane (265). Thus, 
the hydroxy and carboxyl groups were protected in one step. The β-carboxy group was 
then transformed into acyl chloride 276 which upon treatment with sodium azide in 
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aqueous acetone at -20 °C resulted in acyl azide intermediate 277. The Curtius 
rearrangement of the acyl azide (277) afforded the corresponding isocyanate intermediate 
278 which upon boiling with aqueous hydrochloric acid yielded amino acid 279. Overall, 
(S)-isoserine hydrochloride (279) was synthesized in a three-step sequence in “one-pot” 
with 62% overall yield.
143 
 Amino acid 279 was transformed into the Cbz-protected (S)-
isoserinal 280 using the modified Schmidt protocol,
144, 145 
which upon stirring with p-
toluenesulfonic acid in methanol gave the the corresponding methyl ester 281. (S)-
Isoserine aldehyde (2e) was obtained from the methyl ester 281 via formation of the 
oxazolidine (282) followed by DIBAL-H reduction of the methyl ester.  
Protected (S)-isoserinal (2e) readily forms the corresponding hydrate 283. The IR spectrum 
of this compound showed the absence of the carbonyl and the presence of a broad peak 
corresponding to the hydroxyl functional groups (3540-3090 cm
-1
) that confirmed the 
existence of the (S)-isoserinal hydrate. Also, the proton NMR analysis showed a small 
signal for the aldehyde functional group (CHO) at the chemical shift of 9.7 (integration for 
0.23 proton), addition of triethylamine to the sample enhanced the aldehyde peak 
(integration of 0.62 protons) which implied that the equilibrium has shifted to the aldehyde 
form 2e. With the hydrate 283 in hand the stage was set for the organocatalytic aldol 
reaction. 
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2.7.1.3 Synthesis of N-isopropyl-L-1-deoxyidonojirimycin 
 
(S)-Proline-catalyzed aldol reaction of 2-tert-butyl-2-methyl dioxanone (1b) with 
(S)-isoserinal hydrate (283) gave the aldol adduct 284 in 69% yield and high 
diastereoselectivity (surprisingly, the syn-aldol adduct was the major product).  It should 
be noted that the total number of stereoisomers possible in this reaction are eight. The C-2 
substitution at the acetal stereogenic centre and also the cis arrangement of the largest 
groups on the dioxanone ring with respect to electrophile has been discussed earlier in 
section 2.4. The syn relative stereochemistry assignments of the aldol adduct was based on 
NMR studies carried out on this compound. The extracted coupling constants from proton 
decoupling experiments were i.e., peak at 4.47 ppm (d, α-CH, J = 3.0 Hz) for compound 
284 (for the full spectra and also 2D-NMR data see the experimental section). Based on the 
extensive NMR studies on compound 284 the absolute stereochemistry of the aldol-adduct 
is believed to be as drawn (Scheme 2.15).  
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Scheme 2.15. 
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At this stage, to be sure of the stereochemical assignment of compound 284, I decided to 
perform the classical chemical correlation method by transforming the aldol adduct 284 
into natural 1-deoxyiminosugar. 
Our initial efforts of direct transformation of the aldol adduct 284 to the corresponding 
iminocyclitol 269 via hydrogenolysis of the Cbz group proceeded with spontaneous 
deprotection of benzyloxycarbonyl group along with reductive ring opening of oxazolidine 
to the N-isopropyl derivative 286. This was an unexpected result, but it should be noted 
that similar observation was made in one instance by Falb during synthesis of chiral 
pyrrolidines for glycosidase inhibition studies.
146
 Compound 286 upon treatment with 1N 
HCl underwent deketalization followed by reductive amination/cyclization that resulted in 
N-isopropyl- L-idonojirimycin (270) in 82 % yield.  The compound was fully 
characterized as the tetraacetate derivative 287. The synthesis and characterization of the 
unnatural derivative N-isopropyl-DIJ was carried out for first time, and thus there was no 
literature data to correlate and confirm the stereochemical assignment made for the syn-
aldol adduct 284. The interesting aspect to note is, as most of the N-alkyl derivatives of 1-
deoxynojirimycin are known to be biologically active compounds for numerous disease 
targets, the new protocol gives an access to N-isopropyl derivatives of 1-
deoxyiminosugars.  
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2.7.1.4 Synthesis of L-1-deoxyidonojirimycin 
 
To obtain the free 1-deoxyiminosugar (no alkyl group on nitrogen) I decided to 
shuffle the deprotection sequence (Scheme 2.16).  One-pot hydrolysis of the acetal moiety 
and the oxazolidine ring of the aldol adduct 284 was carried out with catalytic amount of p-
toluenesulfonic acid in methanol and was followed by Cbz deprotection via palladium 
catalyzed hydrogenation, followed in turn by an in situ cyclization and reductive amination 
of intermediate 288 to give the tosylate salt of 1-deoxy-L-idonojirimycin (269). This C5-
epimer of 1-deoxynojirimycin was obtained in 66% overall yield and high 
diastereoselectivity. The reaction mixture was converted into the acetate derivative for 
complete characterization. The analytical data of tetraacetate derivative 288 were an exact 
match with the literature data
147
 which confirmed the stereochemical assignments for 
compounds shown in Scheme 2.16 
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Scheme 2.16. 
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Scheme 2.17 illustrates the stereochemical rationale for the intramolecular reductive 
amination of ketoamine 288 to give L-1-deoxyidonojirimycin. The ketoamine readily 
forms the cyclic hemiaminal, which, upon dehydration produces the imine intermediate. 
Finally, the positioning of hydroxyl groups on iminium piperidine frame dictates the 
stereochemistry on carbon-5 via palladium-catalyzed reductive amination.
148
 Reduction of 
the imine could occur from the si-face of the double bond would result in 1-DNJ 146, but 
the double bond was reduced from the re-face to afford L-DIJ 269. 
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Scheme 2.17. 
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2.7.1.5 Synthesis of L-deoxymannojirimycin 
 
D-1-Deoxymannojirimycin (the C2-epimer of DNJ), isolated from Lonchocarpus 
sericeus is an inhibitor of α–D-mannosidase, α -D-glucosidase and  α -L-fucosidase.149 To 
eliminate any uncertainties in stereochemical assignments of the compounds produced in 
the above protocol, similar transformations were carried out on compounds 1b and 283 via 
D-proline-catalyzed aldol reactions to yield the complementary syn-aldol adduct 290. The 
syn relative stereochemistry assignments of the aldol adduct 290 was based on NMR 
studies. The extracted J-coupling values from proton decoupling experiment for a peak at δ 
4.20 ppm (d, α-CH, J = 2.3 Hz) supported the syn connectivity.  
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Scheme 2.18. 
Repeating the deprotection/hydrogenation protocol on compound 290 gave the tosyl salt of 
L-deoxymannojirimycin. The crude tosyl salt was passed through the cation exchange 
resin Amberlite IR 120 to obtain the hydrochloride salt of L-1-deoxymannojirimycin 
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(271). The optical rotation, melting point values and NMR data for compound 271 were in 
good agreement with the previously reported data.
150 
In summary, L-deoxyidonojirimycin (269), N-isopropyl-L-deoxynojirimycin (270), and L-
deoxymannojirimycin (271) were synthesized from readily available dioxanone (1b) and 
(S)-isoserinal hydrate (283) in short sequences of reactions. The key step involved the 
proline-catalyzed syn selective direct aldol reaction. Also, I was able to establish the 
absolute stereochemistry to the aldol adducts 284 and 290 by correlation with known 
natural products L-DIJ and L-DMJ.
136
 
2.7.2 Stereoselective synthesis of (+) D-glycero-D-manno-2-octulose  
My next synthetic target was D-glycero-D-manno-2-octulose (292), a higher-
carbon sugar found in opium poppy seeds (Papaver somniferum L.)
151
 Several synthetic 
approaches were developed over the years to access such higher ketoses.  The majority of 
the methodologies employed pentoses or hexoses as starting materials and homologation or 
coupling as the strategy.
152
 Dondoni has extensively studied one-carbon sequential chain-
elongation of lower monosaccharides
153
 and Jarosz
154
 tail-to-tail coupling methods are 
common routes towards the higher ketoses. 
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Figure 2.4: Synthetic target (+)-D-glycero-D-manno-2-octulose 
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Dioxanones have proven to be good substrates for reactions involving organocatalysis and 
several studies on the proline-catalyzed stereoselective transformations of dioxanones were 
reported, including syntheses of ketohexoses and some higher sugars.
8-16
 Below, I describe 
observations pertaining to stereocontrolled synthesis of higher sugars from dioxanones via 
proline-catalyzed aldol reaction as the key step.
155
 
 
 
2.7.2.1 Total dioxanone approach to ketooctulose 
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Scheme 2.19: Retrosynthetic plan to ketooctulose starting from dioxanones 
The retrosynthetic scheme 2.19 illustrates the synthetic strategy towards the target 
higher monosaccharide 292.  It was visualized that the synthesis of a ketooctulose can be 
viable from two dioxanone units coupled together with one equivalent of glyoxal (2p).  
Hypothetically, the above sequence could be done either in "one pot" or stepwise, by 
manipulation with numerous protecting groups.
12
 Upon optimization of reaction 
conditions, this strategy could lead to the stereoselective synthesis of any desired isomer; 
in order to achieve that, the control of absolute and relative stereochemistry would be 
necessary. The previous work on dioxanones involving enantioselective deprotonation, as 
discussed in introduction to this thesis, combined with the observations made during the 
initial methodological studies on organocatalysis made me optimistic as to the potential for 
enantioselectivity control.  The extensive literature related to diastereoselectivity control in 
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aldol chemistry, indicated that it should be possible to control relative stereochemistry of 
aldol adducts from dioxanones. The underlying principle was to develop a dioxanone-
based versatile synthetic strategy which ultimately would allow synthesis of several 
ketooctulose stereoisomers (ideally all 32 of them).  In the preliminary study, I have 
focused on synthesis of D-glycero-D-manno-2-octulose which is one of the natural 
products found in opium poppy.
151
 
Initial experimental efforts to perform a "one pot" approach were unpromising.  Then I 
directed my attention to the stepwise approach i.e.  C3+ (C2 + C3). The synthetic plan was 
to treat dioxanone 1 with glyoxal (2p) to obtain five-carbon fragment, which upon 
coupling with another equivalent of dioxanone would give the eight-carbon skeleton of the 
target ketooctulose 292.   
 
2.7.2.2 Synthesis of the protected D-ribose building block 
1,3-Dithiane-2-carboxaldehyde (2b) was used as a synthetic equivalent of glyoxal 
in the first, organocatalytic step.  It should be noted that this aldehyde works well in 
organocatalytic reactions, as reported by other groups.
27b,156
 Aldol adducts 250 were 
obtained stereoselectively and in good yields. In the next step various reducing agents were 
screened; the best result was obtained by using NaBH(OAc)3 at -20 °C to produce the syn-
1,3-diol product 294 in high yield and with excellent diastereoselectivity (98:02).  This 
interesting (note syn selectivity and not anti that might have been expected) result was in 
agreement with reports by both Barbas,
14
 and Enders.
20
  The hydroxyl groups in the 
reduced product were protected as methyl or benzyl ethers using standard conditions 
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giving the protected form of D-ribose where the thioacetal group masked the aldehyde 
functionality. 
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Scheme 2.20.  
  In order to unmask this group compound 296 was first subjected to oxidative hydrolysis 
conditions using several different protocols (HgCl2/HgO, I2/NaHCO3, Dess-Martin 
periodinane) but the reaction gave a mixture of products in each case.  Fortunately, Corey‟s 
protocol
157
 (NBS/AgNO3 in aqueous acetonitrile) gave cleanly aldehyde 298, a protected 
form of D-ribose. The oxidative hydrolysis was complete within 5 minutes at 0 °C with 
moderate yields of 60-70%. This reaction spontaneously generates hydrobromic acid 
which could potentially destroy the dioxanone ring. The aldehyde 297 turned out to be a 
volatile compound which appeared to co-distill with the solvents during the workup 
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procedure. The dibenzylated aldehyde 298 worked well in the aldol reaction as well as it 
proved to be more convenient to handle.  
   
O O
OH
t -Bu Me
OH
S
S
294b  
Figure 2.5: ORTEP diagram for compound 294b 
To eliminate any uncertainties in stereochemical assignments we needed a crystalline 
derivative.  Thus, we prepared compound 294b from tert-butylmethyl dioxanone (1b) by 
an analogous approach (Scheme 2.20).  Only one diastereoisomer of the aldol was detected 
by NMR spectroscopy in this case.  Fortunately, the corresponding reduction product 294b 
was crystalline and provided us with a crystal structure confirming the cis-anti 
stereochemistry of the aldol and the syn-arrangement of the two hydroxyl groups in the 
reduced aldol (Figure 2.5). It should be noted that Evans hypothesized that the bulky 
reducing agents reduce cyclic β-hydroxy ketones to anti-diols as a major product.162 The 
formation of syn-diols was an interesting observation as it contradicts the broadly 
successful Evans protocol. Similar observations were made by Enders and co-workers 
during the reduction process of dioxanone aldol adducts.
20
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2.7.2.3 Synthesis of (+)-D-glycero-D-manno-2-octulose 
 
With the aldehyde reagent 298 in hand the stage was set for the key aldol reaction.  
We have used organocatalytic conditions and two different dioxanones as the nucleophiles.  
The results are summarized in Table 6. 
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Scheme 2.21. 
Table 6: Proline-catalyzed aldol reactions of 2,2-disubstituted-1,3-dioxan-5-ones. 
Entry 
Dioxanone  Additive 
a
 
 
Conversion 
a
 
(%) 
Yield (%)
b
 
299 
dr 
a
 
299 : 300 
R1 R2 
1 Me Me - 92 42 67 : 33 
2 Me Me LiCl 88 51 88 : 12 
3 t-Bu Me - >98 56 90 : 10 
4 t-Bu Me LiCl 94 69      94 : 06 
a
 Determined by 
1
H NMR of the crude product. 
b
 After column chromatography  
As expected, the reaction gave two different diastereoisomeric aldols (299 & 300) and, less 
expectedly, the corresponding dehydration product (301).  The aldol product 299 (Scheme 
2.21) with an eight-carbon skeleton and the desired stereochemistry seen in the target 
compound was obtained from (S)-proline-catalyzed aldol reaction of 2,2-dialkyl-1,3-
dioxan-5-one (1) with the protected form of D-ribose 298. This was a good example which 
showcases the importance of steric effects on the diastereoselectivity of enamine-mediated 
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organocatalytic aldol reactions (cf. entry 1 vs. 3). The reaction involving 2-tert-butyl-2-
methyl-1,3-dioxan-5-one (1b, achiral) with aldehyde 298 resulted an aldol product 299 in 
69% yield with excellent diastereoselectivity (94:06). The similar transformation, using the 
C2-symmetrical dioxanone was non-diastereoselective (67:33). Thus, switching from the 
C2- to the CS-symmetrical dioxanone has substantially improved diastereoselectivity (de up 
to 92% from 34%). As observed before, mild Lewis acid additives such as LiCl showed 
enhanced effect on the diastereoslectivity (cf. entries 1 and 2, and 3 with 4) as summarized 
in Table 6. 
At this stage, the stereochemical assignments for aldol adducts 299 were based on the 
extensive NMR analysis and also by analogy to previously synthesized compounds. The 
absolute stereochemistry of compounds 299 and 300 was believed to be as drawn based on 
the following reasons:  
i. Aldol addition of dioxanones to aldehydes under organocatalytic conditions is well 
known to give anti aldols with high selectivity
8,9,14,132
  
ii. Aldol addition of dioxanone enolates proceeds via equatorial attack,16 and  
iii. Addition of dioxanone nucleophiles to chiral aldehydes having a stereocentre at the 
a carbon does not follow the Felkin-Anh model
158
 and results in the OH group at 
the new carbinol stereocentre being syn to the α-alkoxy group derived from the 
aldehyde.
16
  
The final deprotection of the aldol product 299 was carried out under acidic conditions (2N 
HCl solution in THF) to provide the eight carbon monosaccharide 302, which readily 
undergoes intramolecular cyclization to form pyranose derivative 303 with the fixed 
stereochemistry of the target compound.  The compound 303 was subjected to standard 
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acetylation and was isolated and characterized as the acetate derivative i.e. the protected 
form of (+)-D-glycero-D-manno-α-oct-2-ulose 304 (25% overall yield in seven steps) as 
illustrated in Scheme 2.22.  
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303
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Scheme 2.22. 
In summary, a naturally occuring higher sugar (+)-D-glycero-D-manno-α-oct-2-ulose 292 
was synthesized in seven steps starting from commercially available dioxanone 1, with the 
key steps comprising two stereoselective aldol reactions catalyzed by proline and 
diastereoselective reduction of dioxanone aldol, illustrating the potential of this synthetic 
strategy.  The striking feature of this approach was that six of the eight carbons of the 
target ketooctulose came from the dioxanone scaffold. 
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2.7.3 Stereodivergent synthesis of DD- and LL- glycero-β-allo-Heptopyranoses 
2.7.3.1 Background and significance 
Aldoheptoses are an important class of higher monosaccharides (cf., section 
1.7.1.1). Naturally occurring aldoheptoses and deoxy-aldoheptoses (Figure 2.6) along with 
3-deoxy-D-manno-oct-2-ulosonic acid (185, Kdo) are chief components of the antigenic 
endotoxins of gram-negative bacterial lipopolysaccharides (LPS).
104,105 
Aldoheptoses 
contain six consecutive stereogenic centers on the seven-carbon skeleton. From the 64 
possible stereoisomers of aldoheptoses, six have been found in LPS. L-Glycero-D-manno-
heptose (179) was one of the first aldoheptose isolated from Shigella flexneri 
polysaccharide by Slein and Schnell,
106
 but only meager amounts of these heptoses are 
available from natural sources.  
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Figure 2.6 Structural components of gram-negative bacterial LPS and human liver tissue     
                  (Synthesis of 182 and 183 is described in the following section) 
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Low natural abundance and immunological importance of the aldoheptoses in LPS 
structure provoked considerable interest towards the development of new synthetic routes 
to obtain heptoses and their derivatives.
107,108 
In majority of the published cases, synthesis 
of higher manosaccharides relied on the classical methods of Kiliani-Fischer homologation 
of abundant lower monosaccharides like pentoses and hexoses.  Although these methods 
are straightforward they suffer from significant limitations such as side reactions and 
difficulty in isolation and purification of desired products from polar reaction mixtures.
118 
  
One of the ongoing projects in our laboratory is to explore the synthetic utility of 
dioxanones (1) in construction of rare, higher carbon-sugars and polyhydroxylated natural 
products. Dioxanone (1) has proven to be a valuable substrate for reactions involving 
organometallic and organocatalytic transformations in organic synthesis.
12,18,132,136,155 
The 
following section presents the recent finding pertaining to a stereodivergent synthesis of 
DD- and LL-glycero-allo-heptoses (182 and 183) higher sugars starting from readily 
available non-chiral aldehydes and dioxanone moiety.
159
  
The presence of D-glycero-D-allo-heptose (182) in the protein fractions of human liver 
tissue was first reported by Missale et al.
160
 In the year 1955 Pratt and Richtmyer described 
the first synthesis of D-glycero-D-allo-heptose (182) via homologation of D-allose.
161 
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2.7.3.2 Synthetic plan  
During recent studies aimed at developing new approaches to synthesis of higher 
carbohydrates, I became attracted to the possibility of construction of both enantiomers of 
an odd-carbon higher sugar from one symmetrical dioxanone precursor 1a and 
differentially protected glyoxals 2a and 2b. 
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HO
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S
S
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S
S
H
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C-3C-2 C-2
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OH OH
OH OHOH
H
O
H
O
meso-dialdehyde
306
1a 2a2b
Scheme 2.23. 
The sequence of unmasking the two terminal aldehydes in the key intermediate 307 
dictates which isomer of the carbohydrate will be produced. The control of stereochemistry 
rests in the choice of the method for discrimination between the two enantiotopic 
nucleophilic sites in the ketone (C4 or C6), the relative stereochemistry of both aldol 
reactions (syn or anti) and the disposition of both newly attached side chains on the ring 
(cis or trans). A combination of these elements such that 306 has CS symmetry would lead 
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to compounds 182 and ent-182 being enantiomers i.e., to a stereodivergent synthesis.  I 
have focused my attention on compound 307 which is a synthetic equivalent to the meso 
dialdehyde 306 and should be accessible by reduction of the corresponding double aldol 
derivative. Thus an aldoheptoses (182 or ent-182) could, in principle, be constructed from 
three building blocks: a dioxanone (1a) and two different synthetic equivalents of glyoxal 
(2a and 2b, Scheme 2.23).  
2.7.3.3 Proline-catalyzed aldol reactions of dioxanones and dimethoxyacetaldehyde 
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Scheme 2.24. 
The first step of the synthetic sequence was the known
 
(S)-proline-catalyzed aldol reaction 
of dioxanones 1a and 1b with 60% aqueous solution of dimethoxyacetaldehyde (2a) to 
afford the crude mixture of aldol aducts (Scheme 2.24).
14,20
 
20
 The 
1
H NMR interpretation 
of the major component of the reaction mixture revealed an unusually small coupling 
constants across the newly formed bond i.e δ 4.07 ppm (dd, J1 = 3.1 Hz, J2 = 6.8 Hz, 1H). 
This observation was in agreement with the previously published data by the groups of  
Barbas
14
 and Enders
20
 for the anti-aldol adduct 309a. 
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2.7.3.4 Stereochemical assignment of aldol adducts 
In order to eliminate the ambiguity of the above observation, I subjected two aldol 
adducts 309a and 309b to stereoselective reduction with NaBH(OAc)3 which led to the 
corresponding diols 311a and 311b respectively (Scheme 2.25). Again, the spectral data 
for 311a were in good agreement with the reported data;
14,20 
 however the 
1
H NMR 
coupling constants seemed to suggest the syn” aldol rather than the more usual anti aldol 
adduct. The relative stereochemistry between the two hydroxyls seemed to be anti. Similar 
observations were made by Enders and co-workers during the reduction process of some 
dioxanone aldol adducts.
20
 Later, Barbas correlated the reduced aldol adduct with naturally 
occurring D-ribose upon acid-catalyzed deacetylation.
14
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cis-diols       (reduction-axial attack)
cis-addition  (t-Bu & electrophile)
cis-diols
 anti-aldol reduction to cis diol
 
 
Scheme 2.25. 
 
To have an additional evidence for the stereochemical assignments, compound 311b was 
acetylated under standard conditions to give the diacetate derivative 312 (Scheme 2.26). 
The 
1
H NMR of the compound 312 was a well resolved spectrum which also showed a 
small coupling constant across the newly formed bond i.e δ 4.09 ppm (dd, J1 = 3.2 Hz, J2 = 
6.7 Hz, 1H).  
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Scheme 2.26. 
Fortunately, compound 311b was crystalline and provided us with a crystal structure 
confirming the absolute stereochemistry of 311b as protected form of D-ribose (313) i.e. 
having the cis relationship between the tert-butyl group and the newly formed C-C bond 
and being the anti aldol derivative with syn arrangement of the two hydroxyl groups in 
compound 311b (Figure 2.7). 
162 
 
 
Figure 2.7: ORTEP diagram for compound 311b 
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2.7.3.5 Acetal deprotection 
To gain further understanding of the underlying process, I subjected the diols 311a and 
311b to acid-catalyzed acetal hydrolysis which resulted in D-ribopyanose (313) as the major 
product (Scheme 2.27). Not only the spectral data of the product were an exact match with an 
authentic sample of D-ribose but also these results were consistent with observations made by 
Barbas
14
 (Entry 4, Table 7). Interestingly, a similar reaction under milder conditions (Entry 2, 
Table 6) resulted in partial hydrolysis of dimethoxyacetal functionality to afford methyl-D-
ribofuranoside (314). 
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O
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O
OMe
OHOH
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Scheme 2.27. 
 
Table 7. Deacetylation conditions on compound 311 and synthesis of ribose conformers 
entry reagent reaction conditions 
ratio of        
313 : 314 
major product 
anomer ratio 
βp : αp : βf : αf 
1 CF3COOH 
0 °C; CHCl3: H2O 
(3:1) 
100 : 0 
75 : 17 : 6 : 2 
2 CH3COOH 0 to 40 °C;  H2O 0 : 100 4 : 2 : 76 : 19 
3 CF3COOH 90 °C;  H2O 100 : 0 74 : 18 : 6 : 2 
4 
DOWEX 
50W2 
rt;  H2O 100 : 0 
74 : 18 : 6 : 2 
 
 101 
 
2.7.3.6 Synthesis of the masked dialdehyde intermediate 
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Scheme 2.28. 
Scheme 2.28 illustrates the synthesis of the chiral compound 318. It should be 
noted that 318 is a synthetic equivalent to the orthogonally protected meso dialdehyde 306. 
The CS-symmetry of the deprotected meso dialdehyde of 306 should, in principle, allow a 
stereodivergent synthesis of either enantiomers of the target aldoheptose (depending on 
which formyl group is ultimately reduced).  
The reaction sequence started with the standard tert-butyldimethylsilyl (TBS) protection of 
the hydroxyl group of the aldol adduct 309a to obtain the silylated aldol 315. The silyl 
compound 315 was then employed in a lithium base-mediated second aldol reaction with 
1,3-dithiane-2-carbaldehyde (2b) as the electrophile (reaction conditions developed in our 
laboratory),
139
 to provide anti-cis-anti aldol adduct 316 in 82% yield with excellent 
selectivity. Then stereoselective reduction of the aldol adduct 316 with NaBH(OAc)3 led to 
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the corresponding cis-1,3-diol product 317 in high diastereoselctivity and 85 % yield. The 
hydroxyl groups of compound 317 were protected as benzyl ethers using the standard 
conditions which resulted in orthogonally protected dialdehyde intermediate 318.  
2.7.3.7 Stereodivergent synthesis: DD- and LL-glycero-allo-heptoses 
The unmasking of the carboxaldehyde functionality embedded in compound 318 
played the central role in carrying out the stereodivergent synthesis of both enantiomers of 
glycero-alloheptose (Scheme 2.29). Corey‟s protocol157 using NBS/AgNO3 in aqueous 
acetonitrile resulted in dithiane hydrolysis of compound 318  to aldehyde 319 which was 
consequently reduced to form the alcohol 320 in 80% yield over 2 steps. The compound 
320 was subjected to one-pot acid-catalyzed acetal/ketal/TBS deprotection followed by 
acetylation to afford 322 with anomeric ratio 23 : 77 (α : β) and 87 % overall yield. Then 
the compound 322 was debenzylated under acid-catalyzed hydrogenolysis and acetylated 
to form hexaacetate- β-D-glycero-D-allo-heptopyranose (323) in 22 % overall yield in 
eleven-steps starting from dioxanone 1a. 
A similar approach was applied in synthesis of L-enantiomer ent-323. Intermediate 318 
was subjected to the sequence of dimethoxyacetal hydrolysis followed by reduction of the 
aldehyde group with NaBH4 to form the tetraol 324. Unfortunately, subsequent dithiane 
hydrolysis of the free tetraol 324 did not yield the desired aldehyde. In order to perform 
radical mediated dithiane hydrolysis, four hydroxyl groups of tetraol 324 needed to be 
protected using 2,2-dimethoxypropane and catalytic amount of p-TsOH.  
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Scheme 2.29. 
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Then dithiane hydrolysis of 325 resulted in aldehyde 326, which was subjected to acid-
catalyzed ketal deprotection followed by acetylation to afford compound 327 with an 
anomeric ratio of 14 : 86 (α : β) and 77% overall yield. Debenzylation of 327 under acid-
catalyzed hydrogenation followed by acetylation resulted in pure hexaacetate- β-L-glycero-
L-allo-heptopyranose (ent-323) in 20% overall yield in 13 steps starting from dioxanone 
(1). 
The optical rotation values for 323 and ent-323 (note opposite signs) were in good 
agreement with the previously reported data for D-glycero-D-allo-heptose.
161
 The exactly 
identical 
1
H and 
13
C NMR spectra for compounds 323 and ent-323 confirmed the 
stereodivergent synthesis of both the enantiomers of β-glycero-allo-heptopyranose. 
In summary, the two enantiomers DD- and LL-glycero-β-allo-heptopyranose (323 and ent-
323) were synthesized starting from commercially available dioxanone 1a in eleven- and 
thirteen-steps respectively, with 22 and 20% respective overall yields. This strategy is the 
first example of a stereodivergent approach to access “rare” aldoheptoses.  
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3 SUMMARY  
 
 
The primary objective of the thesis to expand dioxanone based methodology in 
synthesis of iminosugars and higher monosaccharides was successfully realized. The main 
synthetic tools are stereoselective aldol reactions of 2-substituted-1,3-dioxan-5-ones.  
Broadly the work presented in the thesis is classified into three projects: 
 Project I:   Organocatalytic aldol reactions of  C2v- and  CS symmetrical dioxanones 
 Project II:  Effect of additives on the proline-catalytic aldol reactions of dioxanones 
 Project III: Building carbohydrates on the dioxanone scaffold 
H Rn
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OH
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Enzymes
Organocatalyst
O O
O
Rn
OH
* *
OH
Rm
Organometallic
RmCHO
*
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O O
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R1 R2
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Scheme 3.1: Project overview: Generic strategy of Cm + C3 + Cn methodology 
The synthesis of polyoxygenated compounds and higher monosaccharides is viable upon 
applying organocatalysis and/or enolate chemistry on dioxanones with appropriate 
aldehyde acceptors (Scheme 3.1).  
1) Methodology: The initial methodological studies were carried out to obtain a set of 
reaction conditions to perform stereoselective “first” aldol reactions on a dioxanone 
substrate. 
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- Proline-catalyzed aldol reactions of CS-symmetrical dioxanones produced higher 
diasteroselective in comparison with C2-symmetrical dioxanones (de up to 88% 
from 34%), which demonstrates the role of steric effects of dioxanones on the 
selectivity of the aldol reactions. 
- Presence of additives such as LiCl (a weak Lewis acid) and pyridinium-p-
toluenesulfonate (PPTS, Brønsted acid) has enhanced the enatioselectivity of 
proline catalyzed aldol reactions. Reactions run without additives might not be 
synthetically useful; these additives move the selectivity into synthetically 
attractive range (from 60 up to 96 % ee).  (cf., Synlett 2006, (15), 2387-2390)
132 
 
2) Synthesis of 1-deoxyiminosugars: Piperidine amino sugars (iminosugars) such as 5-
amino-5-deoxyaldohexoses and their 1-deoxy derivatives are a class of monosaccharides 
with the nitrogen atom in place of the ring oxygen of the corresponding monosaccharide. 
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Scheme 3.2: Quick two-step synthesis to 1-deoxyiminosugars 
A simple two-step dioxanone route was developed to access L-1-deoxymannojirimycin, L-
1-deoxyidonojirimycin, and the N-isopropyl deoxyidonojirimycin from readily available 
starting materials such as dioxanone and (S)-isoserinal hydrate (283). The key steps 
include diastereoselective proline-catalyzed syn-aldol transformation and a reductive 
amination/cyclization. (cf., J. Org. Chem. 2009, 74, (11), 4390-4392)
136
 
 107 
 
3) Synthesis of (+)-D-glycero-D-manno-2-octulose: The title compound, a higher-carbon 
sugar isolated from opium poppies, has been synthesized in enantiomerically pure 
form.  The short synthetic sequence involved two proline-catalyzed aldol addition 
reactions of 2,2-dialkyl-1,3-dioxan-5-ones to appropriate aldehydes: the first addition 
to 1,3-dithiane-2-carboxaldehyde (2b), followed by reduction to the corresponding 
diol, protection of the hydroxy groups and dithiane hydrolysis afforded a protected D-
ribose (298) that was used in the second aldol reaction.  
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AcO OAc
AcO
BnO
OBn
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S
S
H
O
O O
OBn OBn
O
H4 steps 3 steps
56% 45%
7 steps
25% overall yield
2b 298 304  
 
Scheme 3.3: Synthetic D-glycero-D-manno-2-ocutlose 
 
     (+)-D-Glycero-D-manno-2-octulose 304 was synthesized in seven steps starting from 
readilly available dioxanone 1 ( 25% overall yield). There by developed a unique and 
complete dioxanone methodology to access “rare” higher carbohydrate fragments in a 
stereocontrolled fashion. (cf., Tetrahedron Lett. 2007, 48, 9195-98)
155
 
4) Stereodivergent synthesis of DD- and LL- glycero-β-allo-heptopyranoses: The 
second nucleophilic site of dioxanone ring was explored to realize the first 
stereodivergent synthesis of two enantiomers of glycero-allo-heptose from readily 
available non chiral starting materials (Scheme 3.4). The short synthetic sequence 
involves enamine and enolate mediated aldol reactions at α and α' positions of 
dioxanone thereby demonstrating the complementary nature of organocatalysis and 
organometallic methods. The new method for the enantioselective stereodivergent first 
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total synthesis of DD- and LL-glycero-β-allo-heptopyranose from simple dioxanone 
moiety was accomplished.   
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Scheme 3.4: Stereodivergent synthesis of  DD and LL-glycero-β-alloheptoses 
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4 EXPERIMENTAL SECTION 
4.1 General Methods  
 
All solvents were distilled prior to use by standard procedures.
163,164
 Anhydrous 
solvents were distilled under nitrogen atmosphere as follows: tetrahydrofuran (THF), 
diethyl ether (Et2O) and benzene (PhH) from benzophenone sodium ketyl; 
dichloromethane (CH2Cl2) and toluene (PhCH3) from calcium hydride (CaH2), 
diisopropylamine (DIA), triethylamine (TEA), diisopropylethylamine (DIPEA) and 
pyridine were distilled from calcium hydride (CaH2) under nitrogen and stored over 4 Å 
molecular sieves. Dimethyl sulfoxide (DMSO) and dimethylformamide (DMF) were dried 
with (CaH2) according to the known procedures.
165
  
All experiments involving air- and/or moisture-sensitive compounds were conducted in an 
oven dried round-bottom flask (or vials) capped with a rubber septum, and attached via a 
needle to a nitrogen manifold. Low temperature baths were ice/water (0 °C), 
ice/NaCl/MeOH (-20 °C), and CO2(s)/acetone (-78 °C).
166
 Reaction temperatures refer to 
the bath temperature. All liquid aldehydes and acetic anhydride (Ac2O) were distilled and 
stored under nitrogen, dimethoxyacetaldehyde was used as an aqueous solution (60%). n-
BuLi was periodically titrated using 2,5-dimethoxybenzyl alcohol as the indicator.
167
 LiCl 
was dried at 130-150 °C under vacuum overnight, and it was kept under nitrogen. All other 
commercially available reagents were used as received without further purification, unless 
stated otherwise. Concentrated phosphate buffer, used to quench reactions, was prepared 
by dissolving Na2HPO4 (47.0 g) and NaH2PO4 (32.0 g) in H2O (500 mL).  
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Thin-Layer chromatography (TLC) was performed on aluminum sheets pre-coated with 
silica gel 60 F254. The compounds were visualized under ultraviolet lamp (254 nm) and by 
treatment with a solution of KMnO4 followed by charring on a hot plate. Flash column 
chromatography (FCC) was performed using the standard procedure of Still et al.,
168
 
employing silica gel (230-400 mesh).
169  
4.2 Spectral Data 
 
Nuclear magnetic resonance (NMR) spectra were recorded on Brucker at 500 MHz 
for 
1
H, 125 MHz for 
13
C in deuterated solvents mentioned. All the NMR data were 
recorded at room temperature unless otherwise mentioned. Chemical shift (δ) values are 
reported in parts per million (ppm). Signals due to the solvent (
13
C NMR) or residual 
protonated solvent (
1
H NMR) served as the internal standard: CDCl3 (δ 7.24, δ 77.23); 
C6D6 (δ 7.16, δ 128.39); D2O (δ 4.80).
170
 Coupling constant (J values) are reported in 
Hertz (Hz), and spin multiplicities are referred by the following symbols: s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), br (broad peak). Couplings constants (J) 
were reported to the nearest 0.5 Hz. The 
1
H NMR assignments were made based on 
chemical shifts and multiplicities. Where necessary, 2D gradient COSY, and homonuclear 
decoupling experiments were used to assign coupling constants for overlapping signals in 
1
H NMR . The 
13
C NMR assignments were made on the basis of chemical shifts and were 
confirmed, where necessary, by two dimensional 
1
H/
13
C correlation experiments (HSQC 
and/or HMBC).
171
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Optical rotations ([α ]D) measurements were determined on a DigiPol 781-T6U automatic 
polarimeter and reported as the average of five measurements at ambient temperature using 
a 1 mL, 10 cm cell; the concentrations (c) are reported in g/100 mL.  
HRMS and LRMS were obtained on an API QSTAR® Pulsar Hybrid LC/MS/MS system 
and/or a VG 70E double focusing high resolution spectrometer; only partial data are 
reported. EI ionization was accomplished at 70 eV and CI at 50 eV with ammonia as the 
reagent gas; only partial data are reported.  
IR spectra were recorded on a Bio-Rad Fourier transform interferometer and only 
diagnostic peaks are reported.  
Melting points and boiling points are uncorrected. Melting points were measured on a 
Gallencamp melting point apparatus. 
The relative configuration of aldol products (syn or anti) were assigned based on 
1
H NMR 
coupling constant (syn J = 2 – 6 Hz, anti J = 7 – 10 Hz) of the vicinal C(O)-CH-CH-OH 172 
Chiral HPLC analysis was performed with Gilson 715 Series HPLC utilizing chiralpak AD 
or chiralpack IB columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, 
Ltd. with detection at 254 nm or 230 nm.  
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4.3 General Procedures and Methods 
4.3.1 General experimental procedure for the organocatalytic aldol reaction 
 
Procedure P1: (S)-Proline-catalyzed aldol reaction without additives
12,14,20
 
To a glass vial containing DMSO (1.0 mL) were added dioxanone (1, 0.50 mmol), the 
aldehyde (0.50 mmol), and (S)-proline (0.15 mmol), followed by LiCl (0.50 mmol) and the 
mixture was flushed with nitrogen and stirred at room temperature for 15 min to dissolve 
all the reactants. The mixture was then refrigerated at 5 
o
C until the reaction was complete 
as shown by TLC (usually 48 hr). Saturated NH4Cl solution and ethyl acetate were added 
with vigorous stirring, then the mixture was extracted with ethyl acetate (2x10 mL), and 
the combined organic layers were washed with brine. The organic phase was dried over 
anhydrous Na2SO4, and concentrated to afford the crude product (the dr was measured by 
1
H NMR on the crude product) which was then purified using flash column 
chromatography (FCC) to afford the aldol product. 
 
Procedure P2: (S)-Proline-catalyzed aldol reaction with additive
12,132
 
A dioxanone (0.50 mmol) and an aldehyde (0.50 mmol) were added to a flame-dried vial 
charged with (S)-proline (0.15 mmol) and respective additive (0.15–0.50 mmol). Dry 
DMSO (0.30 mL) was added; the vial was flushed with nitrogen and stored in a 
refrigerator at 4 °C for 1–7 d. The reaction was then quenched with sat. NH4Cl solution 
(5.0 mL) and the mixture were extracted with EtOAc. The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, concentrated and purified by FCC to 
afford the aldol product.  
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4.3.2 General experimental procedure for TBS or TIPS protection reaction 
Procedure P3: TIPS/TBS protection in the presence of 2,6-lutidine
173,20
 
To a cold solution of a dioxanone aldol (1.0 eq) in dry THF (5.0 mL/1.0 mmol) were added 
dropwise 2,6-lutidine (2.0 eq) at 0 C or -78 C followed by TIPSOTf / TBSOTf (1.2 - 1.5 
eq). The reaction was warmed up to room temperature and stirred until no starting material 
was detected by TLC (usually 1 to 3 hr depending on the substrate. Occasionally, the 
reaction required overnight stirring). The saturated solution of sodium bicarbonate was 
then added, the mixture was extracted with dichloromethane (50 mL x 3) and the combined 
organic layers were washed with saturated solution of sodium chloride, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by flash chromatography to afford the TIPS- or TBS-protected products. 
4.3.3 General procedure for aldol reaction of protected β-hydroxydioxanone 
            (This procedure was adapted from Niewczas’ thesis)12,18 
Procedure P4: A solution of n-BuLi in hexaness (2.5 M; 3.8 to 5.5 eq), was added 
dropwise to the stirred solution of DIA (3.5 to 5.0 eq) in dry THF (5 vol) at 0 °C under 
nitrogen. After 30 min a solution of a dioxanone mono-aldol (1.0 eq) in THF (5 vol) was 
added slowly and the mixture was stirred at -78 °C for 0.5-2 h. The aldehyde (3.0 to 5.5 
eq) was then added and, after 20 min, the reaction was quenched with concentrated 
phosphate buffer (pH 7) and extracted with ether (x 3). The combined organic layers were 
washed with saturated solution of NaCl, dried over anhydrous Na2SO4 and concentrated to 
give the crude product. The crude product was fractionated by FCC to provide the double 
aldol products.  
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4.3.4 General experimental procedure for reduction of aldol adducts into 
corresponding alcohols with NaBH(OAc)3 
Procedure P5: Based on modified procedure from ref. 14 and 174 
To a solution of -hydroxyketone (1.0 eq) in dry CH2Cl2 (0.40 mL/mmol) AcOH (0.17 eq) 
and NaBH(OAc)3 (1.2 eq) were added at -20 C. The reaction was keept at that 
temperature for 1-5 d (TLC controled).The reaction mixture was quenched with saturated 
NaHCO3 solution and extracted with CH2Cl2 (50 mL x 3).The combined organic layers 
were washed with aqueus saturated NaCl, dried over anhydrous Na2SO4 and concentrated 
to give a crude diols mixture which was purified by flash column chromatography on silica 
gel to give pure products. 
4.3.5 Corey’s protocol for dithiane hydrolysis to aldehyde 
Procedure P6: To a solution of dithiane compound (1.0 eq.) in 10 mL of acetonitrile: 
water (4 : 1), at 0
o
 C added N-bromosuccinimide (4.0 eq.) followed by silver nitrate (4.5 
eq.) and stirred at stirred at same temperature for 5 minutes. Reaction was follwed by TLC 
(generally, product and starting material had similar Rf). The reaction was quenched with 
10% sodium sulfite solution and filtered over celite bed ,washed with CH2Cl2 (15 ml) and 
the resulting mixture was extracted with CH2Cl2 (2x15 mL). The combined organic layers 
were washed with saturated NaHCO3 solution follwed by brine, dried over anhydrous 
Na2SO4. Concentration under reduced pressure gave the crude aldehyde that was purified 
by flash chromatography on silica gel to give the desired aldehyde.  
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4.3.6 General hydrogenolysis procedure 
Procedure P7: To the aldol adduct (0.5 mmol) in MeOH (3.0 mL) added 10% Pd/C (30 
mg). The resulting suspension was stirred under H2 (~5 psi) at ambient temperature and the 
reaction was monitored by TLC (12 to 24 hr). The reaction mixture was then acidified with 
HCl solution (0.5 mL, 2N), and was stirred under H2 for 6 hr at room temperature. The 
catalyst was filtered off through Celite and evaporation of the solvent afforded the crude 
product. 
Procedure P8: (hydrogenolysis under acidic conditions): The aldol adduct (0.50 mmol) 
in MeOH (3.0 mL), was charged with p-toluenesulfonic acid (0.10 mmol) and the resulting 
solution was stirred at room temperature for 15 min. The catalyst (10% Pd/C; 30 mg) was 
then added and the resulting suspension was stirred under H2 (~5.0 psi) at ambient 
temperature for 24 hr. The mixture was then acidified with HCl solution (0.50 mL, 2.0 N), 
and was stirred under H2 for 6.0 hr at room temperature. The catalyst was filtered off 
through Celite and evaporation of the solvent afforded the crude product. 
4.3.7 General procedure for acetylation 
Reduced aldol products were subjected to deprotection using acidic conditions to  afford 
the corresponding monosaccharides which were generally characterized as acetate 
derivatives.  
Procedure P9: To the crude polyol compound were added sodium acetate (12 eq.) and 
acetic anhydride (5.0 vol.). The resulting mixture was heated to 90 
o
C for  2.0 hr and the 
reaction was quenched with ice and saturated NaHCO3 solution. Then the mixture was 
extracted with ethyl acetate (3 x 20 mL), and then combined organic layers were washed 
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with brine. The organic phase was dried over anhydrous Na2SO4, concentrated to get a 
crude product which was purified by silica-gel flash column chromatography to yield the 
fully acetylated product. 
 
4.4 Experimental Procedures and Data 
 
Dioxanone 1a and 1d were synthesized according to the established procedure 
within the group and their spectra data were consistent with that reported.
10-13,175
 
Dimethoxyacetaldehyde (2a) was obtained from Aldrich as an aqueous solution (60 wt %),  
1,3-dithiane-2-carbaldehyde (2b) was prepared according to the Meyers procedure,
176
 and 
D-glyceraldehyde acetonide (2c) was prepared using standard procedure from D-
mannitol.
177 
All other reagents were commercially available and unless otherwise noted, 
were used as received. 
4.4.1 Synthesis of dioxanone starting materials 
 
2-tert-Butyl-2-methyl-1,3-dioxan-5-one (1b)
11
 
 
OH OH
O2N OH
O O
Met-Bu
O2N OH
O O
Met-Bu
H2N OH
O O
Me
O
t-Bu
1b240 242b 243b  
The compound 1b was prepared according to the modified literature procedure
11
 
 
Tris(hydroxymethyl)nitromethane (240, 10.0 g, 66.2 mmol, 1 eq.) and  p-TsOH.H2O (127 
mg, 0.66 mmol, 0.01 eq.) were dissolved in dry benzene (200 mL). Pinacolone (241b, 9.90 
mL, 7.95 g, 79.4 mmol, 1.20 eq.) was added and the mixture was refluxed with removal of 
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water using a Soxhlet apparatus with 4 Å molecular sieves. After the reaction was 
completed (TLC and 
1
H NMR monitoring) the reaction mixture was cooled to room 
temperature and diluted with EtOAc (150 mL). The organic layer was washed with 
saturated solution of NaHCO3 (150 mL), followed by saturated brine solution (150 mL) 
and dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure to 
yield the crude product 242b as a mixture of cis/trans isomers in 1: 1.1 ratio as a pale 
yellow solid in 89 % yield (13.7 g, 58.9 mmol). No effort was made to separate cis/trans 
isomers. 
A solution of the crude mixture of both isomers of (2-tert-butyl-2-methyl-5-nitro-1,3-
dioxan-5-yl) methanol (242b) (13.6 g, 58.4 mmol) was dissolved in methanol (100 mL). 
Raney nickel (ca 0.200 g) was added and the solution was stirred for 5 min, filtered, and a 
fresh portion of Raney nickel was added (ca 2.00 g). Reaction mixture was hydrogenated 
overnight (50 psi, room temperature). TLC showed the completion of the reaction. The 
reaction mixture was filtered through the Celite bed to remove the catalyst. Then the filter 
bed was washed with methanol (50.0 mL) and the solvent was removed under reduced 
pressure to provide the crude product 243b as a mixture of isomers in a ratio of 1 : 1 as a 
white solid (11.4 g, 56.0 mmol) in 96.0 % yield. No efforts were made to assign cis/trans 
configuration. 
 
To an ice cold (0-5
 C) solution of sodium periodate (17.4 g, 81.3 mmol, 1.50 eq) in H2O 
(40 mL) added, over 10 min. at 0 C to the -amino alcohol 243b (11.0 g, 54.2 mmol, 1.00 
eq) dissolved in H2O-MeOH (1 : 3; 100 mL). The mixture was stirred at this temperature 
for 4 h. Next, the white suspension was filtered off and the solution was thoroughly 
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extracted with CH2Cl2 (4 x 75 mL). The combined organic layers were washed with a 
saturated sodium bicarbonate solution (50 mL), dried with anhydrous Na2SO4 and 
evaporated on a rotovap (temp < 30 C). The crude product was purified by passing 
through silica column (hexanes : ethyl acetate 98 : 2) to give pure 2-tert-butyl-2-methyl-
1,3-dioxan-5-one (1b) (8.25 g, 47.9 mmol, 88 %) as a colorless viscous product which 
crystallized upon storing in refrigerator. Dioxanone 1b has a characteristic peppermint 
odor and readily sublimes under reduced pressure. 
Melting point: 47-48 °C; (Lit
11
: 47-49 °C) 
1
H NMR (500 MHz, CDCl3) δ 4.30 (d, J = 18.2 Hz, 2H), 4.23 (d, J = 18.2 Hz, 2H), 1.36 (s, 
3H), 1.02 (s, 9H) 
13
C NMR (125 MHz, CDCl3) δ 207.9, 103.5, 68.7, 40.4, 25.3, 15.8. 
HRMS (CI, NH3) exact mass calcd for (C9H16O3 + H)
+
  173.1178, found m/z 173.1178 
LRMS (CI, NH3): m/z (relative intensity %): 173 (M+1, 100), 115 (25). 
IR (KBr): 2893 (w), 1735 (s), 1142 (s) cm
-1
. 
1,5-Dioxaspiro[5.5]undecan-3-one (1d) 
 
OH OH
O2N OH
O O
O2N OH
O O
H2N OH
O O
O
1d
240
242d 243d
 
 
A similar three step procedure as described for compound 1b produced dioxanone 1d   
(5.04 g, 29.6 mmol, 80 %) as a colourless liquid.  
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1
H NMR (500 MHz, CDCl3) δ 4.15 (s, 4H), 1.72 (m, 4H). 1.58 (m, 4H), 1.43 (m, 2H) 
13
C NMR (125 MHz, CDCl3) δ 207.3, 102.4, 69.2, 38.4, 26.6, 23.1. 
HRMS (CI, NH3) exact mass calcd for (C9H14O3 + H)
+
  171.1021, found m/z 171.1015 
LRMS (CI, NH3): m/z (relative intensity %): 171 (M+1, 100), 143 (44), 108 (19). 
IR (KBr): 2916-2806 (w), 1739 (s), 1108 (s) cm
-1
. 
 
2-Methyl-2-(4-(trifluoromethyl)phenyl)-1,3-dioxan-5-one (1d) 
 
OH OH
O2N OH
O O
Me
O2N OH
O O
Me
H2N OH
O O
Me
O
1e
240
242e 243eCF3 CF3CF3  
 
The similar three step procedure as described for compound 1b produced dioxanone 1e   
(1.06 g, 4.07 mmol, 48 %) as a pale yellow liquid.  
1
H NMR (500 MHz, CDCl3) δ 7.64 (s, 4H), 4.26 (d, J = 16.7 Hz, 2H), 4.07 (d, J = 16.7 Hz, 
2H), 1.64 (s, 3H) 
13
C NMR (125 MHz, CDCl3) δ 207.1, 149.2, 130.1, 127.8, 124.9, 123.3, 104.2, 68.2, 21.1. 
HRMS (CI, NH3) exact mass calcd for (C12H11F3O3 + H)
+
  261.0739, found m/z 261.0735 
LRMS (CI, NH3): m/z (relative intensity %): 261 (M+1, 100), 212 (54), 157 (43), 108 
(22). 
IR (KBr): 3039 (w), 2955 (w), 1745 (s), 1605, 1308 (w), 1111(s) cm
-1
. 
 
 
 120 
 
4.4.2 Methodological studies on proline-catalyzed aldol reactions of 
dioxanones (c.f. page 66) 
 
(2R,4S)-2-tert-butyl-4-((S)-hydroxy(phenyl)methyl)-2-methyl-1,3-dioxan-5-one (3bf) 
O O
O
t-Bu Me
O O
O
t-Bu Me
OH
1b 3bf  
Procedure P1 (0.50 mmol scale) afforded the viscous crude product. Diastereoselectivity of 
the reaction was determined on the crude product mixture by integration of 
1
H NMR peaks 
at 5.23 ppm (J = 2.8 Hz) and 5.02 ppm (J = 6.5 Hz) and was found to be 6 : 94 (syn : anti). 
The crude product was purified by FCC (hexanes : ethyl acetate 9 : 1) to provide the anti 
aldol adduct 3bf (87 mg, 0.315 mmol) in 63 % yield as a yellowish oil. Enantioselectivity 
was measured by 
1
H NMR in deuterated benzene with Eu(tfc)3 as a shift reagent and was 
found to be 60 %. 
 
[]25D = -29 (c 1.1, CHCl3)  (ee: 60 %) 
 
Procedure P2 (0.50 mmol scale) with LiCl as the additive afforded the crude product. 
1
H 
NMR spectrum of the crude product mixture showed only the anti-diastereoisomer at 5.02 
ppm (J = 6.5 Hz). The crude product was purified by FCC (hexanes : ethyl acetate 9 : 1) to 
provide the anti aldol adduct 3bf (101 mg, 0.315 mmol) in 72 % yield as a yellowish oil. 
Enantioselectivity was measured by 
1
H NMR in deuterated benzene with Eu(tfc)3 as a shift 
reagent and was found to be 68 %. 
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[]25D = -34 (c 1.0, CHCl3)  (ee: 68 %) 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.28 (m, 5H), 5.01 (dd, J1 = 2.5 Hz, J2 = 6.3 Hz, 1H), 
4.36 (d, J = 6.3 Hz, 1H), 4.23 (d, J = 18.3 Hz, 1H), 4.16 (d, J = 18.3 Hz, 1H), 3.47 (d, J = 
2.5 Hz, 1H, OH), 1.25 (s, 3H), 0.94 (s, 9H) 
13
C NMR (125 MHz, CDCl3) δ 209.4, 138.8, 128.0, 127.9, 127.0, 104.1, 78.7, 73.7, 69.7, 
40.3, 25.1, 16.1 
 Compound 3bf was also characterized in benzene: 
1
H NMR (500 MHz, C6D6) δ: 7.43 (d, 
J = 7.7 Hz, 2H), 7.15 (d, J = 7.7 Hz, 2H), 7.10 (t, J = 7.7 Hz, 1H), 4.89 (dd, J1 = 6.3 Hz, J2 
= 2.5 Hz, 1H), 4.10 (d, J = 6.3 Hz, 1H), 3.93 (d, J = 17.9 Hz, 1H), 3.75 (d, J = 17.9 Hz, 
1H), 3.3 (d, J = 2.5 Hz, 1H, OH), 0.87 (s, 3H), 0.86 (s, 9H) 
HRMS m/z calcd for C16H22O4 278.1518 (M), found 278.1518 (EI) 
LRMS (CI, NH3), m/z (relative intensity): 296 ([M+18]
+
, 52), 279 ([M+1]
+
, 100), 196 (17), 
178 (23), 155 (34), 118 (32). 
IR (KBr): 3378 (br), 3069, 3029, 2964, 2912, 1732, 1604, 1453, 1261, 1090, 799, 699 cm
-1
 
 
 
 
 
 
 
 
 
 
 
 122 
 
(2R,4S)-2-tert-Butyl-4-((S)-hydroxy(4-nitrophenyl)methyl)-2-methyl-1,3-dioxan-5-one 
(330) 
O O
O
t-Bu Me
O O
O
t-Bu Me
OH
NO2
1b 330  
Procedure P2 (0.50 mmol scale) with LiCl as the additive afforded a gummy crude 
product. 
1
H NMR spectrum of the crude product mixture just showed only the anti-
diastereoisomer at 5.09 ppm (J = 6.7 Hz). The crude product was purified by FCC 
(hexanes : ethyl acetate 8 : 2) to provide the anti aldol adduct 330 (98.5 mg, 0.305 mmol) 
in 61 % yield as a yellow solid.  
[]25D = -25 (c 1.0, CHCl3) 
Melting Point: 126-128 °C 
 
1
H NMR (500 MHz, CDCl3) δ: 8.18 (d, J = 8.7 Hz, 2H), 7.55 (d, J = 8.7 Hz, 2H),  5.09 
(dd, J1 = 1.5 Hz, J2 = 6.7 Hz, 1H),  4.31 (dd, J1 = 1.5 Hz, J2 = 18.2 Hz, 1H), 4.28 (d, J = 
6.7 Hz, 1H), 4.22 (d, J = 18.2 Hz, 1H), 3.73 (br, 1H, OH), 1.24 (s, 3H), 0.93 (s, 9H).  
13
C NMR (125 MHz, CDCl3) δ: 209.3, 147.9, 146.3, 128.1, 123.3, 104.5, 78.4, 73.0, 69.8, 
40.4, 25.3, 16.1. 
HRMS m/z calcd for C16H21NO6 323.1369 (M), found 323.1368 (EI) 
LRMS (CI, NH3), m/z (relative intensity): 324 ([M+1]
+
, 100), 286 (16), 222 (46), 156 (76), 
108 (28). 
IR (KBr): 3449 (br), 3032, 1742, 1544, 1393, 1098 cm
-1
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(2R,4S)-2-tert-Butyl-4-((S)-hydroxy(4-methoxyphenyl)methyl)-2-methyl-1,3-dioxan-5-
one (331) 
 
1b 331
O O
O
t-Bu Me
O O
O
t-Bu Me
OH
OMe
 
Procedure P2 (0.50 mmol scale) with LiCl as the additive resulted in a gummy crude 
product. 
1
H NMR spectrum of the crude product mixture showed only the anti-
diastereoisomer at 4.95 ppm (J = 6.3 Hz). The crude product was purified by FCC 
(hexanes : ethyl acetate 8 : 2) to provide the anti aldol adduct 331 (82 mg, 0.266 mmol) in 
53 % yield as a pale yellow solid.  
[]25D = -32 (c 1.1, CHCl3) 
1
H NMR (500 MHz, CDCl3) δ: 7.27 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H),  4.95 (d, 
J = 6.3 Hz, 1H),  4.33 (dd, J1 = 1.2 Hz, J2 = 6.3 Hz, 1H), 4.20 (dd, J1 = 1.2 Hz, J2 = 18.2 
Hz, 1H), 4.13 (d, J = 18.2 Hz, 1H), 3.78 (s, 3H), 3.40 (br, 1H, OH), 1.26 (s, 3H), 0.94 (s, 
9H). 
13
C NMR (125 MHz, CDCl3) δ: 209.8, 159.6, 131.3, 128.4, 113.6, 104.3, 78.9, 73.5, 69.9, 
55.5, 40.5, 25.4, 16.4. 
HRMS m/z calcd for C17H24O5 308.1624 (M), found 308.1621 (EI) 
LRMS (CI, NH3), m/z (relative intensity): 326 ([M+18]
+
, 33), 309 ([M+1]
+
, 44), 254 (32), 
196 (100), 154 (16), 118 (26) 
IR (KBr): 3491(br), 3048, 1736, 1168, 1086 cm
-1
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4-(S)-4-[(R)-Furan-2-yl(hydroxy)methyl]-2,2-dimethyl-1,3-dioxan-5-one (3ag)
12 
1a
O O
O OH
O O
O
anti-3ag
O O O
O OH
O
+
syn-3ag
 
 
Procedure P1 with three days of reaction time resulted in a dark gummy crude product. 
Diastereoselectivity of the reaction was determined by integration of 
1
H NMR (CDCl3) 
peaks at 5.21 ppm (J = 2.9 Hz) and 4.97 ppm (J = 7.0 Hz) and was found to be 40 : 60 (syn 
: anti). The crude product was purified by FCC (hexanes : ethyl acetate 8 : 2) to provide 
the mixture of syn and anti isomers in 21 % yield as a brown liquid.  
Procedure P2 with three days of reaction time and LiCl as an additive resulted in a mixture 
of  syn and anti isomers. Diastereoselectivity of the reaction was determined by integration 
of 
1
H NMR (CDCl3) peaks at 5.21 ppm (J = 2.9 Hz) and 4.97 ppm (J = 7.0 Hz) and was 
found to be 25 : 75 (syn : anti). The crude product was purified by FCC (hexanes : ethyl 
acetate 8 : 2) to provide the mixture of syn and anti isomer in 33 % yield as a brown liquid. 
The efforts to separate the syn and anti isomers were unsuccessful hence the optical 
rotation and enantiomeric excess were not determined. The NMR spectral data were 
obtained on the mixture of two isomers. 
1
H NMR (500 MHz, C6D6) δ: 7.07 (s, 1H), 6.25 (m, 1H), 6.05 (m, 1H), 5.01 (d, J=6.7 Hz, 
1H), 4.45 (dd, J1=1.2 Hz, J2=6.7 Hz, 1H), 3.79 (dd, J1=1.2 Hz, J2=17.3 Hz, 1H), 3.60 (d, 
J=17.3 Hz, 1H) 3.19 ( br s, 1H), 1.16 (s, 3H), 1.03 (s, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 206.4, 153.9, 142.5, 110.8, 108.7, 101.4, 75.7, 67.6, 66.9, 
23.9, 23.5 
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(2R,4S)-2-(tert-Butyl)-4-[(R)-furan-2-yl(hydroxy)methyl]-2-methyl-1,3-dioxan-5-one 
(3bg) 
1b
O O
O
t-Bu Me
OH
O O
O
t-Bu Me
3bg
O
 
Procedure P1 with three days of reaction time resulted in a dark gummy crude product. 
Diastereoselectivity of the reaction was determined by integration of 
1
H NMR (CDCl3) 
peaks at 4.57 ppm (J = 2.6 Hz) and 4.61 ppm (J1 = 1.0 Hz, J2 = 5.5 Hz) and was found to 
be 5 : 95 (syn : anti). The crude product was purified by FCC (hexanes : ethyl acetate 9 : 1) 
to provide the anti isomer 3bg in 30 % yield as a brown viscous liquid.  
Procedure P2 with three days of reaction time and LiCl as the additive afforded the crude 
product as a brown oil.  Diastereoselectivity of the reaction was determined by integration 
of 
1
H NMR (CDCl3) peaks at 4.57 ppm (J = 2.6 Hz) and 4.61 ppm (J1 = 1.0 Hz, J2 = 5.5 
Hz) and was found to be 3 : 97 (syn : anti). The crude product was purified by FCC 
(hexanes : ethyl acetate 9 : 1) to provide the anti isomer in 37 % yield as a brown liquid.  
[]25D = -51 (c 1.0, CHCl3) (ee: 76%)  
Chiral-phase HPLC (Daicel Chiralpac IB column, hexanes/isopropanol 96 : 4, flow rate 
1ml/min, λ = 254nm) 
1
H NMR (500 MHz, CDCl3) δ: 7.35 (m, 1H), 6.32 (m, 2H), 5.09 (dd, J1 = 5.4 Hz, J2 = 6.8 
Hz, 1H), 4.61 (dd, J1 = 1.3 Hz, J2 = 5.4 Hz, 1H), 4.28 (dd, J1 = 1.3 Hz, J2 = 18.3 Hz, 1H), 
4.19 (d, J = 18.3 Hz, 1H), 3.07 (d, J = 6.8 Hz, 1H, OH), 1.38 (s, 3H), 0.94 (s, 9H) ppm 
 126 
 
13
C NMR (125 MHz, CDCl3) δ: 207.9, 152.3, 142.3, 110.4, 108.1, 104.1, 77.9, 69.6, 68.4, 
40.3, 25.3, 16.0 ppm 
HRMS (CI, NH3) m/z calcd for (C14H20O5 + NH4) requires 286.1700, found 286.1701 
LRMS (CI, NH3), m/z (relative intensity): 286 ([M+18]
+
, 11), 269 ([M+1]
+
, 25), 251 (27), 
193 (30), 173 (100), 151 (12), 115 (41). 
IR (KBr): 3460 (br), 2962, 2915, 2877, 1741, 1597, 1483, 1394, 1278, 1165, 1012 cm
-1 
 
 
(S)-2-((R)-(1,3-Dithian-2-yl)(hydroxy)methyl)-1,5-dioxaspiro[5.5]undecan-3-one (3db) 
O O
O
O O
O OH
S
S
1d 3db  
Procedure P1 afforded a viscous crude product. 
1
H NMR spectrum of the crude product 
mixture showed only the anti-diastereoisomer at 3.96 (d, J = 4.8 Hz, 1H).  The crude 
product was purified by FCC (hexanes : ethyl acetate 9 : 1) to provide the anti-aldol adduct 
3db in 72 % yield as a pale-yellow solid. Enantioselectivity was measured by 
1
H NMR in 
deuterated benzene with Eu(tfc)3 as a shift reagent and was found to be 67 %. 
 []25D = -89 (c 1.1, CHCl3)  (ee: 67 %) 
 
Procedure P2 with LiCl as an additive afforded the crude product that was purified by FCC 
(hexanes : ethyl acetate 9 : 1) to provide the anti-aldol adduct 3db in 86% yield as  a pale-
yellow solid. Enantioselectivity was measured by 
1
H NMR in deuterated benzene with 
Eu(tfc)3 as the shift reagent and was found to be 92 %. 
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Melting point: 69- 70 °C 
[]25D = -125 (c 1.0, CHCl3) 
1
H NMR (500 MHz, C6D6) δ: 4.66 (br, 2H), 4.15 (d, J = 16.4 Hz, 1H), 3.96 (d, J = 4.8 Hz, 
1H), 3.71 (d, J = 16.4 Hz, 1H), 3.18 (br, 1H),  2.87 (ddd, J1 = 2.5 Hz, J2 = 12 Hz, J3 = 13.9 
Hz 1H), 2.69 (ddd, J1 = 2.5 Hz, J2 = 12 Hz, J3 = 13.9 Hz 1H), 2.04 (m, 1H), 1.92 (m, 1H), 
1.63 (m, 4H). 1.42 (m, 4H), 1.17 (m, 2H) ppm 
1
H NMR (500 MHz, CDCl3) δ: 4.56 (d, J = 5.1 Hz, 1H), 4.49 (dd, J1 = 5.1 Hz, J2 = 6.6 Hz, 
1H), 4.41 (d, J = 17 Hz, 1H), 3.96 (d, J = 17 Hz,  1H), 3.91 (d, J = 6.6 Hz,  1H), 3.15 (br, 
OH, 1H), 3.01 (ddd, J1 = 2.9 Hz, J2 = 10.5 Hz, J3 = 13.5 Hz 1H), 2.87 (ddd, J1 = 2.9 Hz, J2 
= 10.5 Hz, J3 = 13.5 Hz 1H), 2.55 (m, 2H), 2.03 (m, 2H), 1.78 (m, 3H), 1.57 (m, 5H), 1.36 
(m, 2H) ppm 
13
C NMR (125 MHz, CDCl3) δ: 208.9, 101.1, 74.8, 73.3, 66.6, 43.9, 33.6, 32.3, 26.8, 26.0, 
25.4, 25.3, 23.1, 23.0 ppm  
HRMS (CI, NH3), m/z calcd for (C15H22O4+ NH4) requires 336.1303 found 336.1301  
LRMS (CI, NH3), m/z (relative intensity): 336 ([M+18]
+
 21), 319 ([M+1]
+
, 100), 259 (13), 
215 (10), 173 (13), 118 (42). 
IR (KBr): 3492 (br), 2938, 2864, 1737, 1432, 1366, 1278, 1160, 1122, 910, 730 cm
-1
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(2R,4S)-2-tert-Butyl-4-((S)-1-hydroxy-2-methylpropyl)-2-methyl-1,3-dioxan-5-one 
(3bj) 
O O
O
t-Bu Me
O O
O
t-Bu Me
OH
1b 3bj  
Procedure P1 afforded a viscous crude product. 
1
H NMR spectrum of the crude product 
mixture showed only the anti-diastereoisomer at 4.20 (dd, J1 = 1.3 Hz, J2 = 6.3 Hz, 1H).  
The crude product was purified by FCC (hexanes : ethyl acetate 9 : 1) to provide the anti-
aldol adduct 3bj in 65 % yield as a colorless gummy product. Enantioselectivity was 
measured by HPLC on 3,5-dinitrobenzoyl derivative of 3bj and was found to be 67 %.
 
Chiral-phase HPLC (Daicel Chiralpac AD column, hexanes/isopropanol 95 : 5, flow rate 
0.5 ml/min, λ = 230 nm) tr = 30.6 (syn) tr = 34.7 (anti).  
[]25D = -89 (c 1.1, CHCl3)  (ee: 67 %) 
 
Procedure P2 with LiCl as an additive afforded a crude product that was purified by FCC 
(hexanes : ethyl acetate 9 : 1) to provide the anti-aldol adduct 3db in 86% yield as a 
colorless gummy solid. Enantioselectivity was measured by HPLC on 3,5-dinitrobenzoyl 
derivative of 3bj and was found to be 92 %.
 
Chiral-phase HPLC (Daicel Chiralpac AD 
column, hexanes/isopropanol 95 : 5, flow rate 0.5 ml/min, λ = 230 nm) tr = 30.6 (syn) tr = 
34.7 (anti).  
 []25D = -112 (c 1.1, CHCl3) (ee: 92 %) 
1
H NMR (500 MHz, CDCl3) δ: 4.33 (dd, J1 = 1.3 Hz, J2 = 18.3 Hz, 1H), 4.20 (dd, J1 = 1.3 
Hz, J2 = 6.3 Hz, 1H), 4.19 (d, J = 18.3 Hz, 1H), 3.70 (dd, J1 = 5.6 Hz, J2 = 6.3 Hz, 1H), 
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2.97 (br, 1H, OH), 1.98 (m, 1H), 1.39 (s, 3H), 1.02 (s, 9H), 0.98 (d, J = 6.9 Hz, 3H), 0.93 
(d, J = 6.9 Hz, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 211.0, 103.9, 76.8, 76.3, 69.9, 40.6, 29.1, 25.4, 19.3, 16.5, 
16.2. 
HRMS m/z calcd for C13H24O4 244.1675 (M), found 244.1675 (EI) 
LRMS (CI, NH3), m/z (relative intensity): 262 ([M+18]
+
, 36), 245 ([M+1]
+
, 76), 186 
(100), 148 (32), 124 (21), 108 (16) 
IR (KBr): 3397 (br), 2966, 2886, 1732, 1464, 1379, 1163, 1018, 954, 899 cm
-1 
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(S)-4-((S)-1-Hydroxyhexyl)-2,2-dimethyl-1,3-dioxan-5-one (3ai) 
 
O O
O
O O
O OH
1a 3ai  
Procedure P1 afforded a gummy crude product that was purified by FCC (hexanes : ethyl 
acetate 9 : 1) to provide the anti aldol adduct 3ai in 18 % yield along with 20 % yield of 
the respective dehydrated product.  
 
Procedure P2 with LiCl as the additive afforded the crude product that was purified by 
FCC (hexanes : ethyl acetate 9 : 1) to provide the anti aldol adduct 3ai in 28 % yield along 
with 18 % yield of the dehydrated product.  
 []25D = -41 (1.2, CHCl3) 
1
H NMR (500 MHz, CDCl3) δ: 4.23 (dd, J1 = 1.3 Hz, J2 = 17.5 Hz, 1H), 4.06 (dd, J1 = 1.3 
Hz, J2 = 6.9 Hz, 1H), 3.99 (d, J = 17.5 Hz, 1H), 3.85 (dd, J1 = 3.0 Hz, J2 = 6.9 Hz, 1H), 
2.79 (d, J = 3.0 Hz, 1H, OH), 1.47-1.53 (m, 4H),  1.45 (s, 3H), 1.42 (s, 3H), 1.2-1.35 (m, 
6H), 0.87 (t, J = 4.2 Hz, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 211.3, 101.2, 76.2, 70.9, 66.9, 32.4, 31.9, 24.9, 23.8, 24.1, 
22.8, 16.3, 14.2. 
HRMS (CI, NH3), m/z calcd for (C12H22O4+NH4) requires 248.1862 (M+14), found 
248.1862  
LRMS (CI, NH3), m/z (relative intensity): 248 ([M+14]
+
, 100), 231 (23), 212 (33), 173 
(54), 109 (13). 
IR (KBr): 3447 (br), 2955, 2929, 2860, 1739, 1459, 1376, 1224, 1093, 863 cm
-1
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(2R,4S)-2-tert-Butyl-4-((S)-1-hydroxyhexyl)-2-methyl-1,3-dioxan-5-one (3bi) 
O O
O
t-Bu Me
O O
O
t-Bu Me
OH
1b 3bi  
Procedure P1 afforded a gummy crude product that was purified by FCC (hexanes : ethyl 
acetate 9 : 1) to provide the anti aldol adduct 3bi in 30 % yield along with 12 % yield of 
the respective dehydrated product.  
Procedure P2 with LiCl as the additive afforded the crude product that was purified by 
FCC (hexanes : ethyl acetate 9 : 1) to provide the anti aldol adduct 3ai in 44 % yield along 
with 5 % yield of the dehydrated product.  
[]25D = -16 (1.0, CHCl3)  
1
H NMR (500 MHz, CDCl3) δ: 4.30 (dd, J1 = 1.3 Hz, J2 = 18.0 Hz, 1H), 4.18 (d, J = 18.0 
Hz, 1H), 4.15 (d, J = 6.1 Hz, 1H), 3.90 (m, 1H), 2.79 (d, J = 4.2 Hz, 1H, OH), 1.4-1.6 (m, 
4H),  1.38 (s, 3H), 1.2-1.35 (m, 6H), 1.01 (s, 9H), 0.87 (t, J = 4.2 Hz, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 209.9, 103.8, 78.7, 72.3, 69.9, 40.4, 32.2, 31.9, 25.4, 25.1, 
22.8, 16.3, 14.2. 
HRMS (CI, NH3), m/z calcd for (C15H28O4+NH4) requires 290.2331 (M+14), found 
290.2327  
LRMS (CI, NH3), m/z (relative intensity): 290 ([M+14]
+
 36), 273 ([M+1]
+
, 100), 259 (13), 
215 (10), 173 (13). 
IR (KBr): 3427 (br), 2959, 2929, 2872, 1734, 1467, 1377, 1260, 1164, 1091, 1023, 903, 
800 cm
-1
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4-(S)-4-[(R)-(1,3-Dithian-2-yl)(hydroxy)methyl]-2,2-dimethyl-1,3-dioxan-5-one 
(250a)
12,132
 
O O
O OH
S
S
O O
O
S
S CHO
+
1a 2b 250a  
To a solution of 2,2-dimethyl-1,3-dioxan-5-one 1a (1.45g, 0.011 mol) in dry DMSO (10 
mL), were added 1,3-dithiane-2-carboxaldehyde 2b (1.5g, 0.01 mol), L-proline (0.35 g, 
0.003 mmol) followed by LiCl (0.44g, 0.01mol) and the resulting mixture was flushed with 
nitrogen and stirred at room temperature for 15 min to dissolve all the reactants. The 
mixture was then refrigerated at 5 
o
C until the reaction was complete as shown by TLC (48 
hr). Saturated NH4Cl solution and ethyl acetate were added with vigorous stirring, then the 
mixture was extracted with ethyl acetate (3 x 50 mL), and then combined organic layers 
were washed with brine. The organic phase was dried over anhydrous Na2SO4, and 
concentrated to yeld the crude product. Only one isomer was detected by 
1
H NMR. The 
crude product was purified by FCC (hexanes : ethyl acetate 9 : 1) to provide the anti 
isomer 250a in 96 % yield as a white solid. Enantioselectivity was measured by 
1
H NMR 
in C6D6 with Eu(tfc)3 as the shift reagent and also by HPLC (Daicel Chiralpac AD column, 
hexanes/isopropanol 95 : 5, flow rate 0.5 ml/min, λ = 230 nm) tr = 47.8 (anti), tr = 52.4 
(syn).  
Melting point: 73-75 C, (Lit. 20,12 74-76 C) 
[]25D = -110 (c 1.05, CHCl3); (ee = 92 %) 
1
H NMR (CDCl3, 500 MHz): δ 4.63 ( dd, J1 = 1.3 Hz, J2 = 4.2 Hz, 1H), 4.56 (dd, J1 = 4.0 
Hz, J2 = 7.5 Hz, 1H), 4.46 (dd, J1 = 1.3 Hz, J2 = 16.6 Hz, 1H), δ3.99 (d, J = 16.6 Hz, 1H), 
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3.90 (d, J = 7.3 Hz, 1H), 3.14 (d, J = 1.9 Hz, OH), 3.05 (m,1H), 2.85 (m,1H), 2.57 (m,1H), 
2.51 (m,1H), 2.06 (m, 2H), 1.51 (s, 3H), 1.47 (s, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 207.8, 101.1, 75.4, 72.5, 66.8, 43.5, 26.4, 25.4, 25.2, 24.4, 
23.4 
HRMS m/z calcd for C11H18O4S2 requires 278.0647 (M), found 278.0639 (EI) 
LRMS (CI, NH3), m/z (relative intensity): 279 ([M+1]
+
, 100), 221 (85), 149 (12), 119 (87) 
IR (KBr): 3489, 2986, 2907, 2894, 2833, 1737, 1423, 1375, 1290, 1222, 1164, 1109, 1041, 
1003 cm
-1 
 
(2R,4S)-4-((R)-(1,3-Dithian-2-yl)(hydroxy)methyl)-2-tert-butyl-2-methyl-1,3-dioxan-5-
one (250b):  
O O
O OH
S
S
O O
O
Met-Bu t-Bu Me
S
S CHO
+
1b 2b 250b  
By following a similar procedure as discribed above, the anti-isomer 250b was obtained in 
84% yield as a white solid. Enantioselectivity was measured by 
1
H NMR in C6D6 with 
Eu(tfc)3 as the shift reagent and also by HPLC (Daicel Chiralpac AD column, 
hexanes/isopropanol 95 : 5, flow rate 0.5 ml/min, λ = 230 nm) tr = 31.7 (syn), tr = 35.9 
(anti).  
Melting point: 67-68 C, 
[]25D = -34 (c 1.0, CHCl3); (ee = 78 %) 
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1
H NMR (CDCl3, 500 MHz):  δ 4.71( dd, J1 = 2.2 Hz, J2 = 9.1 Hz, 1H), 4.67 (d, J1 = 2.2 
Hz, 1H), 4.53 (d, J = 18 Hz, 1H), 4.22 (d, J = 18 Hz, 1H), 3.85 (d, J = 9.1 Hz, 1H), 3.04 
(m, 2H), 2.96 (s, OH), 2.71 (t, J = 2.4 Hz, 1H), 2.56 (m, 1H), 2.41 (m, 1H), 2.05 (m, 2H), 
1.4 (s, 3H), 1.04 (s, 9H). 
13
C NMR (CDCl3, 125 MHz): δ 205.4, 103.6, 77.5, 72.3, 69.2, 43.2, 40.4, 25.4, 25.35, 
24.9, 24.5, 15.4. 
Compound 250b was also characterized in benzene: 
1
H NMR (C6D6, 500 MHz):  δ 4.79 
(ddd, J1 = 1.9 Hz, J2 = 2.2 Hz,  J3 = 8.8  1H), 4.72 (d, J1 = 2.2 Hz, 1H), 4.40 (dd, J1 = 1.6 
Hz, J2 = 17.8 Hz, 1H), 3.97 (dd, J1 = 1.6 Hz, J2 = 8.8 Hz, 1H), 3.94 (d, J  = 17.8 Hz, 1H), 
2.88 (d, J  = 17.8 Hz, 1H, OH), 2.54 (ddd, J1 = 2.5 Hz, J2 = 12.6 Hz,  J3 = 14.5, 1H), 2.39 
(ddd, J1 = 2.5 Hz, J2 = 12.6 Hz,  J3 = 14.5, 1H), 1.86 (m, 1H), 1.77 (m, 1H), 1.58 (m, 1H), 
1.32 (m, 1H), 1.06 (s, 3H), 1.01 (s, 9H). 
HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C14H24O4S2) requires 320.1116, found  
m/z 320.1114.  
LRMS (EI, 70 eV): m/z (%) = 320 (4) [M]
+
, 203 (16), 147 (57), 115 (100), 101 (57), 
83(33), 57 (71). 
IR (KBr): 3472 (br), 2958 (s), 1708 (s), 1486 (w) 1454 (m), 1152 (s) cm
-1
. 
Anal.Calcd for C14H24O4S2: C, 52.47; H, 7.55. Found: C, 52.76; H, 7.35. 
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4.4.3 Second aldol reactions on dioxanone aldol derivatives 
 
(2R,4S)-2-tert-Butyl-2-methyl-4-((S)-2-methyl-1-(triisopropylsilyloxy)propyl)-1,3-
dioxan-5-one (267) 
O O
O
t-Bu Me
OH
O O
O
t-Bu Me
OTIPS
267266  
Reaction was done based on procedure P3 
 
To an ice cold solution of 266 (0.30 g, 1.2 mmol, 1.0 eq) in dry THF (5.0 mL) were added 
dropwise 2,6-lutidine (0.29 mL, 2.5 mmol, 2.0 eq) followed by TIPSOTf (0.50 mL, 1.8 
mmol, 1.5 eq). The reaction was stirred at room temperature until no starting material was 
detected by TLC (6 h). Then saturated solution of NaHCO3 was added, extracted with ether 
(3 x 20 mL) and the combined organic layers were washed with saturated solution of NaCl, 
dried over Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by FCC, product eluted in pure hexanes to afford silylated product 267 (0.43 g, 1.1 
mmol, 87 %) as a pale yellow oil.  
1
H NMR (500 MHz, CDCl3) δ: 4.44 (br (s), 1H), 4.31 (dd, J1 = 1.6 Hz, J2 = 18.2 Hz, 1H), 
4.18 (d, J = 18.2 Hz, 1H), 4.17 (dd, J1 = 1.6 Hz, J2 = 6.6 Hz, 1H), 1.96 (m, 1H), 1.37 (s, 
3H), 1.07 (s, 21H), 1.03 (s, 9H), 0.99 (d, J = 6.9 Hz, 3H), 0. 79 (d, J = 6.9 Hz, 3H) 
13
C NMR (125 MHz, CDCl3) δ: 207.1, 103.5, 82.0, 78.6, 69.3, 40.4, 31.9, 26.6, 25.3, 19.9, 
19.7, 18.4, 15.0, 13.2. 
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(2R,4S)-2-tert-Butyl-4-((S)-1-(tert-butyldimethylsilyloxy)-2-methylpropyl)-2-methyl-
1,3-dioxan-5-one (267a) 
O O
O
t-Bu Me
OH
O O
O
t-Bu Me
OTBS
267a266  
Reaction was done based on modified procedure P3 
To an ice cold solution of 266 (0.67 g, 2.1 mmol, 1.0 eq) in dry THF (8.0 mL) were added 
dropwise 2,6-lutidine (0.71 mL, 6.1 mmol, 2.0 eq) followed by TBSOTf (0.76 mL, 3.3 
mmol, 1.2 eq). The reaction was stirred at room temperature until no starting material was 
detected by TLC (3 h). Then saturated solution of NaHCO3 was added, extracted with ether 
(3 x 20 mL) and the combined organic layers were washed with saturated solution of NaCl, 
dried over Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by FCC, product elutes in pure hexanes to afford silylated product 267a (0.86 g, 
2.4 mmol, 88 %) as a colorless oil. 
 
1
H NMR (500 MHz, CDCl3) δ: 4.33 (dd, J1 = 1.3 Hz, J2 = 18.0 Hz, 1H), 4.32 (br, 1H), 4.15 
(d, J = 18.0 Hz, 1H), 3.93 (dd, J1 = 2.2 Hz, J2 = 7.3 Hz, 1H), 1.95 (m, 1H), 1.35 (s, 3H), 
1.05 (s, 9H), 0.92 (d, J = 6.9 Hz, 3H), 0.87 (s, 9H),  0. 78 (d, J = 6.9 Hz, 3H), 0.06 (s, 6H). 
13
C NMR (125 MHz, CDCl3) δ: 207.6, 103.8, 81.1, 77.7, 69.7, 40.6, 31.1, 25.9, 25.4, 19.8, 
19.5, 18.3, 15.6, -4.3, -4.4. 
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(2R,4R,6R)-4-((S)-(1,3-Dithian-2-yl)(hydroxy)methyl)-2-tert-butyl-2-methyl-6-((S)-2-
methyl-1-(triisopropylsilyl)propyl)-1,3-dioxan-5-one (268ab) 
O O
O
t-Bu Me
OTIPSOH
O O
O
t -Bu Me
OTIPS
267 268ab
S
S
 
Reaction was done based on modified procedure P4 
 
To a stirred solution of diisopropylamine (0.10 mL, 0.79 mmol, 4.8 eq) in dry THF (2.0 
mL) at 0 
o
C in an ice bath, added n-BuLi (0.26 mL, 0.73 mmol, 2.2 M, 4.4 eq) and the 
mixture was stirred at 0 
o
C for 30 minutes. The resulting mixture was cooled to -78 
o
C in a 
dry ice-acetone bath, then the solution of 267 (66 mg, 0.17 mmol, 1.0 eq) in dry THF (2.0 
mL) was added dropwise. The reaction mixture was stirred at the same temperature for 2 h 
and then was added aldehyde 2b (0.11 g, 0.74 mmol, 4.5 eq). After 20 min. the reaction 
was quenched with pH 7 buffer solution (2 mL) and slowly brought to room temperature.  
The mixture was extracted with diethyl ether (3 x 15 mL), the ether layer was washed with 
saturated NH4Cl followed by brine and dried over anhydrous Na2SO4, and concentrated. 
The 
1
H NMR of the crude product showed excess of aldehyde peaks, though spectrum 
showed the desired product peaks but the spectra was too complicated to determine 
diasteromeric ratio. The crude product was purified by flash chromatography on silica gel 
using increasing amounts of EtOAc in hexanes (2%>5%>10%) that yielded 66 mg of 
compound 268ab in 71% yield. 
[]22D = +24 (c 1.1, CHCl3)  
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1
H NMR (500 MHz, CDCl3) δ: 4.52 (d, J = 7.4 Hz, 1H), 4.48 (br, 1H), , 4.37 (dd, J1 = 7.2 
Hz, J1 = 7.4 Hz 1H ), 4.25 (d, J = 7.2 Hz, 1H ), 4.02 (d, J = 2.9 Hz, 1H), 3.79 (s, 1H, OH), 
3.17 (m, 2H), 2.70 (m, 1H), 2.60 (m, 1H), 2.05 (m, 2H), 1.98 (m, 1H), 1.50 (s, 3H), 1.08 (s, 
21H), 1.03 (s, 9H), 1.01 (d, J = 6.9 Hz, 3H), 0.76 (d, J = 6.9 Hz ,3H)  
13
C NMR (125 MHz, CDCl3) δ: 209.6, 103.1, 82.2, 78.1, 77.9, 75.7, 44.7, 39.9, 31.4, 28.4, 
28.0, 25.8, 25.1, 20.5, 19.7, 18.4, 18.3, 13.3, 13.2. 
HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C27H52O5S2Si) requires 548.3025, found  
m/z 548.3018.  
LRMS (CI, NH3), m/z (relative intensity): 566 ([M+18]
+
, 5), 549 ([M+1]
+
, 100) 476 (12), 
412 (30), 298 (12), 156 (60), 91 (19). 
IR (KBr): 3496 (br), 2961, 2868, 1710, 1465, 1386, 1171, 1107, 1014, 920, 883, 813, 677 
cm
-1
. 
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(2R,4R,6R)-2-tert-Butyl-4-((R)-hydroxy(phenyl)methyl)-2-methyl-6-((S)-2-methyl-1-
(triisopropylsilyl)propyl)-1,3-dioxan-5-one (268af) 
O O
O
t-Bu Me
OTIPSOH
O O
O
t-Bu Me
OTIPS
267 268af  
Reaction was done based on modified procedure P4 
Using procedure P4 on compound 267 (0.15 mmol) with benzaldehyde (2f) as the 
electrophile produced compound 268af (43 mg) in 57% yield.  
[]22D = +111 (c 1.1, CHCl3)  
1
H NMR (500 MHz, CDCl3) δ: 7.38-7.25 (m, 5H), 4.89 (d, J = 7.9 Hz, 1H), 4.46 (br, 1H), 
4.23 (m, 2H), 3.97 (br (s), 1H, OH), 1.89 (m, 1H), 1.33 (s, 3H), 1.06 (s, 21H), 0.99 (d, J = 
6.9 Hz, 3H), 0.87 (s, 9H), 0.72 (d, J = 6.9 Hz, 3H)  
13
C NMR (125 MHz, CDCl3) δ: 209.8, 139.7, 128.5, 128.4, 128.2, 128.1, 127.8, 103.1, 
82.4, 78.7, 78.5, 74.9, 40.2, 31.8, 25.1, 20.5, 20.1, 18.7, 18.5, 13.6, 13.4, 13.3. 
HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C29H50O5Si) requires 506.3428, found  
m/z 506.3422.  
LRMS (CI, NH3), m/z (relative intensity): 507 ([M+1]
+
, 32) 443 (63), 399 (72), 298 (15), 
159 (100), 108 (21) 
IR (Kubelka-Munk): 3422 (br), 3098, 2962, 2868, 1722, 1603, 1465, 1385, 1132, 1090, 
884, 700  cm
-1
. 
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 (4R,6R)-4-((S)-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)(triisopropylsilyl)methyl)-6-((S)-
furan-2-yl(hydroxy)methyl)-2,2-dimethyl-1,3-dioxan-5-one (333) 
 
O O
O OTIPS
O
O
O O
O OTIPS
O
O
OH
O O O
O OTIPS
O
O
OH
O
+
332 333 334  
 
To a stirred solution of diisopropylamine (0.10 mL, 0.73 mmol, 4.8 eq) in dry THF (3 ml) 
at 0 
o
C in an ice bath was added n-BuLi (0.35mL, 0.68 mmol, 1.95 M, 4.5 eq). The 
resulting solution was stirred at 0 
o
C for 30 minutes. The reaction mixtures was cooled to -
78 
o
C in a dry ice-acetone bath, after 10 minutes the solution of the protected aldol adduct 
332 (63 mg, 0.15 mmol, 1eq) in dry THF (1 mL) was added dropwise. The reaction 
mixture was stirred at the same temperature for 2 h and then 2-furaldehyde 2g (65 mg, 0.68 
mmol, 4.5 eq) was added. After 20 min, the reaction was quenched with a pH 7 buffer 
solution (2.0 mL) and slowly brought to room temperature. The mixture was extracted with 
diethyl ether (3 x 15 mL), ether layer was washed with saturated NH4Cl followed by brine 
and dried over NaSO4. Concentration yielded the crude product (156 mg). The 
1
H NMR of 
the crude product showed excess of aldehyde and although the spectrum showed the 
typical product peaks it was too complicated to detemine the diasteromeric ratio.The crude 
product was purified by flash chromatography on silica gel using increasing amounts of 
EtOAc in hexanes (5%>10%>15%>25%) that yielded two isomers of the desired product. 
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Compound 333: 
1
H NMR (500 MHz, ,CDCl3): δ 7.39 ( s, 1H), 6.35 (s, 1H), 4.94 (dd, J1 = 4.8 Hz, J2 = 7.4 
Hz, 1H), 4.65 (d, J = 7.4 Hz, 1H), 4.52 (dd, J1 = 1.5 Hz, J2 = 7.1 Hz, 1H), 4.37 (dd, J1 = 
7.1 Hz, J2 = 7.4 Hz, 1H), 4.29 (br (s), 1H), 3.96 (t,  J = 7.9 Hz, 1H), 3.91 (t, J = 7.9 Hz, 
1H), 3.33 (d, J = 4.8 Hz, 1H, OH), 1.46 (s, 3H), 1.43 (s, 3H), 1.38 (s, 3H), 1.35 (s, 3H), 
1.13 (m, 3H), 1.1 (br, 18H). 
  
13
C NMR (125 MHz CDCl3): 209.1, 152.3, 142.9, 110.2, 109.3, 108.4, 101.9, 78.1, 73.7, 
73.1, 66.5, 66.2, 26.6, 25.2, 23.9, 23.4, 18.1, 18.0, 12.4.  
HRMS (CI, NH3), m/z calcd for (C26H44O8Si + NH4) is 530.3149, found (M+NH4) 
530.3156 
LRMS (CI, NH3), m/z (relative intensity): 530 ([M+18]
+
, 50), 495 (15), 472 (7), 414 (22), 
359 (17), 257 (6), 185 (13), 151 (100), 58 (14). 
IR (KBr): 2963, 2869, 1745, 1596, 1485, 1464, 1392, 1376, 1364, 1344, 1243, 1149, 1013, 
920, 884, 823, 809 cm
-1 
 Compound 334: 
 
 
1
HNMR (500 MHz, ,CDCl3): δ 7.38 ( s, 1H), 6.36 (s, 1H),  5.19 (dd, J1 = 3.4 Hz, J2 = 7.6 
Hz, 1H), 4.64 (d, J = 3.4 Hz, 1H),  4.48  (dd, J1 = 1.7 Hz, J2 = 7.4 Hz, 1H), 4.37 (dd, J1 = 
7.4 Hz, J2 = 7.6 Hz, 1H), 4.28 (s, 1H), 3.94 (t, J = 7.6 Hz, 1H), 3.79 (t, J = 7.9 Hz, 1H), 
2.67 (d, J = 7.6 Hz, 1H, OH), 1.50 (s, 3H), 1.47 (s, 3H), 1.43 (s, 3H), 1.33 (s, 3H), 1.15 (m, 
3H), 1.07 (dd, 18H). 
  
13
C NMR (125 MHz CDCl3): 205.7, 153.0, 142.1, 110.1, 109.1, 107.6, 101.9,  78.3, 74.9, 
73.1, 66.2, 65.4, 26.6, 25.3, 24.3, 23.6, 18.1, 18.0, 12.4. 
 142 
 
4.4.4 Dioxanone route of 1-deoxyiminosugars 
 
 
(2R, 4S)-syn-2-tert-Butyl-(2’,2’-dibromo-1’-hydroxyethyl)-2-methyl-1,3-dioxan-5-one 
(252)  
251
O O
O
t-Bu Me
+ O O
O
t-Bu Me
OH
1b 252
(S)-proline; LiCl
DMSO; 5 oC
2 days
OH
OH
Br
Br
O O
O
t -Bu Me
OH
Br
253
+
major minor
Br Br
Br
Y: 59%
dr: > 95:05
 
Reaction was done based on modified procedure P2 
The reaction was carried out using the procedure P2. Dioxanone 1b (0.09 g; 0.53 mmol) 
and 2,2-dibromoacetal hydrate 251 (0.11 g; 0.50 mmol) afforded, in the presence of LiCl 
(21 mg; 0.50 mmol) and H2O (0.10 mL), the syn-aldol adduct 252 in high 
diastereoselectivity (dr > 95:5). The crude product was fractionated by FCC (10-15% 
EtOAc in hexanes) to yield the title compound as a pale yellow gummy product (0.10 g, 
59%) and a small amount of another stereoisomer 253 (12 mg).  
Compound 252 data: [α]D
24  
= +59 (c 1.1, C6H6)
 
1
H NMR (C6D6, 500 MHz): δ 5.54 (d, 1H, J = 7.4 Hz), 4.77 (d, 1H, J = 1.5 Hz), 4.47 (d, 
1H, J = 7.25 Hz), 3.76 (dd, 1H, J1 = 1.1, J2 = 17.6 Hz), 3.64 (d, 1H, J = 17.6 Hz),  2.57 (br, 
1H), 0.94 (s, 9H), 0.92 (s, 3H);  
 13
C NMR (C6D6, 125 MHz): δ 205.5, 106.1, 77.6, 75.2, 67.2, 47.95, 41.3, 25.8 , 17.4  
HRMS (CI, NH3) exact mass calcd for (C11H18Br2O4 + H)
+
  372.9650, found m/z 372.9665 
[M]
+
, 374.9643 [M+2], 376.9622 [M+4].  
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LRMS (CI, NH3): m/z (relative intensity %): 394 (M+4+NH3, 10), 392 (M+2+NH3, 18), 
390 (M+NH3, 10), 377 (58), 375 (100), 373 (59), 317 (19), 173 (26), 118 (20). 
IR (KBr): 3638-3192 (br), 1747 (s) cm
-1
. 
Spectral data for the minor anti-compound 253 
(2R,4S)-anti-2-tert-Butyl-4-((R)- 2’,2’-dibromo-1’-hydroxyethyl)-2-methyl-1,3-dioxan-
5-one (253) 
O O
O
t-Bu Me
OH
Br
253
minor
Br
 
Compound 253 data: 
 [α]D
24  
= -34.4 (c 1.05, C6H6) 
 
1
H NMR (C6D6, 500 MHz): δ 5.87 (d, 1H, J = 3.6 Hz), 4.15 (d, 1H, J = 6.5 Hz), 3.91 (m, 
1H), 3.90 ( dd, 1H, J1 = 1.3, J2 = 18.1 Hz), 3.70 (d, 1H, J = 18.1 Hz),  3.23 (br, 1H), 0.95 
(s, 3H), 0.86 (s, 9H).  
 13
C NMR (C6D6, 125 MHz): δ 207.4, 104.5, 76.7, 76.4, 69.6, 46.95, 40.4, 25.6, 15.8.  
 HRMS (CI, NH3) exact mass calcd for (C11H18Br2O4 + H)
+
  372.9650, found m/z 
372.9651 [M]
+
, 374.9632 [M+2], 376.9616 [M+4]. 
 LRMS (CI, NH3): m/z (%): 394 (M+4+NH3, 8), 392 (M+2+NH3, 15), 390 (M+NH3, 8), 
377 (61), 375 (100), 373 (62), 317 (16), 173 (31), 118 (50). 
IR (KBr): 3627-3137 (br), 1739 (s) cm
-1
. 
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(S)-2-(2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic acid (275)
136,143,178
  
(S)
O
O
O
HO
O
(S)
HOOC
COOH
OH
274
L-Malic acid
MeO OMe
p-TSA (S)-275
265
 
L-(-)-Malic acid (274, 10.0 g, 75.0 mmol), 2,2-dimethoxypropane (265, 75 mL) and p-
toluenesulfonic acid monohydrate (0.14 g, 0.8 mmol) were placed in a 250 mL RBF fitted 
with a N2 inlet at room temperature. The resulting mixture was stirred at room temperature 
for 5 hr and then H2O (50 mL) and NaHCO3 (62 mg, 0.8 mmol) were added. The reaction 
mixture was extracted with DCM (3 x 100 mL), and the combined organic layers were 
dried over anhydrous Na2SO4; filtration and evaporation yielded the crude product which 
was dissolved in Et2O (20 mL) and diluted with hexanes (300 mL). The solvents were 
concentrated on a rotary evaporator to approx. half volume. The mixture was allowed to 
stand at 0 
o
C for 30 min and the solid that precipitated was filtered and washed with 
hexanes to afford compound (S)-275 (11.3 g, 87%) as a white fluffy solid, which has 
spectroscopic data consistent with the reported data. 
1
H NMR (CDCl3, 500 MHz): δ 4.72 (dd, 1H, J1 = 3.8, J2 = 6.7 Hz), 3.01 (dd, 1H, J1 = 3.8, 
J2 = 17.3 Hz), 2.86 (dd, 1H, J1 = 6.7, J2 = 17.3 Hz), 1.63 (s, 3H), 1.58 (s, 3H).
  
Literature data
178
: (Denmark, S. E.; Yang, S.–M. J. Am. Chem. Soc., 2004, 126, 12432.) 
1
H NMR (CDCl3, 500 MHz): δ 4.71 (dd, 1H, J1 = 4.0, J2 = 7.0 Hz), 3.00 (dd, 1H, J1 = 4.0, 
J2 = 17.5 Hz), 2.86 (dd, 1H, J1 = 7.0, J2 = 17.5 Hz), 1.62 (s, 3H), 1.57 (s, 3H).
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(S)-Isoserine hydrochloride (279)
 136,143,144,145 
 
O
O
O
N
C
O
O
O
O
HO
O
O
O
O
Cl
O
O
O
O
N3
O
OH
OHO
HCl.H2N
(S)-275
1. SOCl2, reflux, 30 min
2. evaporation with CCl4 276
NaN3
acetone: water
-20 oC, 30 min
C6H6 reflux,
then evaporation
conc. HCl / H2O
reflux, 30 min
279
L-Isoserine.HCl
277
278
Y: 62% (overall; 5 steps)
 
Compound (S)-275 (10.0 g, 57.0 mmol) was refluxed with thionyl chloride (75 mL) for 30 
min. Excess of SOCl2 was evaporated under reduced pressure and traces were removed by 
co-distillation with CCl4 (100 mL).  The resulting residue was dissolved in acetone (40 
mL), cooled to -20 
o
C and added to a saturated solution of sodium azide (5.6 g, 86 mmol) 
in water (15 mL). The resulting mixture was stirred at -20 
o
C for 30 min and acetone was 
evaporated at 0 
o
C using high vacuum. The acyl azide 277 was then extracted with benzene 
(2 x 100 mL) and the combined organic layers were dried over anhydrous Na2SO4 and 
filtered. The solvent was concentrated to less than half volume (~40 mL) and the reaction 
mixture was set to reflux (slowly) until release of N2 has ceased (1 hr), after which time 
benzene was completely evaporated. The crude isocyanate 278 was treated with 6N HCl 
(60 mL) and heated to reflux for 4 hr. The reaction mixture was concentrated to yield the 
crude product. The crude product was dissolved in water (10 mL) and purified on a cation 
exchange column (Amberlite IR-120, H
+
 form). The column was first eluted with water 
and then with 5% aqueous ammonia. The alkaline phase was concentrated under reduced 
pressure and co-distilled thrice with toluene to yield a pale yellow solid (hydroscopic). The 
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resulting residue was stirred with etheric HCl for 10 minutes, then the solvent was 
evaporated and the product was dried under high vacuum to afford pure (S)-isoserine 
hydrochloride (279, 6.3 g, 78%). 
[α]D
24  
= 
 
-30 (c 1.2, H2O); [Lit. [α]D
24 
= -32.3 (c 1.3, H2O)]
136,143,144,145  
 
1
H NMR (D2O, 500 MHz): δ 4.2 (dd, 1H, J1 = 3.4,  J2 = 7.7 Hz), 3.30 (dd,1H, J1 = 3.6, J2 = 
13 Hz), 3.09 (dd, 1H, J1 = 8.4, J2 = 13 Hz). 
13
C NMR (D2O, 125 MHz): δ 177.5 , 68.8, 42.9. 
 
 (S)-3-(Benzyloxycarbonylamino)-2-hydroxypropanoic acid (280)
136,144,145
 
OH
OHO
HCl.H2N
HO
O
OH
N
H
O
O
279
0 oC to rt
4hr; Y : 73% 280
1N NaOH
CbzCl; dioxane
 
To a stirred solution of (S)-isoserine hydrochloride (279, 4.1 g, 39 mmol) in 1N aq NaOH 
(120 mL) at 0 
o
C was added a solution of benzylchloroformate (6.90 mL, 48.8 mmol) in 
dioxane (5.0 mL) over a period of 30 minutes. The resulting mixture was stirred at room 
temperature for 2 hr, then dioxane was evaporated at reduced pressure. The resulting 
aqueous layer was first washed with Et2O (50 mL) and next acidified with 1N aq. KHSO4 ( 
50 mL) at 0 
o
C. The mixture was extracted with EtOAc (3 x 100 mL). The combined 
organic layers were washed with brine solution and then dried over NaSO4 and  
concentrated to give the crude product. The solid product was washed with Et2O (50 mL) 
to remove non-polar impurities and then dried over high vacuum to yield compound 280 as 
a pale-yellow solid. Yield: 5.8 g (61 %) pure and 3.2 g of impure product. 
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Melting Point: 129-130 
o
C  (Lit mp: 129 
o
C)
144
 
[α]D
24 
 = +2.1 (c 1.02, MeOH) 
 
1
H NMR (DMSO, 500 MHz): δ 12.1 (br, 1H), 7.38-7.28 (br, 5H), 7.26 (t, 1H, J = 5.8 Hz). 
5.04 (br, 1H), 5.01 (s, 2H),  4.02 (dd, 1H, J1 = 4.9, J2 = 7.2 Hz),  3.30 ( ddd, 1H,  J1 = 5.4, J2 
= 10.4, J3 = 13.6 Hz), 3.14 (ddd, 1H, J1 = 6.6, J2 =10.4, J3 =13.6 Hz). 
13
C NMR (DMSO, 125 MHz): δ 173.9, 156.2, 137.1, 128.3, 127.7, 127.6, 69.3, 65.3, 44.3.  
HRMS (EI+, 70 eV) exact mass calcd for (C11H13NO5)  239.0794, found m/z  239.0794. 
LRMS (EI+, 70 eV): m/z (%): 239 (100)  221 (22), 194 (12), 148 (9), 108 (17), 91 (22). 
IR (KBr): 3430 (m), 3343 (m), 3300-2500 (br), 1738 (s), 1689 (s), cm
-1
. 
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(S)-Methyl 3-(benzyloxycarbonylamino)-2-hydroxypropanoate (21a)
 136,144
 
HO
O
OH
N
H
O
O
OH
O
OMeCbzHN
p-TsOH (cat..)
MeOH; reflux
280 2818 hr
Y: 91%  
To a solution of α-hydroxyacid 280 (5.1g, 21.3 mmol) in MeOH (60 mL) was added p-
toluenesulfonic acid (81 mg, 0.43 mmol) and the mixture was refluxed for 8 hr. After TLC 
showed no starting material the reaction mixture was concentrated under reduced pressure. 
The residue was dissolved in EtOAC (100 mL), washed with saturated NaHCO3, water and 
brine, and dried over anhydrous Na2SO4. Purification by FCC on silica gel (6 : 4, hexanes : 
ethyl acetate) gave α-hydroxy ester 281 (4.9 g, 91%) 
 
Melting Point: 44-45 
o
C 
[α]D
24 
= +19 (c 1.1, MeOH)  
1
H NMR (CDCl3, 500 MHz): δ 7.36-7.28 (br, 5H), 5.13 (br, 1H), 5.08 (br, 2H),  4.26 ( br, 
1H),  3.77 ( s, 3H), 3.55 (m, 2H), 3.17 ( d, 1H, J = 4.7 Hz). 
13
C NMR (CDCl3, 125 MHz): δ 173.3, 156.8, 136.3, 128.3, 128.0, 127.9, 70.0, 66.7, 52.4, 
44.2.  
HRMS (EI+, 70 eV) m/z calcd for  (C12H15NO5) 253.0950, found m/z  253.0945.  
LRMS (EI+, 70 eV): m/z (relative intensity %): 253 (
 
3), 164 (7), 120 (12), 108 (12), 91 
(100). 
IR νmax: 3550-3120 (br), 3032, 1719 (s) cm
-1
.  
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(S)-3-Benzyl 5-methyl 2,2-dimethyloxazolidine-3,5-dicarboxylate (282)
 136,144
 
282
O
O
OMe
CbzNOH
O
OMeCbzHN
BF3.OEt
281
r.t, overnight
Y: 65%
Recoverded SM: 30%
(265)
MeO OMe
 
To a solution of ester 281 (4.40 g, 17.4 mmol) in acetone (70.0 mL) was added 2,2-
dimethoxypropane (265, 4.30 mL, 34.8 mmol) and four drops of BF3.Et2O. The mixture 
was stirred at room temperature for overnight. The solvent was evaporated at reduced 
pressure and the residue was partitioned between Et2O (100 mL) and saturated NaHCO3 
solution. The organic layers were separated, dried over anhydrous Na2SO4 and 
concentrated at reduced pressure to afford crude product which was purified by FCC (1 : 1, 
hexanes-ethyl acetate) to afford the desired oxazolidine methylester 282 (3.3 g, 65%) and 
unreacted 281 (1.3 g, 30%). 
[α]D
24 
= +15 (c 1.1, MeOH)  
1
H NMR (CDCl3, 500 MHz): δ 7.36-7.28 (br, 5H), 5.11 (br, 2H),  4.62 (t, 1H, J = 7.25 
Hz), 3.92 (br, 1H), 3.77 (s, 3H), 3.71 (br, 1H), 1.65 (s, 3H), 1.54 (s, 3H). 
  
13
C NMR (CDCl3, 125 MHz): δ 170.5, 152.1, 136.4, 128.7, 128.3, 128.2, 99.3, 95.8, 72.7, 
66.9, 52.6, 47.7, 25.8, 24.9  
HRMS (CI) m/z calcd for (C15H20NO5 + H )
+
 294.1341, found m/z  294.1338.  
LRMS (CI): m/z (%): 294 (100)  [M+1 ]
+
, 278 (22), 250 (12), 234 (9), 108 (17), 91 (22). 
IR (KBr): 3112 (w), 3032 (w), 2983 (m), 2951 (w), 2892 (w), 1740 (s), 1703 (s) 
(carbamate C=O), 1498 (w), 1483 (w), 1408(s), 1354 (m), 1256(m), 1213( m), 1072 (s), 
911 (m),  867 (w) cm
-1
. 
 150 
 
(S)-Benzyl 5-(dihydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate (283)
 136,144
 
O
(S)
O
H
CbzN
282
DIBAL-H
-78 oC; toluene
3 hrO
O
OMe
CbzN
O
(S)
H
NO
O
OH
OH
(S)-2e 283
Et3N; CDCl3
Y: 88%
 
To a solution of protected isoserine ester 282 (3.20 g, 10.9 mmol) in dry toluene (50.0 mL) 
cooled under nitrogen to -78
 o
C, was added 1N solution of DIBAL in toluene (17 mL, 
16.38 mmol) over a period of one hour keeping the reaction temperature below -65 
o
C. The 
resulting mixture was stirred for a furthur two hours at -78
 o
C, then quenched with dry 
methanol (7 mL). The mixture was warmed up to -20
 o
C and then poured into a stirred 
solution of Rochelles‟s salt (1.2 M potassium sodium tartrate, 60 mL), stirred for an hour, 
and then extracted with EtOAc (3 x 50 mL). The combined  organic layers were dried over 
anhydrous Na2SO4, evaporated and subjected to flash chromatography on silica gel with 
1:1 hexanes: ethylacetate  that afforded thehydrated aldehyde 283 ( 2.5 g, 88%).  
Protected (S)-isoserinal (2e) readily formed the corresponding hydrate 283. The IR 
spectrum of this compound showed the absence of the carbonyl signal and the presence of 
a broad peak corresponding to the hydroxyl functional groups (3540-3090 cm
-1
) that 
confirmed the existence of the (S)-isoserinal hydrate. Also, the proton NMR analysis 
showed a small signal for the aldehyde functional group (CHO) at the chemical shift of 9.7 
(integration for 0.23 proton), addition of triethylamine to the sample enhanced the 
aldehyde peak (integration of 0.62 protons) which implied that the equilibrium has shifted 
to the aldehyde form 2e.  
[α]D
24 
= -25 (c 1.15, CHCl3 ) 
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1
H NMR (CDCl3, 2 eq. NEt3; 500 MHz): δ 9.74 (s, 0.7H, CHO), 7.36-7.28 (br, 5H), 5.10 
(s, 2H),  4.41 (dd, 1H , J1 = 1.2, J2 = 8.1 Hz), 3.80 (t, 1H, J = 18.1 Hz), 3.71 (dd, 1H, J1 = 
6.4, J2 = 8.1 Hz), 1.59 (s, 3H), 1.54 (s, 3H). 
 
13
C NMR (CDCl3, 125 MHz): δ 200.1 (weak), 171.3, 152.3, 136.2, 128.6, 128.3, 98.2, 
90.9, 78.2, 66.7, 60.5, 46.9, 25.2, 21.0 ppm. 
 
HRMS (EI+, 70 eV) m/z calcd for  (C14H19NO5) 281.1263, found m/z  281.1237.  
LRMS (EI+, 70 eV): m/z (relative intensity %): 282 (5), 281 (31), 264 (100), 248 (37), 
108 (38), 91 (74). 
IR (KBr): (Isoserinal hydrate 283): 3413 (br), 3032 (w), 2982 (m), 1703 (s), 1072 (s) cm
-1
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Compound 284  
283
O O
O
t-Bu Me
+ O O
O
t -Bu Me
O
NCbz
OH
1b 284
(S)-proline 30 mol%;
LiCl (1 eq); DMSO
48 hr; 5 oCO
OH
HO
NCbz
dr: 20:01
Y: 69%
 
Reaction was done based on modified procedure P2 
The reaction was carried out using the procedure P2. Dioxanone 1b (216 mg, 1.25 mmol), 
aldehyde hydrate 283 (300 mg, 1.15 mmol), (S)-proline (40.0 mg, 0.34 mmol) and LiCl 
(48.0 mg, 1.15 mmol) were dissolved in DMSO (5.0 mL) and the resulting mixture was 
flushed with nitrogen and stirred at room temperature for 15 min. The mixture was 
refrigerated at 5 
o
C until the reaction was complete as shown by TLC (48 hr). Saturated 
NH4Cl solution and EtOAc were added with vigorous stirring, then the mixture was 
extracted with EtOAc (3 x 20 mL), and the combined organic layers were washed with 
brine. The organic phase was dried over anhydrous Na2SO4 and concentrated to afford the 
crude product (dr 96 : 04 was determined at this stage by 
1
H NMR). The resulting crude 
product was fractionated by FCC (15-20% EtOAc in hexanes) to yield the title compound 
284 as a thick oil (0.34 g, 69 %).   
 [α]D
24 
= -51 (c 1.05, C6H6) and  [α]D
24 
= -61 (c 1.08, CHCl3). 
1
H NMR (CDCl3, 500 MHz): δ7.36-7.28 (br, 5H), 5.10 (br, 2H), 4.47 (d, 1H, J = 3.0 Hz), 
4.35 (d, 1H, J = 18.1 Hz), 4.30 (ddd, 1H, J1 = 7.0, J2 =  7.6, J3 = 8.1 Hz ), 4.19 (d, 1H, J = 
18.1 Hz), 4.10 (ddd, 1H,  J1 = 3.0, J2 = 6.1, J3 = 7.0 Hz), 3.79 (dd, 1H,  J1 = 8.1, J2 = 10.6 
Hz), 3.48 (dd, 1H, J1 = 7.6, J2 = 10.6 Hz), 2.40 (d, 1H, J = 6.1 Hz),  1.54 (s, 3H), 1.50 (s, 
3H), 1.38 (s, 3H), 1.01 (s, 9H).  
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 13
C NMR (CDCl3, 125 MHz): δ 206.3, 152.4, 136.6, 128.5,  128.0, 127.8, 103.5, 94.5, 
78.34, 73.9, 73.1, 72.6, 69.5, 66.6, 48.5, 40.2, 25.9, 25.4, 25.2, 24.3, 15.9. 
Compound 284 was also characterized in C6D6: 
1
H NMR (C6D6, 500 MHz): δ7.30-7.02 
(br, 5H), 5.10 (br, 2H), 4.30 (br, 2H), 4.17 (dd, 1H, J1 = 1.3, J2 = 17.7 Hz), 3.98 (ddd, 1H J1  
= 2.6, J2 = 6.4, J3 = 7.8 Hz), 3.90 (dd, 1H, J1 = 1.1, J2 = 17.7 Hz), 3.70 (t, 1H, J = 7.8 Hz), 
3.38 (t, 1H, J = 8.7 Hz), 1.68 (s, 3H), 1.56 (s, 3H), 1.04 (s, 3H), 0.98 (s, 12H). 
 
 13
C NMR (C6D6, 125 MHz): δ 205.7, 152.9, 137.7, 129.1,  128.7, 128.6, 128.2,  103.7, 
95.2, 79.4, 75.0, 73. 8, 70.1, 67.1, 49.5, 40.6, 26.5, 25.8, 25.6, 24. 8, 15.9.  
 
HRMS exact mass calcd for (C23H33NO7 + H )
+
  requires 436.2335, found  m/z . 436.2335. 
LRMS (EI+, 70 eV): m/z (%): 436 (100)  [M+1 ]
+
, 420 (38), 360 (57), 336 (25), 108 (48), 
91 (37). 
 
IR (KBr): 3622-3202 (br), 2981 (m), 1732( m), 1706 (s), 1163 (s), 1064 (s) cm
-1
. 
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N-Isopropyl-L-idonojirimycin (270) 
N
OH
OH
OH
HOPd/C; H2
O O
O
t-Bu Me
O
NCbz
OH
284
270
MeOH; 12hr
Y : 82%
 
Reaction was done based on modified procedure P7 
To a solution of the aldol adduct 284 (90 mg, 0.21mmol) in MeOH (3.0 mL) was added 
10% Pd/C (30 mg). The suspension was stirred under H2 (~5.0 psi) at ambient temperature 
for 24 hours. The solution was acidified (2N HCl; 0.5 mL) and stirred under H2 for 6 hr at 
room temperature. The reaction mixture was then filtered through Celite and the solvent 
was removed under reduced pressure to yield the crude N-isopropyl iminosugar. The 
residue was purified by column chromatography on silica gel (hexanes/ethyl acetate 1 : 5) 
to afford compound 270 as a pale yellow gummy product (34 mg; 82%).  
 [α]D
24
 = -28 (c 1.2, H2O); 
 
1
H NMR (D2O, 500 MHz): δ 4.33 ( br, 1H), 4.30 (br, 1H), 4.09 (dd, 1H, J1 = 5.2, J2 = 12.8 
Hz ), 4.05-3.95 (m, 2H), 3.86 (t, 1H, J = 2.8 Hz), 3.61-3.54 (m, 2H), 3.25 (br, 1H), 1.42 (d, 
J = 6.5 Hz, 3H),  1.31 (d, J = 6.5 Hz, 3H).  
 
13
C NMR (D2O, 125 MHz): δ 70.04, 66.96, 66.63, 63.82, 58.89, 54.14, 48.69, 17.83, 
13.31.   
HRMS exact mass calcd for (C9H19NO4 + H )
+
  requires 205.1314, found  205.1311m/z 
LRMS (EI+, 70 eV): m/z (%): 205 (100), 188 (46), 156 (22), 120 (37). 
IR (KBr): 3560-3100 (br), 2996 (m), 1232 (s) cm
-1 
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N-Isopropyl-L-idonojirimycin tetraacetate (287) 
N
OH
OH
OH
HO
N
OAc
OAc
AcO
NaOAc , Ac2O
ref lux, 2hr
Y: 77%
OAc
270 287  
Reaction was done based on modified procedure P9 
To the crude compound 270 (20 mg; 0.10 mmol), was added sodium acetate (82 mg, 1.0 
mmol) and acetic anhydride (3mL). The resulting mixture was heated to 90 
o
C for 2 hr and 
the reaction was quenched with ice and saturated NaHCO3 solution. Then the mixture was 
extracted with ethyl acetate (3 x 20 mL), and the combined organic layers were washed 
with brine. The organic phase was dried over anhydrous Na2SO4, concentrated to get the 
crude product which was purified by silica-gel flash column chromatography where 
product eluted at 30-35% EtOAc in hexanes to yield the acetylated title compound 287 (21 
mg, 58%) as a thick oil. 
[α]D
24 
= -41 (c 0.85, CHCl3) 
1
H NMR (CDCl3, 500 MHz): δ 5.43 (dd, 1H, J1 = 1.8, J2 = 6.0 Hz), 5.02       (dd, 1H, J1 = 
1.8, J2 = 6.0 Hz), 4.85 (ddd, 1H, J1 = 2.6, J2 = 5.0, J3 = 7.6 Hz), 4.39 (dd, 1H, J1 = 8.2, J2 = 
12.05 Hz), 4.22 (dd, 1H, J1 = 2.5, J2 = 12.05 Hz), 3.37 (ddd, 1H, J1 = 2.5, J2 = 6.0, J3 = 8.2 
Hz), 3.01 (m, 1H, J = 6.6 Hz), 2.84 (dd, 1H, J1 = 5.0, J2 = 12.7 Hz), 2.75 (dd, 1H, J1 = 7.6, 
J2 = 12.7 Hz),  2.11 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.98 (s, 3H), 1.03 (t, 6H, J = 6.6 
Hz).  
 13
C NMR (CDCl3, 125 MHz): δ 171.1, 170.09, 170.08, 169.67,  69.5, 68.5, 67.7, 60.8, 
57.0, 52.8, 40.2, 21.4, 21.2, 21.17, 21.07, 21.02.  
 156 
 
HRMS (EI+, 70 eV) exact mass calcd for (C17H27NO8 + H )
+
 requires 373.1737, found m/z  
373.1738.  
LRMS (EI+, 70 eV): m/z (%): 373 (23), 358 (19), 300 (100), 240 (22), 180 (15), 138 (37). 
IR (KBr): 2969 (m), 2934 (w), 2867 (w), 1744 (s), 1435 (w), 1369 (m), 1232 (s), 1033 
(m),  1061 (s), 891 (w) cm
-1
. 
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1-Deoxy-L-idonorijimycin tosylate (269)  
N OH
OH
OH
HO
269.PTSA
H HTsO
O O
O
t -Bu
O
NCbz
OH
284
Me
2) Pd/C; H2
MeOH; 12hr
1) p-TSA (0.2 eq)
Y: 90%
MeOH
 
Reaction was done based on modified procedure P8 
 
To a solution of aldol adduct 284 (85 mg, 0.20 mmol) in MeOH (3 mL) was added p-
TsOH (7.0 mg, 0.04 mmol). The resulting mixture was stirred at ambient temperature for 
15 min and then 10% Pd/C (30 mg) was added and the mixture was stirred under H2 (~5 
psi) at ambient temperature for 24 hr. Acid was then added (2N HCl; 0.5 mL) and the 
mixture was stirred under H2 for 12 hr at room temperature. The reaction mixture was 
filtered through Celite and the residue was washed with EtOH/H2O (10 : 1); evaporation of 
the solvent afforded a mixture of partially tosylate salt of L-DIJ (269) along with free 
amine of L-DIJ as a light brown solid (57 mg). The crude product was subjected to 
acetylation without furthur purification.  
1
H NMR (D2O, 500 MHz): δ 7.66 (d, 2H, J = 7.7 Hz),  7.35 (d, 2H, J = 7.7 Hz), 4.22 (br, 
1H), 4.14 (br, 1H), 3.86 (m, 2H), 3.50 (d, 1H, J = 13.8 Hz), 3.39 (t, 1H, J = 6.4 Hz), 3.24 
(d, 1H, J = 13.8 Hz), 2.94 (br, 1H), 2.37 (s, 3H). 
 13
C NMR (D2O, 125 MHz): δ 142.7, 139.7, 129.7, 125.6, 67.9, 67.4, 66.9, 60.6, 59.5, 
48.6, 20.7.  
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1-Deoxy-L-idonorijimycin pentaacetate (289) 
Ac2O, Py
cat.,DMAP
12 hr; rt
Y: 55%
N OH
OH
OH
HO
269
H HTsO
N
OAc
OAc
OAc
AcO
289O
 
To a solution of compound 269 (60 mg, 0.18 mmol) in CH2Cl2 (2 mL) were added pyridine 
(0.50 mL), acetic anhydride (0.50 mL), and DMAP (cat. amount).  The resulting mixture 
was stirred at room temperature for 12 hr. Then reaction was quenched with a saturated 
solution of NaHCO3 (2.0 mL) and extracted with CH2Cl2 (2 x 10 mL) and the combined 
organic layers were dried (Na2SO4) concentrated under reduced pressure and dried under 
high vacuum to yield the crude DIJ-pentaacetate. The residue was purified by FCC over 
silica gel (the product eluted at 70-75% ethyl acetate in hexanes), evaporation and drying 
afforded the pentaacetate 289 (36 mg, 55%) as a yellow oil. 
[α]D
24 
= -9 (c 1.1, CH2Cl2) 
1
H NMR (95
o 
C, C5D5N, 500 MHz): δ 5.98 (t, 1H, J = 2.5 Hz ), 5.31 (t, 1H,  J = 4.2 Hz ), 
5.13 (ddd, 1H, J1 = 3.05, J2  = 5.2, J3 = 8.2 Hz ), 5.00 (t, 1H, J = 10.5 Hz ), 4.60 (d, 1H, J =  
11.2 Hz),  3.63 (br, 1H), 3.48 (br, 1H), 2.23 (s, 3H), 2.19 (s, 3H), 2.05 (s, 6H), 2.01 (s, 3H). 
               
HRMS (CI, NH3) exact mass calcd for (C16H23NO9 + H )
+
 requires 374.1451, found m/z  
374.1461.  
LRMS (CI, NH3): m/z (%): 391 (M+NH3, 40), 374 (100), 346 (68), 314 (22), 272 (11), 180 
(17).
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Compound (290) 
283
O O
O
t-Bu Me
+ O O
O
t -Bu Me
O
N
O
O
OH
1b 290
(R)-proline 30 mol%;
LiCl (1 eq); DMSO
48 hr; 5 oCO
HO
OH
N
O
O
dr: 5 : 01
Y: 58%  
Reaction was done based on modified procedure P2 
 
(R)-Proline catalyzed aldol reaction of dioxanone 1b (145 mg; 0.840 mmol) and (S)-
isoserinal hydrate 283 (200 mg, 0.760 mmol) in the presence of LiCl (32 mg, 0.76 mmol) 
gave a gummy crude product. The product was fractionated by FCC (20-25% EtOAc in 
hexanes) to yield the title compound 290 as a thick oil (191 mg, 58%).   
 [α]D
22 
= +32 (c 1.02, C6H6) 
1
H NMR (C6D6, 500 MHz): δ7.31-7.02 (br, 5H), 5.11 (d, 2H, J = 12.5 Hz), 4.20 (br, 2H), 
4.05 (dd, 1H,  J1 = 1.1, J2 = 18 Hz), 3.83 (dd, 1H, J1 = 1.1, J2 = 18 Hz), 3.73 (br, 1H), 3.48 
(m, 2H), 3.14 (br, 1H),  1.77 (s, 3H), 1.55 (s, 3H), 1.04 (s, 3H), 0.97 (s, 9H).  
 
13
C NMR (C6D6, 125 MHz): δ 209.0, 152.8, 137.9, 129.0,  128.7, 128.6, 128.2,  104.4, 
94.8, 76.3, 73.9, 73.7, 71.1, 69.9, 67.1, 48.8, 40.6, 25.6, 25.4, 25.0, 24.3, 16.2. 
 HRMS exact mass calcd for (C23H33NO7 + H )
+
 requires 436.2335, found  m/z . 436.2331.  
LRMS (EI+, 70 eV): m/z (%): 436 (100), 420 (48), 360 (35), 336 (25), 108 (41), 91 (55).  
IR νmax: 3640-3244 (br), 1738 (m), 1710 (s), 1091 (s) cm
-1
. 
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1-Deoxy-L-mannorijimycin tosylate salt 
2N HCl
EtOH
271.HCl
O O
O
t-Bu
O
NCbz
OH
290
Me
N
OH
OH
HO
H H
TsO
N
OH
OH
HO
H H
Cl
OHOH2) Pd/C; H2
MeOH; 12hr
1) p-TSA (0.2 eq)
Y: 90%
MeOH
Amberlite IR-120
 
Reaction was done based on modified procedure P8 
To a solution of aldol adduct 290 (0.11 g, 0.25 mmol) in MeOH (3.0 mL) was added p-
TsOH (9.0 mg, 0.25 mmol). The resulting mixture was stirred at ambient temperature for 
15 min and then Pd/C was added (10 %, 30 mg) and the mixture was stirred under H2 (~5 
psi) at ambient temperature for 24 hr. Acid (2N HCl, 0.5 mL) was then added and the 
mixture was stirred under H2 for 12 hr at room temperature. The reaction mixture was 
filtered through Celite and the residue was washed with EtOH/H2O (10 : 1); evaporation of 
the solvent afforded the tosyl salt of L-DMJ as a light brown gummy compound (55 mg, 
62%).        
 
13
C NMR (D2O, 125 MHz): δ 141.7, 136.9, 129.3, 125.2, 72.7, 66.6, 64.4, 59.9, 58.9, 
45.9, and 20.3.  
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1-Deoxy-L-mannorijimycin hydrochloride (271)  
 
To a solution of the tosylate salt (40 mg; 0.12 mmol) in EtOH (5 mL) was added conc. HCl 
(0.5 mL) and the solution was stirred at room teperature for 2 hr. The solvent was 
evaporated under reduced pressure to yield a gummy solid. The crude product was purified 
on a cation exchange column (Amberlite IR-120, H
+
 form). The column was first eluted 
with MeOH and then with 5% aqueous ammonia. The alkaline phase was evaporated under 
reduced pressure and co-distilled thrice with toluene to yield a gummy product. The 
resulting residue was stirred with etheric HCl for 10 minutes, then solvent was evaporated 
and  the sample was dried under high vacuum to yield the 1-DMJ hydrochloride (271) as a 
pale yellow solid (15 mg, 66%). 
Melting point: 183-186 
o
C; (Lit:
 150b
 185-187 
o
C)  
[α]D
24 
= +11.3 (c 0.33; H2O); (Lit:
150b
 [α]D
24 
= +10.2, c 0.37, H2O) 
1
H NMR (D2O, 500 MHz):  δ 4.18 (dd, 1H, J1 = 2.9, J2 = 2.2 Hz), 4.08 (ddd, 1H,  J1 = 1.7, 
J2 = 4.9, J3 = 12.2 Hz), 3.90 (dd, 1H, J1 = 5.2, J2 = 13.2 Hz), 3.82 (dd, 1H, J1 = 8.5, J2 = 
13.2 Hz), 3.65 (dd, 1H, J1 = 2.9, J2 = 9.5 Hz), 3.52 (dd, 1H,  J1 = 4.9, J2 = 12.4 Hz), 3.43 
(ddd, 1H, J1 = 2.2, J2 = 5.2, J3 = 8.8 Hz), 2.89 (t, 1H, J = 12.4 Hz).  
13
C NMR (D2O, 125 MHz): δ 73.17, 67.13, 64.8, 60.3, 59.3, 46.3. 
HRMS (ESI) exact mass calcd for (C6H13NO4 + H)
+
 requires 164.0922, found  m/z . 
164.0920.  
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Literature data for L-DMJ are provided below for comparison:  
 
Meyers, A. I.; Anders, C. J.; Resek, J. E.; Woodall, C. C.; McLaughlin, M. A.; Lee, P. H.; 
Price, D. A. Tetrahedron, 1999, 55, 8931-8952 
 
L-deoxymannojirimycin.HCl : [α]D
20 
= +9.6 (c 1.2, H2O), mp: 182-184 
o
C 
 
1
H NMR (D2O):  δ 4.28 (br(s), 1H), 4.02 (dd, 1H, J = 12.5, 3.0 Hz), 3.92 (t, 1H, J = 8.8 
Hz), 3.89 (d, 1H, J = 12.5 Hz), 3.74 (dd, 1H, J = 9.5, 2.5 Hz), 3.47 (dd, 1H, J = 13.6, 2.2 
Hz), 3.30 (d, 1H, J = 12.5, 3.0 Hz), 3.21 (m, 1H). 
13
C NMR (D2O): δ 73.2, 66.7, 66.5, 61.2, 58.9, 48.3. 
 
Fleet, G. W. J.; Ramsden, N. G.; Witty, D. R. Tetrahedron, 1989, 45, 1, 319-326 
 
L-deoxymannojirimycin.HCl : [α]D
20 
 +10.2 (c 0.37;H2O), mp: 185-187 
o
C 
 
1
H NMR (D2O):  δ 4.10 (ddd, 1H), 3.72 (dd, 1H), 3.69 (dd, 1H), 3.54 (dd, 1H), 3.27 (dd, 
1H), 3.10 (dd, 1H), 3.01 (ddd, 1H).
   
 
13
C NMR (D2O): δ 73.1, 66.6, 66.5, 61.1, 58.8, 48.3. 
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Miscellaneous   
(S)-Methyl 2-oxooxazolidine-5-carboxylate (336): 
O
O
O
N
C
O
O
O
O
HO
O
O
O
O
Cl
O
O
O
O
N3
O
(S)-275
1. SOCl2, reflux, 30 min
2. evaporation with CCl4 276
NaN3
acetone: water
-20 oC, 30 min
 C6H6 reflux,
 then evaporation
1) conc. HCl
0 oC to rt.; 30 min
277
278
HN
O
(S)
O
OO
336
SOCl2; MeOH
Y: 58%
2)
 
Compound (S)-275 (2.5 g, 14.4 mmol) was sequentially transformed into isocyanate 
intermediate 278 under same conditions as described before. To the resulting isocyanate 
278, concentrated HCl (10 mL) was added at 0 
o
C and stirred at room temperature for half-
hour. The reaction mixture was evaporated under high vacuum. The resulting residue was 
dissolved in methanol (25 mL), added SOCl2 (5 mL) at 0 
o
C and stirred at room 
temperature for 6 hours.  The solvent was evaporated and the product was purified by FCC 
afford pure (S)-methyl 2-oxooxazolidine-5-carboxylate (336, 1.2 g, 58%). 
[α] 25 D = +18 (c 1.05, EtOAc) 
1
H NMR (CDCl3, 500 MHz): δ 5.78 (br, 1H (NH) ), 5.02 ( dd, 1H, J1 = 5.4 Hz, J2 = 9.5 
Hz), 3.88 (dd, 1H, J1 = 0.8 Hz, J2 = 9.5 Hz), 3.83 (s, 3H), 3.69 (ddd, 1H, J1 = 0.8 Hz, J2 = 
5.4 Hz, J3 = 9.5 Hz). 
  
13
C NMR (CDCl3, 125 MHz): δ 169.6 , 159.1, 72.8, 53.2, 43.8. 
IR (KBr): 3288 (br), 2964, 2913, 1756 (s), 1437, 1244, 1094, 1027, 925, 662 cm
-1
. 
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(S)-3-Benzyl 5-methyl 2-oxooxazolidine-3,5-dicarboxylate (337): 
HN
O
(S)
O
OO O
(S)
O
OO
NO
O
336 337
CbzCl; Et3N
Cat. DMAP; THF
-20o C ; overnight
Y: 91%  
To a stirred solution of oxazolidinone methyl ester 336 (1.10 g, 7.58 mmol) in 1N aq 
NaOH (20.0 mL) at 0 
o
C was added a solution of benzylchloroformate (1.3 mL, 9.1 mmol) 
in dioxane (5.0 mL) over a period of 30 minutes. The resulting mixture was stirred at room 
temperature for 2 hr, then dioxane was evaporated at reduced pressure. The resulting 
aqueous solution was first washed with Et2O (30 mL) and was next acidified with 1N aq. 
KHSO4 ( 20 mL) at 0 
o
C. The mixture was extracted with EtOAc (3 x 50 mL). The 
combined organic layers were washed with brine solution and then dried over NaSO4, 
concentrated to get a crude product. This solid was washed with Et2O (50 mL) to remove 
the non-polar impurities and then dried over high vacuum to yield compound 337 (1.9 g, 
91%).  
Melting Point: 49-50 
o
C 
[α] 25 D= +24 (c 1.0, CHCl3) 
1
H NMR (CDCl3, 500 MHz): δ 7.33-7.41 (m, 5H), 5.29 (s, 2H), 4.92 ( dd, 1H, J1 = 5.1 Hz, 
J2 = 9.5 Hz), 4.20 (dd, 1H, J1 = 9.5, J2 = 10.7 Hz), 4.08 (ddd, 1H, J1 = 5.1, J2 =10.7 Hz), 
3.83 (s, 3H). 
  
13
C NMR (D2O, 125 MHz): δ 168.4, 153.1, 150.4, 134.8, 128.8, 128.5, 69.4, 69.0, 53.3, 
46.1. 
IR (KBr): 3031, 2960, 1822, 1733, 1388, 1286, 1214, 1061, 769, 744, 699 cm
-1
. 
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4.4.5 Synthesis of (+) D-glycero-D-manno-2-octulose  
 
(4R,5R)-4-[(R)-(1,3-Dithian-2-yl)(hydroxy)methyl]-2,2-dimethyl-1,3-dioxan-5-ol 
(294a)
12,20 
O O
O OH
S
S
O O
OH OH
S
S
250a 294a
-20 oC, 24hr;
NaBH(OAc)3
AcOH:DCM (1:5),
Y : 96%
dr : 98 :02  
Reaction was done based on modified procedure P5 
 
To a solution of -hydroxyketone 250a (1.5g, 5.4 mmol) in dry CH2Cl2 (20 mL) were 
added AcOH (3.8 mL) and NaBH(OAc)3 (1.7 g, 8.1 mmol) at -20 C. The mixture was 
stirred at -20 C for 36 hr (reaction was followed by TLC). The reaction mixture was 
quenched with saturated sodium bicarbonate solution and extracted with CH2Cl2 (3 x 50 
mL). The combined organic layers were washed with brine, dried over anhydrous Na2SO4, 
concentrated to get the crude diol mixture in a ratio of 2 : 98 trans : cis (by 
1
H NMR), 
which was purified by FCC on silica gel (hexanes : ethyl acetate 30%) to give the pure 
product which was dried under high vacuum to yield 294a (1.45 g,  96.0%).  
 []23D = -15.1 (c 1.2, CHCl3), Melting point: 60-61 C 
 
1
H NMR (500 MHz, CDCl3) δ: 4.42 (d, J = 3.1 Hz, 1H,), 3.95 (m, 1H), 3.90 (m, 2H), 3.82 
(m, 1H), 3.64 (dd, J1 = 8.8 Hz, J2 = 11.4 Hz, 1H), 3.36 (d, J = 1.9 Hz, 1H), 3.05 (d, J = 3.8 
Hz, 1H), 2.93 (m, 1H), 2.83 (m,1H), 2.10 (m, 1H), 1.91 (m, 1H), 1.48 (s, 3H), 1.37 (s, 3H). 
  
13
C NMR (125 MHz, CDCl3) δ: 99.2, 78.5, 71.8, 67.2, 64.2, 49.1, 29.8, 29.0, 28.5, 26.0, 
19.7 
IR (KBr): 3412 (b), 2910 (s), 2820 (m), 1478 (w), 1456 (m), 1103 (s) cm
-1
. 
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 (4R,5R)-5-(Benzyloxy)-4-((R)-benzyloxy(1,3-dithian-2-yl)methyl)-2,2-dimethyl-1,3-
dioxane) (296) 
O O
OH OH
S
S
O O
OBn OBn
S
S
294a 296
0 oC to rt, 6hr
Y : 87%
NaH, BnBr
TBAI, THF
 
To a stirred solution of NaH (80% w/w) (0.24 g, 7.86 mmol) in dry THF (2 mL) at 0
o
 C 
under inert atmosphere, was added compound 294a (1.0 g, 3.57 mmol) in dry THF (10 
mL). The resulting mixture was stirred at 0 
o
C for 15 minutes and benzylbromide (0.95 
mL, 7.86 mmol) and TBAI (1.3 g, 3.57 mmol) were added. The resulting mixture was 
stirred at ambient temperature for 6 hr. After TLC showed no starting material the reaction 
was quenched with saturated NaHCO3 solution and extracted with EtOAc (3x50 mL). The 
combined organic layers were washed with brine, dried over anhydrous Na2SO4 and 
concentrated to yield the crude product which was purified by flash chromatography on 
silica gel using hexanes : EtOAc (5%>10%) to give the desired product 296 (1.42 g, 87.0 
%). 
[]23D = -4.2 (c 1.23, CHCl3) 
1
H NMR (CDCl3, 500 MHz):  δ 7.47-7.28 (m, 10H), 4.83 (m, 2H), 4.55 (dd, 2H, J1 = 11.4 
Hz, J2 = 18.6 Hz), 4.46 (d, 1H, J = 9.2 Hz), 4.30 (dd, 1H, J1 = 1.9 Hz, J2 = 8.6 Hz), 3.90 
(m, 2H), 3.72 (m, 2H), 2.80 (m, 2H),  2.70 (m, 2H),  2.03 (m, 1H), 1.88 (m, 1H), 1.48 (s, 
3H), 1.41 (s, 3H). 
13
C NMR (CDCl3, 125 MHz): δ 200.8, 137.7, 137.6, 128.5, 127.98, 127.97, 127.96, 99.2, 
83.5, 74.9, 73.2, 72.1, 69.2, 62.6, 28.6, 19.0. 
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HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C25H32O4S2) requires 460.1742, found  
m/z 460.1741.  
LRMS (EI+, 70 eV): m/z (%) = 460 (0.5) [M ]
+
, 445 (1), 352 (4), 294 (10), 203 (12), 160 
(21), 91 (100). 
IR (KBr): 3083 (w), 3071 (w), 3019 (w), 2989 (s), 2892 (s), 1496 (w) 1453 (m), 1376 (m), 
1090 (s), 735 (m), 698 (s) cm
-1
. 
 
(R)-2-(Benzyloxy)-2-((4R,5R)-5-(benzyloxy)-2,2-dimethyl-1,3-dioxan-4-
yl)acetaldehyde (298) 
O O
OBn OBn
S
S
O O
OBn OBn
O
H
296 298
0 oC, 15min.
NBS, AgNO3,
CH3CN:H2O (4:1)
Y : 69%
 
Reaction was done based on the modified Corey procedure P6
157
 
To a solution of dithiane compound 296 (0.560 g, 1.23 mmol) in 10 mL of acetonitrile : 
water (4 : 1) at 0 
o
C added N-bromosuccinimide (0.870 g, 4.87 mmol) followed by silver 
nitrate (0.930 g, 5.48 mmol) and the mixture was stirred at same temperature for 5 minutes. 
TLC showed no starting material (both product and starting material have similar Rf). The 
reaction was quenched with 10% sodium sulfite solution and filtered through the celite 
bed, washed with CH2Cl2 (15.0 mL), the resulting mixture was extracted with CH2Cl2 (2 x 
15 mL). The combined organic layers were washed with saturated NaHCO3 solution 
followed by brine, dried over anhydrous Na2SO4. Concentration under reduced pressure 
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gave a crude aldehyde (0.41 g, 91 %). Purification by flash chromatography on silica gel 
and using hexanes : EtOAc (5%>10%) gave the desired product 298 (0.31 g, 68%) 
[]25D = -25.7 (c 1.0, CHCl3).  
1
H NMR (CDCl3, 500 MHz): δ 9.57 ( d, 1H, J = 0.92 Hz), 7.4-7.23 (m, 10H), 4.80 (m, 
2H), 4.51 (dd, 2H, J1 = 11.5 Hz, J2 = 18.1 Hz), 4.15 (dd, 1H, J = 9.2 Hz,), 3.97 (d, 1H), 
3.86 (m, 2H), 3.65 (dd, 1H, J1 10.3 Hz, J2 1 Hz), 1.48 (s, 3H), 1.41(s,3H).  
13
C NMR (CDCl3, 125 MHz): δ 200.8, 137.7, 137.6, 128.5, 127.98, 127.97, 127.96, 99.2, 
83.5, 74.9, 73.2, 72.1, 69.2, 62.6, 28.6, 19.0. 
HRMS (CI, NH3) exact mass calcd for [M]
+ 
(C22H26O5 + NH4
+
) requires 388.2124, found  
m/z 388.2124.  
LRMS (CI, NH3): m/z (%) = 388 (100) [M + NH4
+
], 371 (26) [M + 1], 330 (27), 280 (10), 
198 (11), 149 (13), 108 (55), 91 (37). 
IR (KBr):  3077 (w), 3066 (w), 3024 (w), 2992 (s), 2868 (s), 1734 (s), 1496 (w) 1454 (m), 
1378 (m), 1096 (s), 866 (m), 739 (m), 699 (s) cm
-1
. 
 
(2R,4R,5R)-4-((R)-(1,3-Dithian-2-yl)(hydroxy)methyl)-2-tert-butyl-2-methyl-1,3-
dioxan-5-ol (294b) 
O O
O OH
S
S
t -Bu Me
O O
OH OH
S
S
t-Bu Me
250b 294b
-20 oC, 24hr;
NaBH(OAc)3
AcOH:DCM (1:5),
Y : 92%
dr : 98 :02
 
Reaction was done based on modified procedure P5 on compound 250b (5.1 mmol) to 
afford compound 294b in 92 % yield. 
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Melting Point: 127-129 
o
C 
[]25D = -24.3 (c 1.0, CHCl3). 
 
1
H NMR (CDCl3, 500 MHz): δ4.38 ( d, 1H, J = 2.8 Hz),  3.96 (q, 1H, J = 2.8 Hz), 3.89 
(dd, 1H, J1 = 5.3 Hz, J2 = 10.8 Hz), 3.83 (t, 1H, J = 8.7 Hz), 3.69 (m, 1H), 3.61 (t, 1H, J = 
10.6 Hz), 3.25 (d, OH), 2.95 (m, 2H), 2.76 (m, 2H), 2.08 (m, 1H), 1.92 (m, 1H), 1.37 (s, 
3H), 0.92 (s, 9H). 
13
C NMR (CDCl3, 125 MHz): δ 102.8, 79.1, 71.6, 67.1, 63.8, 49.6, 39.4, 30.1, 29.3, 26.0, 
24.9, 12.5. 
HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C14H24O4S2) requires 322.1273, found  
m/z 320.1275.  
LRMS (EI, 70 eV): m/z (%) = 322 (11) [M]
+
, 307 (11), 265 (19), 187 (19), 161 (100), 
143(22), 101 (33). 
IR (KBr): 3377 (br), 2952 (s), 2902 (s), 1486 (w) 1454 (m), 1158 (s), 1098 (s)  cm
-1
. 
X-ray structure of compound 294b: (crystal was prepared by slow evaporation of a 
solution of 294b in CH2Cl2 and hexanes (30 : 70. The ORTEP diagram is shown below. 
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(2R,4S)-4-((1S,2S)-2-(Benzyloxy)-2-((4R,5R)-5-(benzyloxy)-2,2-dimethyl-1,3-dioxan -
4-yl)-1-hydroxyethyl)-2-tert-butyl-2-methyl-1,3-dioxan-5-one (299) 
O O
O
Met-Bu
+
O O
OBn OBn
O
H
1b 298
O O
O OH
OBn
t -Bu
OO
OBn
O O
O
OBn
t-Bu
OO
OBn+
299 301
Me
Me
O O
O OH
OBn
t-Bu
OO
OBn
300
Me
+
 
Reaction was done based on modified procedure P2 
[]25D = -54.6 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 MHz): δ 7.34-7.22 (m, 10H), 4.80 (d, 
1H, J = 11.6 Hz), 4.59 (d, 1H, J = 11.6 Hz), 4.47 (s, 2H), 4.41 (d, 1H, J = 5.6 Hz), 4.32 (d, 
1H, J  = 17.6 Hz), 4.16 (d, 1H, J  = 17.7 Hz), 4.10 (m, 2H), 3.95 (m, 1H), 3.88 (dd, 1H, J1 
= 4.6 Hz, J1 = 11.6 Hz), 3.78 (m, 1H), 3.67 (dd, 1H, J1 = 7.3 Hz, J1 = 11.5 Hz), 3.46 (s, 
OH),  1.41 (s, 3H), 1.36 (s, 3H), 1.24 (s, 3H), 0.96 (s, 9H). 
13
C NMR (CDCl3, 125 MHz): δ 208.3, 138.8, 137.8, 128.7- 127.8 (8 CH), 103.99, 99.6, 
78.7, 76.4, 74.2, 73.9, 72.2,  71.9,  71.8,  70.1,  62.5, 40.3, 27.9, 25.4, 20.2, 16.6. 
HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C31H42O8) requires 542.2880, found  m/z 
542.2878.  
LRMS (EI+, 70 eV): m/z (%) = 542 (10.6) [M ]
+
, 527 (39), 485 (92), 427 (46), 393 (32), 
371 (100), 355 (30), 321 (44), 304 (71). 
IR (KBr): 3465 (Br), 3064 (w), 3030 (w), 2982 (s), 2962(s), 2871(s),  1737 (s), 1484 (w) 
1453 (m), 1376 (m), 1214(s), 1158 (s), 1087 (s), 889 (m), 726 (m), 690 (s) cm
-1
. 
Anal. Calcd for C31H42O8: C, 68.61; H, 7.8. Found: C, 68.69; H, 7.84. 
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(3S,4R,5S,6R,7R)-5,7-bis(Benzyloxy)-1,3,4,6,8-pentahydroxyoctan-2-one (303):  
O O
O OH
OBn
t-Bu
OO
OBn
299Me 304
O
OH
HO OH
HO
BnO
OBn
OH
O
OAc
AcO OAc
AcO
BnO
OBn
OAc
303  
A 25 mL RBF was charged with compound 299 (32 mg, 0.06 mmol) and THF (2.0 mL) 
and 2N HCl (2.0 mL) was added. The resulting mixture was stirred at ambient temperature 
for one hour, after which time TLC showed no staring material. The reaction mixture was 
concentrated and dried over high vacuum to afford  gummy crude product 303 which was 
subjected to acetylation without further purification. 
(3S,4S,5S)-6-((R)-2-Acetoxy-1-(benzyloxy)ethyl)-2-(acetoxymethyl)-5-benzyloxy) 
tetrahydro-2H-pyran-2,3,4-triyl triacetate (304): 
Reaction was done based on modified procedure P9 
 To the crude compound 303 was added sodium acetate (58 mg, 0.70 mmol) and acetic 
anhydride (3 mL).The resulting mixture was heated to 90 
o
C for 2 hr and the reaction was 
quenched with ice and with saturated NaHCO3 solution. The mixture was then extracted 
with ethyl acetate (3 x 20 mL), and the combined organic layers were washed with brine. 
The organic phase was dried over anhydrous Na2SO4, concentrated to yield the crude 
product which was purified by silica-gel flash column chromatography where product 
eluted at 30% EtOAc : hexanes to yield compound 304 (24 mg, 65%).  
[]23D = +44.6 (c 1, CHCl3)  
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1
H NMR (CDCl3, 500 MHz): δ 7.35-7.19 (m, 10H), 5.43 (d, 1H, J = 3.2 Hz), 5.35 (dd, 
1H, J1 = 3.2 Hz, J1 = 9.9 Hz), 4.77 (dd, 2H, J1 = 12.1 Hz, J2 = 12.0 Hz), 4.65 (dd, 3H, J1 = 
10.1 Hz, J2 = 11.0 Hz), 4.42 (d, 1H, J = 12.1 Hz), 4.26 (dd, 1H, J1 = 8.2 Hz, J2 = 8.1 Hz), 
4.18 (dd, 1H, J1 = 4.1 Hz, J2 = 4.0 Hz), 4.1 (t, 1H, J = 9.9 Hz), 3.95 (dd, 1H, J1 = 0.92 Hz, 
J2 = 4.0 Hz), 3.82 (dd, 1H, J1 = 0.92 Hz, J2 = 9.9 Hz), 2.12 (s, 3H), 2.10 (s, 3H), 2.00 (s, 
3H), 1.99 (s, 3H), 1.92 (s, 3H).  
 
13
C NMR (CDCl3, 125 MHz): δ 170.9, 170.2, 170.0, 169.6, 168.0,  138.5, 137.7, 128.7- 
127.9 (8 CH), 103.99, 77.96, 75.2, 74.8, 73.4, 72.5, 72.3, 67.5, 64.8, 60.6,  22.0, 21.1, 
20.95, 20.87, 20.79. 
HRMS (CI, NH3) exact mass calcd for [M]
+ 
(C32H38O13 + NH4
+
) requires 648.2656, found  
m/z 648.2641.  
LRMS (CI, NH3): m/z (%) = 648 (100) [M + NH4
+
], 588 (12), 571 (71), 359 (9), 240 (6), 
108 (32), 91 (22), 77 (24). 
 
IR (KBr): 3024 (w), 2928 (m), 2868 (m), 1751 (s), 1493 (w), 1451 (m), 1369 (m), 1217 
(s),  1061 (s), 918 (m),  699 (w) cm
-1
. 
 
Anal. Calcd for C32H38O13: C, 60.95; H, 6.07. Found: C, 61.01; H, 6.07. 
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Miscellaneous 
 
(4R,5R)-4-((R)-(1,3-Dithian-2-yl)(methoxy)methyl)-5-methoxy-2,2-dimethyl-1,3-
dioxane (295) 
O O
OH OH
S
S
O O
OMe OMe
S
S
294a 295
0 oC to rt, 6hr
Y :89 %
NaH, MeI
 THF
 
 
To a stirred suspension of NaH (80 % w/w) (0.320 g, 10.7 mmol) in dry THF (1.0 mL) at 0 
o
C under inert atmosphere was added compound 294a (1.20 g, 4.29 mmol) in dry THF 
(10.0 mL). The resulting mixture was stirred at 0 
o
C for 15 minutes and added MeI (0.67 
mL, 10.7 mmol) was added and the resulting mixture was stirred at 0 
o
C for an hour. TLC 
showed no starting material, the reaction was quenched with saturated NaHCO3 solution 
and extracted with EtOAc (3 x 50 mL). The combined organic layers were washed with 
brine, dried over anhydrous Na2SO4, concentrated to get the crude product which was 
purified by flash chromatography on silica gel using hexanes : EtOAc (5%>10%>15%) to 
give the desired product 295 (1.2 g, 89%) as a thick oil.  
[]23D = -12 (c 1.1, CHCl3) 
1
H NMR (CDCl3, 500 MHz):  δ 4.34 (d, 1H, J = 7.8 Hz), 4.11 (dd, 1H, J1 = 3.0 Hz, J2 = 
8.4 Hz), 3.95 (dd, 1H, J1 = 4.6 Hz, J2 = 11.4 Hz), 3.68 (dd, 1H, J1 = 6.9 Hz, J2 = 11.4 Hz), 
3.61(dd, 1H, J1 = 4.5 Hz, J2 = 8.4 Hz), 3.60 (s, 3H), 3.45 (dd, 1H, J1 = 3.0 Hz, J2 = 7.8 Hz), 
3.37 (s, 3H), 2.8-2.9 (m, 4H), 2.01 (m, 1H), 1.93 (m, 1H), 1.44 (s, 3H), 1.37 (s, 3H).  
13
C NMR (CDCl3, 125 MHz):  δ 99.3, 84.5, 74.0, 72.3, 61.6, 61.1, 56.8, 48.5, 29.7, 29.2, 
27.5, 25.9, 20.4. 
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HRMS (EI+, 70 eV) exact mass calcd for [M]
+ 
(C13H24O4S2) requires 308.1116, found  
m/z 308.1124.  
LRMS (EI, 70 eV): m/z (%) = 308 (6) [M]
+
, 293 (5), 233 (6), 218 (25), 175 (13), 160 
(100), 121 (34), 101 (66), 59 (71). 
IR (KBr): 2988 (s), 2928 (s), 2898 (s), 2826 (s), 1438 (m), 1367 (m), 1104 (s) cm
-1
. 
Anal. Calcd for C13H24O4S2: C, 50.62; H, 7.84. Found: C, 50.65; H, 7.83.   
 
 
(R)-2-Methoxy-2-((4R,5R)-5-methoxy-2,2-dimethyl-1,3-dioxan-4-yl)acetaldehyde 
(297) 
 
O O
OMe OMe
S
S
O O
OMe OMe
O
H
295 297
 0 oC, 15min.
NBS, AgNO3, 
CH3CN:H2O (4:1)
Y : 51%
 
Reaction was done based on the modified Corey procedure P6
157
 
 
 To a solution of dithiane compound 295 (0.41 g, 1.3 mmol) in 20 mL of acetonitrile : 
water (4 : 1) at 0 
o
C was added N-bromosuccinimide (1.43 g, 8.01 mmol) followed by 
silver nitrate (1.48 g, 8.70 mmol) and the mixture was stirred at same temperature for 20 
minutes. TLC showed no starting material (both product and SM have similar Rf). The 
reaction was quenched with 10 % sodium sulfite solution and filtered through the Celite 
bed, washed with CH2Cl2 (15 mL) and the resulting mixture was extracted with CH2Cl2 (2 
x 15 mL). The combined organic layers were washed with saturated NaHCO3 solution 
follwed by brine and dried over anhydrous Na2SO4,. Up on concentration under reduced 
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pressure gave the crude aldehyde 297 (0.15 g, 51%). The aldehyde 297 turned out to be a 
volatile compound which appears to co-distill with the solvents during the workup 
procedure. 
[α] 25 D = -17 (c 1.0, CHCl3) 
1
H NMR (CDCl3, 500 MHz):  δ 9.58 ( d, 1H, J = 0.92 Hz), 4.0 (ddd, 2H, J1 = 4.3 Hz, J2 = 
11.6 Hz, J3 = 16.2 Hz), 3.73 (br, 1H), 3.62 (dd, 1H, J1= 9.2 Hz, J2 = 11.2 Hz), 3.57 (s, 3H), 
3.51 (dd, 1H, J1 = 4.3 Hz, J2 = 9.2 Hz), 3.32 (s, 3H), 1.46 (s, 3H), 1.38 (s, 3H). 
 
13
C NMR (CDCl3, 125 MHz):  δ 201.3, 99.9, 85.8, 74.5, 70.7, 62.0, 59.5, 57.3, 28.3, 19.2. 
 
HRMS (CI, NH3)exact mass calcd for [M]
+ 
(C10H18O5 + NH4
+
) requires 236.1496, found  
m/z 236.1490.  
 
IR (KBr):  2912, 2892, 1722, 1293, 1116, 1054, 865, 740, 699 cm
-1
. 
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4.4.6 Stereodivergent synthesis of DD- and LL- glycero-β-allo-heptopyranoses 
 
 
(S)-4-[(R)-1-Hydroxy-2,2-dimethoxyethyl]-2,2-dimethyl-1,3-dioxan-5-one (309a): 
 
 
1a
O O
O
Me Me
O O
O
Me Me
OH
310a (syn)
OMe
OMe O O
O
Me Me
OH
309a (anti)
OMe
OMe
2a
+
(S)-proline (30 mol%)
LiCl (1 eq); DMSO
4 days; 5 oC
yield (anti) : 67%
dr 92 : 08
er (anti) 98 : 02
H
O
O
O
+
 
Reaction was done based on modified procedure P2 
 
 To the solution of 2,2-dimethyl-1,3-dioxan-5-one 1a (2.00 g; 14.4 mmol) in dry DMSO 
(5.0 mL), added 60% aqueous solution of 2,2-dimethoxyacetaldehyde 2a (2.90 g; 16.9 
mmol), (S)-proline (530 mg, 4.60 mmol) followed by LiCl (647 mg; 15.4 mmol). The 
resulting mixture was flushed with nitrogen and stirred at room temperature for 15 min to 
dissolve all the reactants. The mixture was then refrigerated at 5 
o
C until the reaction was 
complete as shown by TLC (72 hr). Saturated NH4Cl solution and ethyl acetate were added 
with vigorous stirring, then the mixture was extracted with ethyl acetate (3 x 50 mL), and 
the combined organic layers were washed with brine. The organic phase was dried over 
anhydrous Na2SO4 and concentrated to afford the crude product. The ratio of 
diastereoisomers was measured by 
1
H NMR on the crude product and was found to be 92 : 
08 anti to syn. The crude product was purified by FCC (hexanes : ethyl acetate 7 : 3) to 
provide the anti-aldol adduct 309a (2.4 g; 67 % yield) as a pale yellow oil. 
Enantioselectivity was measured by 
1
H NMR in C6D6 with Eu(tfc)3 as a shift reagent. 
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[]25D = -134 (c 1.15, CHCl3) (96 % ee), (Lit. []
25
D = -122 (c 1.05, CHCl3) (90 % ee)
20,14
 
1
H NMR (500 MHz, CDCl3) δ: 4.65 (d, J = 6.8 Hz, 1H), 4.44 (dd, J1 = 1.3 Hz, J2 = 3.1 Hz, 
1H), 4.25 (dd, J1 = 1.5 Hz, J2 = 16.7 Hz, 1H), 4.07 (dd, J1 = 3.1 Hz, J2 = 6.8 Hz, 1H), 3.99 
(d, J = 16.7 Hz, 1H), 3.43 (s, 3H), 3.38 (s, 3H), 2.42 (br s, 1H), 1.47 (s, 6H).  
13
C NMR (125 MHz, CDCl3) δ: 206.5, 103.4, 100.5, 76.3, 71.2, 67.1, 55.4, 54.3, 25.0, 
23.0. 
 HRMS (CI, NH3) exact mass calcd., for [M + NH4]
+
 (C10H18O6 + NH4)
+
 requires 
252.1447, found 252.1451 m/z.  
LRMS (CI, NH3): m/z (%): 252 ([M+18]
+
, 20), 238 (22), 220 (56), 206( 44), 188 (70), 152 
(100), 148 (28). 
 IR (KBr): 3377 (br), 2941, 1747, 1446, 1377, 1193, 1074 cm
-1 
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(2R,4S)-2-tert-Butyl-4-((R)-1-hydroxy-2,2-dimethoxyethyl)-2-methyl-1,3-dioxan-5-one 
(310b): 
2a
H
O
O
O
+
1b
O O
O
t-Bu Me
O O
O
t -Bu Me
OH
310b (syn)
OMe
OMe O O
O
t -Bu Me
OH
309b (anti)
OMe
OMe
+
(S)-proline (30 mol%)
LiCl (1 eq); DMSO
4 days; 5 oC
yield (anti) : 73%
dr 96 : 04
er (anti) 98 : 02  
The reaction was carried out following a similar procedure to that described above for  
309a. Dioxanone 1b (1.0 g; 5.8 mmol) reacted with 60% aqueous solution of 2,2-
dimethoxyacetaldehyde 2a (1.1 g; 6.4 mmol) and LiCl (0.24 g; 5.8 mmol) in the presence 
of (S)-proline (0.2 g, 1.7 mmol) in DMSO (3 mL). The ratio of diastereoisomers was 
measured by 
1
H NMR of crude product and was found to be 96 : 04 anti to syn. The crude 
product was purified by FCC (hexanes : ethyl acetate 8 : 2) to provide the pure compound 
309b (1.2 g; 73 % yield) as a pale yellow oil. Enantioselectivity was measured by 
1
H NMR 
in C6D6 with Eu(tfc)3 as a shift reagent. 
[]25D = -45 (c 1.1, chloroform) (96 % ee)  
1
H NMR (500 MHz, CDCl3) δ: 4.66 (d, J = 7.4 Hz, 1H), 4.49 (dd, J1 = 1.4 Hz, J2 = 2.4 Hz, 
1H), 4.31 (dd, J1 = 1.4 Hz, J2 = 18.1 Hz, 1H), 4.18 (dd, J1 = 1.1 Hz, J2 = 18.1 Hz, 1H), 4.12 
(ddd, J1 = 2.4 Hz, J2 = 5.1 Hz, J3 = 7.4 Hz, 1H), 3.39 (s, 3H), 3.37 (s, 3H), 2.26 (d, J = 5.1 
Hz, 1H (OH)), 1.38 (s, 3H), 1.03 (s, 9H). 
 
13
C NMR (125 MHz, CDCl3) δ: 205.8, 103.4, 103.1, 78.3, 72.3, 69.4, 55.3, 53.3, 40.2, 
25.4, 15.6.  
HRMS (CI, NH3) exact mass calcd., for [M + NH4]
+
 (C13H24O6 + NH4)
+
 requires 
294.1917, found 294.1920 m/z. 
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 LRMS (CI, NH3): m/z (%): 294 ([M+18]
+
, 5), 277 (8), 262 (17), 245 (29), 230(15), 173 
(100), 115(24), 75 (34).  
IR (KBr): 3467 (br), 2960, 2834, 1730, 1462, 1393, 1166, 1086, 981, 890 cm
-1 
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(4R,5R)-4-((R)-1-Hydroxy-2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-5-ol 
(311a)
14,20 
NaBH(OAc)3
AcOH; DCM
-20 oC; 3 days
Y 73%; dr 98:02
O O
O OH
O
O
309a
O O
OH OH
O
O
311a  
Reaction was done based on modified procedure P5 
To a solution of -hydroxyketone 309a (0.25 g, 1.1 mmol, 1.0 eq) in dry CH2Cl2 (3.0 mL) 
AcOH (0.70 mL) and NaBH(OAc)3 (0.34 g, 1.6 mmol, 1.5 eq) were added at -20 C. The 
mixture was stirred at -20 C for 12 h and then was kept at that temperature for 2 days. The 
reaction was quenched with saturated NaHCO3 solution and extracted with CH2Cl2 (3 x 30 
mL).The combined organic layers were washed with aqueous saturated NaCl, dried over 
anhydrous Na2SO4 and concentrated to give a crude diol mixture in a ratio of 2 : 98, which 
was purified by FCC on silica gel (hexanes : ethyl acetate 60 %) to give the pure product 
311a (0.18 g, 73%). 
[]25D = -18 (c 1.12, CHCl3), (Lit. []
25
D = -7.3 (c 0.52, MeOH)
14
 
 
1
H NMR (500 MHz, CDCl3) δ: 4.44 (d, J = 3.0 Hz, 1H), 3.90 (dd, J1 = 5.5 Hz, J2 = 11.3 
Hz, 1H), 3.80 (m, 2H), 3.72 (dd, J1 = 6.6 Hz, J2 = 8.9 Hz, 1H), 3.62 (dd, J1 = 9.1 Hz, J2 = 
11.3 Hz, 1H), 3.50 (s, 3H), 3.47 (s, 3H), 3.45 (d, J = 4.6 Hz, 1H, OH), 3.46 (d, J = 4.5 Hz, 
1H, OH), 2.58 (d, J = 4.3 Hz, 1H, OH), 1.45 (s, 3H), 1.36 (s, 3H) ppm.  
13
C NMR (125 MHz, CDCl3) δ: 103.6, 98.7, 74.8, 72.5, 65.3, 64.0, 56.4, 55.9, 28.4, 19.6 
ppm.  
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HRMS (CI, NH3) exact mass calcd., for [M + NH4]
+
 (C10H20O6 + NH4)
+
 requires 
254.1604, found 254.1599 m/z.  
LRMS (CI, NH3): m/z (%): 254 ([M+18]
+
, 86), 222 (39), 205 (100), 190  (67), 173 (19), 
75 (80). 
 IR (KBr): 3442 (br), 2991, 2939, 2834, 1451, 1374, 1199, 1123, 1068, 975, 864 cm
-1 
 
(2R,4R,5R)-2-tert-Butyl-4-((R)-1-hydroxy-2,2-dimethoxyethyl)-2-methyl-1,3-dioxan-5-
ol (311b):
 
O O
O
t-Bu Me
OH
O
O
309b
O O
OH
t-Bu Me
OH
O
O
311b
NaBH(OAc)3
AcOH; DCM
-20 oC; 3 days
Y 81%; dr 98:02  
Reaction was done based on modified procedure P5 
To a solution of -hydroxyketone 309b (0.25 g, 0.91 mmol, 1.0 eq) in dry CH2Cl2 (3.0  
mL). AcOH (0.70 mL) and NaBH(OAc)3 (0.29 g, 1.4 mmol, 1.5 eq) were added at -20 C. 
The mixture was stirred at -20 C for 12 h and then was kept at that temperature for 2 days. 
The reaction was quenched with saturated NaHCO3 solution and extracted with CH2Cl2 (3 
x 30 mL). The combined organic layers were washed with aqueous saturated NaCl, dried 
over anhydrous MgSO4 and concentrated to give the crude diol as a mixture of two isomers 
in a ratio of 2 : 98 (by 
1
H NMR), which was purified by FCC on silica gel (hexanes : ethyl 
acetate 1 :1) to give the pure product 311b (0.21 g, 81%). 
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Melting point: 82-84 °C 
[]25D = -27 (c 1.1, CHCl3) 
1
H NMR (500 MHz, CDCl3) δ: 4.41 (d, J = 2.7 Hz, 1H), 3.89 (ddd, J1 = 1.5 Hz, J2 = 4.8 
Hz, J3 = 10.9 Hz, 1H), 3.78 (m, 1H), 3.68 (m, 2H), 3.60 (br, 2H),  3.50 (s, 3H), 3.46 (s, 
3H), 2.61 (d, J = 4.6 Hz, 1H, OH), 1.36 (s, 3H), 0.92 (s, 9H) ppm.  
13
C NMR (125 MHz, CDCl3) δ: 103.5, 102.4, 75.9, 71.9, 65.8, 63.6, 57.0, 55.8, 39.4, 24.9, 
12.7 ppm.  
HRMS (CI, NH3) exact mass calcd., for [M + NH4]
+
 (C13H26O6 + NH4)
+
 requires 
296.2073, found 296.2073 m/z. 
LRMS (CI, NH3): m/z (%): 296 ([M+18]
+
, 8), 283 (100), 279 (15), 264 (51), 253 (6).  
IR (KBr): 3430(br), 2956, 2876, 2835, 1450, 1374, 1168, 1066, 975, 894 cm
-1 
X-ray structure of compound 311b  
           
O O
OH
t-Bu Me
OH
O
O
311b
              
 
The crystal was prepared by slow evaporation of a solution of 311b in CH2Cl2 and hexanes 
(30:70). The ORTEP diagram is shown above 
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(2R,4R,5R)-4-((R)-1-Acetoxy-2,2-dimethoxyethyl)-2-tert-butyl-2-methyl-1,3-dioxan-5-
yl acetate (312): 
O O
OH
t-Bu
OH
O
O
80 oC; 3 hr
CH3COONa
Ac2O
O O
t-Bu
O
O
O
O
O
O
311b
312
Y: 98%
 
A 10 mL RBF was  charged with diol 311b (50 mg, 0.18 mmol), sodium acetate (0.18 g, 
2.2 mmol) and acetic anhydride (3.0 mL) and the resulting mixture was heated to 90
 
°C for 
2 hr. The reaction was quenched with ice followed by saturated NaHCO3 solution. The 
mixture was then extracted with ethyl acetate (3 x 20 mL) and the combined organic layers 
were washed with brine. The organic phase was dried over anhydrous Na2SO4 and 
concentrated to afford the crude product which was purified by silica-gel flash column 
chromatography (20% EtOAc: hexanes) to yield the pure diacetylated product 312 (64 mg, 
98%). 
[]25D = -13 (c 1.1, CHCl3) 
1
H NMR (500 MHz, CDCl3) δ: 5.17 (dd, J1 = 3.2 Hz, J2 = 6.7 Hz,1H), 4.94 (ddd, J1 = 4.8 
Hz, J2 = 8.1 Hz, J3 = 8.6 Hz, 1H), 4.47 (d, J = 6.7 Hz, 1H), 4.09 (dd, J1 = 3.2 Hz, J2 = 8.6 
Hz, 1H), 3.98 (dd, J1 = 4.8 Hz, J2 = 11.2 Hz, 1H), 3.58 (dd, J1 = 8.1 Hz, J2 = 11.2 Hz, 1H), 
3.37 (s, 3H), 3.33 (s, 3H), 2.08 (s, 3H), 2.05 (s, 3H), 1.36 (s, 3H), 0.92 (s, 9H) ppm.  
13
C NMR (125 MHz, CDCl3) δ: 169.9, 169.8, 103.1, 101.7, 71.2, 70.7, 66.4, 61.8, 55.3, 
53.4, 39.9, 24.9, 21.2, 21.1, 13.6 ppm.  
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HRMS (CI, NH3) exact mass calcd., for [M]
+
 (C17H30O8 + NH4)
+
 requires 362.1941/ [M+ 
NH4]
+
 requires 380.2284 , found 380.2280 m/z.  
LRMS (CI, NH3): m/z (%): 380 ([M+18]
+
, 13), 363 ([M+1]
+
, 24), 331 (76), 305 (13), 263 
(100), 75 (35).  
IR (KBr): 2987, 2931, 2856, 1751, 1743 1469, 1374, 1224, 1116, 1000, 864, 836, 778 cm
-1
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β-D-Ribopyranose (313): 
O O
OH
t -Bu Me
OH
OMe
OMe
311b
OH OH
OH OH
H
O
D-ribose
D-ribopyranose
O
OH
HO
OH
OH
313
AcOH; H2O
80 oC
TFA; H2O
0 oC
(or)
 
To an ice cooled solution of diol 311b (50 mg, 0.18 mmol) in CHCl3 : H2O (3 : 1; 2 mL) 
was added trifluroaceticacid (0.20 mL). The resulting mixture was stirred at 0 °C for 3 hr 
after which time the TLC showed no staring material. The reaction mixture was 
concentrated and dried over high vacuum to give D-ribopyranose (313; 28 mg, 100%). 
Alternative procedure: 
A 25 mL RBF was charged with diol 311b (50 mg, 0.18 mmol) and 40 % aqueous AcOH 
(2.0 mL) and the resulting mixture was stirred at 90 °C for 3 hr. The reaction mixture was 
concentrated and dried over high vacuum to give D-ribopyranose (313; 24 mg, 89%). 
[]25D = -17.9 (c 1.2, H2O), (Lit. []
20
D = -19.7 (c 4.0, H2O)
179 
1
H NMR (500 MHz, D2O) δ: 4.90(d, J = 6.6 Hz, 1H), 4.08 (br, 1H), 3.84 (m, 2H), 3.66 
(dd, J1 = 8.7 Hz, J2 = 11.1 Hz, 1H), 3.50 (dd, J1 = 2.7 Hz, J2 = 6.6 Hz, 1H) ppm. 
 
13
C NMR (125 MHz, D2O) δ: 95.3, 72.5, 70.4, 68.7, 64.5 ppm.  
HRMS (EI, 70 Ev) exact mass calcd., for [M]
+
 (C5H10O5)
+
 requires 150.0528, found 
150.0522 m/z. 
Reference 179: 
13
C NMR (125 MHz, D2O) δ: 95.3, 72.5, 70.4, 68.7, 64.5 
(Reference 179: Aldrich Chemistry: Handbook of Fine Chemicals 2009) 
 and http://www.omicronbio.com/Pdf/D-ribosenmr.pdf 
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Methyl-D-ribofuranoside (314): 
O O
OH
t-Bu Me
OH
OMe
OMe
311
O OMe
OHOH
HO
methyl-D-ribofuranoside
314
AcOH; H2O
0 oC to 40 oC
 
A 25 mL RBF was charged with diol 311b (30 mg, 0.11 mmol) and 40 % aqueous AcOH 
at 0 °C and the resulting mixture was slowly warmed up to 40 °C over the period of 3 hr. 
The reaction mixture was concentrated and dried over high vacuum to yield methyl-D-
ribofuranoside (314; 17 mg, 99%). 
[]25D = -31 (c 0.9, H2O), (Lit. []
25
D = -38 (c 0.15, H2O)
180
 
1
H NMR (500 MHz, D2O) δ: 4.92 (br, 1H), 4.18 (dd, J1 = 4.7 Hz, J2 = 6.6 Hz, 1H), 4.05 
(m, 2H), 3.82 (dd, J1 = 3.4 Hz, J2 = 12.4 Hz, 1H), 3.62 (dd, J1 = 6.6 Hz, J2 = 12.4 Hz, 1H), 
3.42 (s, 3H) ppm. 
 
13
C NMR (125 MHz, D2O) δ: 107.5, 82.4, 73.7, 70.3, 62.3, 54.7 ppm. 
 HRMS (EI, 70 Ev) exact mass calcd., for [M]
+
 (C6H12O5)
+
 requires 164.0685, found 
164.0684 m/z.  
 (Reference 180: Li, N.-S.; Lu, J.; Piccirilli, J. A. Org. Lett. 2007, 9, 3009-3012) 
13
C NMR (125 MHz, D2O) δ: 107.5, 82.3, 73.7, 70.3, 62.3, 54.7 ppm. 
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 (S)-4-[(R)-1-(tert-Butyldimethylsilyloxy)-2,2-dimethoxyethyl]-2,2-dimethyl-1,3-
dioxan-5-one (315)
12,14,20,173
 
O O
O
Me
OH
OMe
OMe
309a
O O
O OTBS
OMe
OMe
TBDMSOTf;
2,6-lutidine
THF, -78 oC
4 hr; Y 93%Me
315
 
(Using Mander‟s protocol):173 To a cold solution of the aldol adduct 309a (2.2 g, 9.4 
mmol) in dry THF (20 mL) was added dropwise 2,6-lutidine (2.20 mL, 18.8 mmol) 
followed by TBSOTf (3.43 mL, 11.3 mmol). The reaction was stirred at -78 C until no 
starting material was detected by TLC (4 h). The saturated solution of NaHCO3 was added, 
then the mixture was extracted with dichloromethane (3 x 30 mL) and the combined 
organic layers were washed with saturated solution of brine, dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by FCC (SiO2, 
hexanes : ethyl acetate 95 : 5) to afford the TBS-protected product 315 (3.05 g, 93%) as a 
clear liquid.  
[]25D = -95 (c 1.1, CHCl3) 
 [Lit. []25D = -101.3 (c 1.0, CHCl3)
20
 and []25D = -88.9 (c 0.69, MeOH)
14
] 
1
H NMR (500 MHz, CDCl3) δ: 4.57 (d, J = 7.4 Hz, 1H), 4.32 (t, J = 1.6 Hz, 1H), 4.20 (dd, 
J1 = 1.6 Hz, J2 = 15.8 Hz, 1H), 4.03 (dd, J1 = 1.6 Hz, J2 = 7.4 Hz, 1H), 3.87 (d, J = 15.8 Hz, 
1H), 3.43 (s, 3H), 3.38 (s, 3H), 1.45 (s, 3H), 1.42 (s, 3H), 0.85 (s, 9H), 0.09 (s, 3H), 0.07 
(s, 3H).  
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13
C NMR (125 MHz, CDCl3) δ: 206.2, 105.6, 100.3, 77.9, 73.7, 67.3, 56.2, 55.8, 26.0, 
25.1, 23.2, 18.1, -4.4, -4.7.  
HRMS (CI, NH3) exact mass calcd., for [M + NH4]
+
 (C16H32O6Si + NH4)
+
 requires 
366.2312, found 366.2316 m/z.  
LRMS (CI, NH3): m/z (%):366 ([M+18]
+
, 60), 348 (5), 334 (100), 317 (52), 302 (33), 266 
(37), 75 (83).  
IR (KBr): 2987, 2931, 2856, 1751, 1469, 1374, 1224, 1116, 1000, 864, 836, 778 cm
-1 
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(4R,6S)-4-((S)-(1,3-Dithian-2-yl)(hydroxy)methyl)-6-((R)-1-(tert-butyldimethyl 
silyloxy)-2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-5-one (316):
 
O O
O OTBS
O
O
OH
S
S
LDA, THF 
-78 oC
 Y 82%; dr 91:09S
S CHO
2b
316
O O
O OTBS
OMe
OMe
315
 
A solution of n-BuLi (4.8 mL, 10 mmol, 2.1 M solution in hexaness, 3.3 eq) was added 
dropwise to a stirred solution of DIA (1.6 mL, 11 mmol, 3.6 eq) in THF (10 mL) at 0 °C 
under nitrogen. After 30 min, a solution of compound 315 (1.1 g, 3.1 mmol, 1.0 eq) was 
added slowly and the mixture was stirred for 2 h at -78 °C. Then dithiane carboxaldehyde 
2b (1.8 g, 12 mmol, 4.0 eq) in dry THF (5.0 mL) was added and the mixture was stirred at 
-78 °C for 30 min. The reaction was quenched with concentrated phosphate buffer (pH 7.0; 
15 mL) and extracted with ether (3x100 mL). The combined organic layers were rinsed 
with saturated solution of NaHCO3 followed by NaCl and dried over anhydrous Na2SO4. 
The solvents were removed under reduced pressure and the diastereoselectivity of the 
reaction was determined by 
1 
H NMR on the crude product by integration of the peaks at 
3.43 ppm and 3.35 ppm and was found to be 9 : 91 anti-anti-trans to anti-anti-cis aldols. 
The crude reaction mixture was fractionated by FCC (5-10% ethyl acetate in hexanes) to 
give the title aldol 316 as a colorless oil (1.33 mg, 87 %).  
[]24D = -3 (c 0.33, CHCl3) 
 
1
H NMR (500 MHz, CDCl3) δ: 4.50 (d, J=7.4 Hz, 1H), 4.37-4.33 (m, 2H), 4.31-4.27 (m, 
1H), 4.11-4.04 (m, 2H), 3.73 (br s, 1H), 3.39 (s, 3H), 3.35 (s, 3H), 3.20-3.10 (m, 2H), 2.75-
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2.67 (m, 1H), 2.64-2.56 (m, 1H), 2.04-1.95 (m, 2H), 1.50 (s, 3H), 1.47 (s, 3H), 0.84 (s, 
9H), 0.08 (s, 3H), 0.06 (s, 3H) ppm. 
 
13
C NMR (125 MHz, CDCl3) δ: 208.8, 105.5, 98.9, 79.8, 77.9, 76.0, 74.4, 56.0, 55.9, 
44.6, 28.9, 28.8, 28.4, 26.0, 25.9, 20.6, 18.3, -4.4, -4.5 ppm.  
HRMS m/z calcd for C21H40O7S2Si 497.2065 (M+H), found 497.2078 (CI).  
LRMS (CI, NH3), m/z (relative intensity): 497 ([M]
+
+1, 56), 465 (44), 407 (8), 366 (17), 
334 (98), 317 (100), 276 (44), 185 (20), 159 (32), 119 (72), 75 (84).  
IR (KBr): 3487, 1709 cm
-1 
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(4S,5R,6R)-4-((S)-(1,3-Dithian-2-yl)(hydroxy)methyl)-6-((R)-1-(tert-butyldimethyl 
silyloxy)-2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-5-ol (317):
 
 
-20°C; 3 days
NaBH(OAc)3
DCM / AcOH
O O
O OTBS
O
O
OH
S
S
316
O O
OH OTBS
O
O
OH
S
S
 Y 85%; dr 98:02317
 
Reaction was done based on modified procedure P5 
To the solution of -hydroxyketone 316 (1.3 g, 2.6 mmol, 1.0 eq) in dry CH2Cl2 (20 mL) 
AcOH (3.2 mL) and NaBH(OAc)3 (1.1 g, 5.2 mmol, 2.0 eq) were added at -20 C. 
Reaction was stirred at -20 C for 12 h and then was kept at that temperature for 3 days 
(TLC monitored). The reaction mixture was quenched with saturated NaHCO3 solution 
and extracted with CH2Cl2 (3 x 100 mL).The combined organic layers were washed with 
aqueous saturated NaCl, dried over anhydrous Na2SO4 and concentrated to give the crude 
product. Diastereoselectivity of the reaction was measured by integrating peaks at 3.45 
ppm and 3.56 ppm and was found to be 2 : 98 syn to anti. The crude mixture was purified 
by flash column chromatography on silica gel (hexanes : ethyl acetate 8 : 2) to give the 
pure diol 317 as a clear oil (1.1 g, 85%).  
 []25D = +23 (c 1.0, C6H6) and []
25
D = +7.0 (c 1.1, CHCl3)  
1
H NMR (500 MHz, CDCl3) δ: 4.93 (br s, 1H (OH)), 4.25 (d, J = 3.8 Hz, 1H), 4.24 (d, J = 
2.6 Hz, 1H), 4.20 (br s, 1H), 4.06 (dd, J1 = 2.6 Hz, J2 = 7.8 Hz, 1H), 3.90 (dd, J1 = 7.8 Hz,  
J2 = 9.2 Hz, 1H), 3.88 (dd, J1 = 1.0 Hz, J2 = 9.1 Hz, 1H), 3.84 (dd, J1 = 1.0 Hz, J2 = 3.8 Hz, 
1H), 3.80 (dd, J1 = 9.1 Hz, J2 = 9.2 Hz, 1H), 3.56 (s, 3H), 3.42 (s, 3H), 3.12-3.02 (m, 2H), 
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2.84-2.79 (m, 1H), 2.72-2.67 (m, 1H), 2.07-1.96 (m, 2H), 1.45 (s, 3H), 1.32 (s, 3H), 0.88 
(s, 9H), 0.10 (s, 3H) 0.07 (s, 3H) ppm. 
 
13
C NMR (125 MHz, CDCl3) δ: 106.8, 98.7, 80.8, 76.2, 72.3, 70.5, 65.0, 58.6, 56.5, 47.5, 
29.5, 29.1, 28.8, 26.2, 26.0, 19.5, 18.4, -4.2, -4.8 ppm.  
HRMS (CI, Na) exact mass calcd., for (C21H42O7S2Si + Na)
+
 [M + Na]
+
 requires 
521.2039, found 521.2038 m/z.  
LRMS (CI, Na), m/z (relative intensity): 521 ([M + 23]
+
, 30), 499 ([M + 1], 21), 484 (19), 
467 (35), 435 (40), 409 (51), 119 (11), 75 (17). 
 IR (KBr): 3457 (br), 2991, 2928, 2854, 1463, 1380, 1255, 1166, 1151, 1070, 1001, 836, 
779, 731cm
-1 
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((S)-1-((4R,5R,6S)-5-(Benzyloxy)-6-((R)-benzyloxy(1,3-dithian-2-yl)methyl)-2,2-
dimethyl-1,3-dioxan-4-yl)-2,2-dimethoxyethoxy)(tert-butyl)dimethylsilane (318): 
 
BnBr: NaH
rt; THF; 12hr
O O
OH OTBS
O
O
OH
S
S O O
OBn OTBS
O
O
OBn
S
S
meso-dialdehyde
 Y 89%
318317
OH OH
OH OH
H
O
OH
H
O
306
 
To a stirred suspension of NaH (80 % w/w) (91 mg, 23 mmol) in dry THF (5.0 mL) at 0 C 
under inert atmosphere was added diol 317 (0.60 g, 1.2 mmol) in dry THF (10 mL). The 
resulting mixture was stirred at 0 C for 15 minutes and benzyl bromide (0.32 mL, 2.6 
mmol) and catalytic amount of TBAI (20 mg) were added. The resulting mixture was 
stirred at ambient temperature for 12 hr. After TLC showed no starting material the 
reaction was quenched with saturated NaHCO3 solution and extracted with EtOAc (3 x 50 
mL). The combined organic layers were washed with brine, dried over anhydrous Na2SO4 
and concentrated to get the crude product which was purified by flash chromatography on 
silica gel using hexanes: EtOAc (5%>10%) to give the desired dibenzylated product 318 
(0.73 g, 89%). 
[]25D = +14 (c 1.0, CHCl3)  
1
H NMR (500 MHz, CDCl3) δ: 7.44-7.22(m, 10H),  4.87 (dd, J1 = 5.5 Hz, J2 = 11.6 Hz, 
2H), 4.77 (t, J  = 12 Hz, 2H), 4.45 (d, J = 10.1 Hz, 1H), 4.28 (d, J= 9.4 Hz, 1H), 4.25 (d, J 
= 8.2 Hz, 1H), 4.05 (t, J = 9.9 Hz, 1H), 4.00 (t, J = 9.7 Hz, 1H), 3.69 (d, J = 8.2 Hz, 1H), 
3.62 (d, J = 9.7 Hz, 1H), 3.28 (s, 3H), 3.27 (s, 3H), 2.71 (m; 1H), 2.61 (m, 2H), 2.36 (m, 
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1H), 1.94 (m, 1H), 1.76 (m, 1H), 1.46 ( s, 3H), 1.40 (s, 3H), 0.88 (s, 9H), 0.1 (s, 3H), 0.07 
(s, 3H).  
13
C NMR (125 MHz, CDCl3) δ: 138.9, 138.3, 128.3, 128.2, 128.1, 127.5, 127.3, 127.0, 
105.6, 99.3, 81.7, 75.5, 74.7, 74.0, 73.7, 72.5, 71.1, 55.9, 54.8, 49.9, 40.6, 30.0, 29.4, 26.0, 
19.2, 18.5, -4.2, -4.6.  
HRMS (CI, Na) exact mass calcd., for (C35H54O7S2Si + Na)
+
 [M + Na]
+
 requires 
701.2978, found 701.2989 m/z. 
 IR (KBr): 3060, 2993, 2928, 2854, 1457, 1380, 1095, 1076, 1000, 836, 778, 697 cm
-1 
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(S)-2-(Benzyloxy)-2-((4S,5R,6R)-5-(benzyloxy)-6-((R)-1-(tert-butyldimethylsilyloxy)-
2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetaldehyde (319): 
NBS,AgNO3
MeCN: H2O
0 oC; Y: 85%
O O
OBn OTBS
O
O
OBn
S
S
318
O O
OBn OTBS
OCH3
OCH3
OBn
O
H
319
 
Reaction was done based on the modified Corey procedure P6
157
 
To a stirred solution of freshly recrystalized N-bromosuccinimide (0.10 g, 0.56 mmol, 4.0 
eq) and silver nitrate (0.11 g, 0.63 mmol, 4.5 eq) in acetonitrile : water (1 : 1; 2 mL) was 
added solution of compound 318 (95 mg, 0.14 mmol, 1.0 eq) in acetonitrile (3 mL) at 0 C. 
The resulting mixture was stirred at 0 C for 5 minutes (TLC showed no starting material). 
The reaction was quenched with sodium sulfite solution (saturated, 3 mL) and the mixture 
was stirred for additional 10 min. Then it was filtered through the Celite bed, rinsed with 
CH2Cl2 and the resulting mixture was extracted with CH2Cl2 (3 x 20 mL). The combined 
organic layers were washed with saturated NaHCO3 solution followed by brine solution 
and dried over anhydrous Na2SO4. Solvents were removed under reduced pressure to give 
the desired aldehyde 319 (70 mg, 85%).  
 [α] 25D = +8 (c 1.0, CHCl3). 
 
1
H NMR (CDCl3, 500 MHz): δ 9.59 ( s (br),1H, CHO), 7.38-7.16 (m, 10H),  4.78 (m, 
4H), 4.21(dd, J1 = 6.2 Hz, J2 = 3.5 Hz, 1H),  4.18 (d, J = 8.2 Hz, 1H), 3.97(m, 3H), 3.69(d, 
J = 8.2 Hz, 1H), 3.27 (s, 3H), 3.22 (s, 3H), 1.47 (s, 3H), 1.40 (s, 3H), 0.94 (s, 9H), 0.12 (s, 
3H), 0.09 (s, 3H) ppm.  
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13
C NMR (CDCl3, 125 MHz): δ 201.4, 138.2, 137.6, 128.6, 128.5, 128.1, 128.0, 127.6, 
127.1, 105.6, 99.2, 83.5, 75.9, 75.6, 73.3, 72.9, 70.0, 55.9, 55.3, 29.3, 26.2, 19.2, 18.5, -4.2, 
-4.6 ppm.  
HRMS (CI, NH3) exact mass calcd., for (C32H48O8Si + NH4)
+
 requires 606.3462, found 
606.3465 m/z.  
IR (KBr): 3117, 2991, 2929, 2855, 1736, 1497, 1380, 1257, 1122, 1092, 837, 778 cm
-1 
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(R)-2-(Benzyloxy)-2-((4R,5R,6R)-5-(benzyloxy)-6-((R)-1-(tert-butyldimethylsilyloxy)-
2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethanol (320):
 
O O
OBn OTBS
OCH3
OCH3
OBn
O
H
319
O O
OBn OTBS
OCH3
OCH3
OBn
OH
320
NaBH4, MeOH;
Y: 94%
rt; 12 hr
 
To the solution of aldehyde 319 (68 mg, 0.12 mmol, 1.0 eq) in MeOH (2.0 mL) was added 
NaBH4 (13 mg, 0.35 mmol, 3.0 eq) at 0  C. The mixture was allowed to warm up to 
ambient temperature and it was stirred at that temperature for 4 hr (TLC controlled). The 
reaction mixture was quenched with saturated NaHCO3 solution and extracted with EtOAc 
(3 x 30 mL). The combined organic layers were washed with aqueous saturated NaCl, 
dried over anhydrous Na2SO4 and concentrated to give the crude product which was 
purified by passing through a short silica gel plug (hexanes : ethyl acetate 30%) to give the 
pure alcohol 320 as a clear oil (64 mg, 94%) 
[]24D = +20 (1.0, CHCl3) 
1
H NMR (500 MHz, CDCl3) δ: 7.34-7.20(m, 10H),  4.74 (dd, J1 = 12.2 Hz, J2 = 11.3 Hz, 
2H), 4.60 (dd, J1 = 12.2 Hz, J2 = 11.3 Hz, 2H), 4.24 (d, J = 8.2 Hz, 1H), 4.03 (d, J = 10.1 
Hz, 1H), 3.95 (d, J = 9.5 Hz, 1H), 3.83 (ddd, J1 = 3.2 Hz, J2 = 6.4 Hz, J3 = 11.9 Hz, 1H), 
3.75 (t, J = 10.1 Hz, 1H), 3.70 (m, 3H), 3.30 (s, 3H), 3.25 (s, 3H), 2.26 (br, 1H, OH), 1.45 ( 
s, 3H), 1.39 (s, 3H), 0.93 (s, 9H), 0.12 (s, 3H), 0.09 (s, 3H) ppm.  
13
C NMR (125 MHz, CDCl3) δ: 138.4, 138.0, 128.6, 128.5, 128.1, 127.9, 127.8, 127.5, 
105.6, 98.9, 78.9, 75.5, 74.7, 74.1, 73.5, 72.1, 71.0, 61.9, 56.0, 55.0, 29.4, 26.2, 19.0, 18.5, 
-4.2, -4.6 ppm.  
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HRMS (CI, Na) exact mass calcd., for (C32H50O8Si + Na)
+
 requires 613.3167, found 
613.3153 m/z.  
IR (KBr): 3465 (br), 3197, 2991, 2928, 2855, 1470, 1380, 1255, 1124, 1093, 1001, 836,  
cm
-1 
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4,6-bis(Benzyloxy)- 1,2,3,7-tetra-O-acetyl-β-D-glycero-D-allo-heptopyranose (322): 
23 : 77
O
OH
BnO
OH
BnO
HO
OH
O
OAc
BnO
OAc
BnO
AcO
OAc
322
321
AcOH : H2O
 (2:1)
80 oC
quant., 80 
oC;2hr
NaOAc;
O O
OBn OTBS
OCH3
OCH3
OBn
OH
320
Ac2O
 
A 10 mL RBF was charged with alcohol 320 (0.032 g, 0.054 mmol) and 40 % aqueous 
AcOH (2.0 mL) and the resulting mixture was stirred at 90 °C for 3 hr. The reaction 
mixture was concentrated and dried over high vacuum to yield the gummy crude product 
321 which was subjected to acetylation without further purification. To the crude 321, 
sodium acetate (55 mg, 0.65 mmol) and acetic anhydride (2 mL) were added and the 
resulting mixture was heated to 90
 
°C for 2 hr. The reaction was quenched with ice 
followed by saturated NaHCO3 solution. Then the mixture was extracted with ethyl acetate 
(3 x 20 mL) and the combined organic layers were washed with brine. The organic phase 
was dried over anhydrous Na2SO4, concentrated to get the crude product as a mixture of 
protected of  and  anomers (23 : 77). Further purification by silica-gel simple column 
chromatography (25% EtOAc : hexanes) yielded the pure products -322  (20 mg, 67%) 
and α-322 product (6 mg) with 87% overall yield over two steps. 
-322:  []24D = +18 (c 1.1, CHCl3).  
1
H NMR (CDCl3, 500 MHz): δ 7.32-7.21 (m, 10H), 5.95 (d, J = 8.6 Hz, 1H), 5.83 (t, J = 
2.9 Hz, 1H), 4.80 (dd, J1 = 2.9 Hz, J2 = 8.6 Hz, 1H), 4.69 (d, J1 = 12.0 Hz, 1H), 4.61(d, J = 
12.0 Hz, 1H), 4.56 (d, J = 10.9 Hz, 1H), 4.38 (d, J = 10.9 Hz, 1H), 4.21 (dd, J1 = 7.8 Hz, 
J2 = 11.8 Hz, 1H), 4.11 (dd, J1 = 3.8 Hz, J2 = 11.8 Hz, 1H), 4.06 (d, J = 9.9 Hz, 1H), 3.91 
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(dd, J1 = 3.8 Hz, J2 = 7.8 Hz, 1H), 3.79 (dd, J1 = 2.9 Hz, J2 = 9.9 Hz, 1H),  2.12 (s, 3H), 
2.09 (s, 3H), 2.01 (s, 3H), 1.96 (s, 3H) ppm. 
 
13
C NMR (CDCl3, 125 MHz): δ 170.9, 170.4, 169.7, 169.4, 138.5, 136.9, 128.7, 128.6, 
128.5, 128.4, 128.2, 128.1, 127.8, 90.2, 77.6, 74.9, 73.3, 72.5, 71.7, 69.0, 67.1, 64.5, 21.2, 
21.1, 21.0, 20.8 ppm. 
 HRMS (CI, NH3) exact mass calcd., for (C29H34O11 + Na)
+
 requires 581.1999, found 
581.2004 m/z.  
IR (KBr): 3029, 2932, 1746, 1453, 1370, 1216, 1068, 740, 699 cm
-1
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(2S,3S,4S,5S,6S)-4,6-bis(Benzyloxy)-6-(1,3-dithian-2-yl)hexane-1,2,3,5-tetraol (324): 
O O
OBn OTBS
O
O
OBn
S
S
318
2) NaBH4, 
MeOH/H2O (4:1) 
rt; 12 hr; Y: 80%
OH OH
OBn OHOBn
S
S OH
1) AcOH : H2O (2:1)
80 oC
324
 
A 10 mL RBF was charged with compound 318 (0.30 g, 0.44 mmol) and 40 % aqueous 
AcOH (3.0 mL) and the resulting mixture was stirred at 90 °C for 2 hr. The reaction 
mixture was concentrated and dried over high vacuum to afford the gummy crude 
hemiacetal product (0.22 g) which was subjected to reduction. To the ice cooled solution 
of crude hemiacetal (0.22 g) in methanol (3 mL) and water (0.5 mL) was added NaBH4 (42 
mg, 1.1 mmol). The mixture was allowed to warm upto room temperature and it was 
stirred at that temperature for 12 hr (TLC monitered). The reaction was quenched with 
saturated NaHCO3 solution and extracted with EtOAc (3 x 30 mL). The combined organic 
layers were washed with aqueous saturated NaCl, dried over anhydrous Na2SO4 and 
concentrated to give the crude product that was purified by passing through a short silica 
gel plug (DCM : MeOH 4%) to give pure tetraol 324 as a white solid (0.17 g, 80%) 
Melting point: 46-47 °C 
[]24D = -20 (1.0, CHCl3);  
1
H NMR (500 MHz, C6D6): δ 7.48-7.06 (m, 10H), 5.15 (d, J = 10.7 Hz, 1H), 4.82 (d, J = 
2.7 Hz, 1H), 4.65 (d, J = 10.7 Hz, 1H), 4.47 (dd, J1 = 2.9 Hz, J2 = 7.6 Hz, 2H), 4.26 (d, J = 
11.1 Hz, 1H) , 4.13 (dd, J1 = 2.7 Hz, J2 = 7.6 Hz, 1H), 3.98 (m, 2H), 3.82 (m; 1H), 3.62 (m, 
2H), 3.04 (br, 1H, OH), 2.55 (d, J = 4.7 Hz, 1H, OH), 2.40 (m; 4H), 1.61 (br, 1H, OH), 
1.42 (m, 1H), 1.33 (m, 1H) ppm. 
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13
C NMR (125 MHz, C6D6) δ: 139.2, 138.5, 129.3, 129.1, 128.9, 128.7, 128.4, 128.2, 
83.8, 80.9, 75.2, 73.1, 72.7, 72.6, 71.8, 64.2, 51.9, 32.1, 30.7, 27.1 ppm.  
HRMS (CI, Na) exact mass calcd., for (C24H32O6S2+ Na)
+
 requires 503.1538, found 
503.1546 m/z. 
 IR (KBr): 3406 (br), 3099, 3029, 2927, 2895, 1496, 1453, 1210, 1065, 1028, 908, 738, 
699 cm
-1 
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(4S,5S,6S)-5-(Benzyloxy)-4-((S)-benzyloxy(1,3-dithian-2-yl)methyl)-6-((R)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-1,3-dioxane (325): 
OH OH
OBn OHOBn
S
S OH
2,2-DMP
p-TSA (cat.,)
O OS
S
O
OOBn OBn
Y: 95%
325324  
Tetraol 324 (120 mg, 0.25 mmol, 1.0 eq) was transferred to the flame dried round bottom 
flask. p-TsOH.H2O (0.005 mg, 0.0025 mmol, 0.01 eq) was added under nitrogen followed 
by freshly distilled 2,2-dimethoxypropane (3.0 mL). The mixture was stirred at room 
temperature for 6 hr after which time TLC showed no starting material. The reaction was 
quenched by addition of saturated solution of NaHCO3 and the product was extracted with 
Et2O (3 x 30 mL), washed with saturated solution of NaCl and dried with Na2SO4. 
Removal of the solvent under reduced pressure provided the crude product which was 
purified by FCC (hexanes : EtOAc 95 : 5) to give pure protected 325 as a colorless oil 
(0.12 g, 95%). 
[]24D = +3 (1.15, CHCl3) 
 
1
H NMR (500 MHz, CDCl3): δ 7.47-7.27 (m, 10H), 4.83 (s, 2H), 4.67 (d, J = 10.4 Hz, 
1H), 4.61 (d, J = 10.4 Hz, 1H), 4.47 (d, J = 9.5 Hz, 1H), 4.28 (dd, J1 = 1.5 Hz, J2 = 8.7 Hz, 
1H), 4.21 (dd, J1 = 6.6 Hz, J2 = 6.8 Hz, 1H), 3.89 (m, 3H), 3.64 (m, 2H), 2.73 (m; 2H), 2.60 
(m, 2H), 1.97 (m, 1H), 1.83 (m, 1H), 1.46 (s, 3H), 1.40 (s, 3H), 1.39 (s, 3H), 1.34 (s, 3H) 
ppm.  
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13
C NMR (125 MHz, CDCl3) δ: 138.4, 138.3, 128.5, 128.4, 128.3, 127.9, 127.8, 109.7, 
99.0, 82.4, 77.0, 75.2, 74.1, 73.6, 73.4, 73.3, 66.6, 49.9, 30.0, 29.7, 29.5, 26.6, 26.2, 25.8, 
20.1   ppm. 
 HRMS (CI, Na) exact mass calcd., for (C30H40O6S2+NH4)
+
 requires 578.2610, found 
578.2611 m/z.  
LRMS (CI, NH3), m/z (relative intensity): 578 ([M + 18]
+
, 7), 561 (11), 503 (100), 233 
(29), 197 (5), 108 (22), 91 (50).        
IR (KBr): 3083, 2987, 2934, 2895, 1454, 1379, 1257, 1205, 1094, 851, 734, 699 cm
-1 
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(S)-2-(Benzyloxy)-2-((4S,5S,6S)-5-(benzyloxy)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-
2,2-dimethyl-1,3-dioxan-4-yl)acetaldehyde (326):
 
O OO
H
O
OOBn OBn
NBS,AgNO3
MeCN: H2O
0 oC; quant.,
326
O O
O
OOBn OBn
325
S
S
 
Reaction was done based on the modified Corey procedure P6
157
 
 
To a stirred solution of freshly recrystalized N-bromosuccinimide (95 mg, 0.54 mmol, 4.0 
eq) and silver nitrate (0.10 g, 0.60 mmol, 4.5 eq) in acetonitrile : water (1 : 1; 2 mL) was 
added a solution of compound 325 (75 mg, 0.13 mmol, 1.0 eq) in acetonitrile (2.0 mL) at 0 
C. The resulting mixture was stirred at 0 C for 5 minutes (TLC showed no starting 
material). The reaction was quenched with a sodium sulfite solution (saturated, 3.0 mL) 
and the mixture was stirred for 10 min. Then the mixture was filtered through a Celite bed 
which was rinsed with CH2Cl2 and the resulting mixture was extracted with CH2Cl2 (3 x 20 
mL). The combined organic layers were washed with saturated NaHCO3 solution, NaCl 
solution and dried over anhydrous Na2SO4. Solvents were removed under reduced pressure 
to give the desired aldehyde 326 (62 mg, 99%).  
[]24D = +6 (c 1.0, CHCl3).  
 
1
H NMR (CDCl3, 500 MHz): δ 9.57 ( s (br),1H, CHO), 7.40-7.25 (m, 10H), 4.80 (s, 2H), 
4.70 (d, J = 10.3 Hz, 1H), 4.51 (d, J = 10.3 Hz, 1H), 4.21 (m, 2H), 3.97 (m, 2H), 3.89 (t, J 
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= 7.3 Hz, 1H), 3.84 (dd, J1 = 5.8 Hz, J2 = 9.6 Hz, 1H), 3.53 (t, J = 9.6 Hz, 1H),  1.48 (s, 
3H), 1.40 (s, 6H), 1.36 (s, 3H) ppm. 
 
13
C NMR (CDCl3, 125 MHz): δ 200.7, 137.7, 137.5, 128.8, 128.7, 128.6, 128.5, 128.4, 
128.1, 109.9, 99.1, 83.4, 77.1, 74.9, 73.7, 73.4, 72.9, 66.7, 29.3, 26.6, 25.8, 19.4 ppm. 
HRMS (CI, NH3) exact mass calcd., for (C27H34O7+ NH4)
+
 requires 488.2648, found 
488.2649 m/z.  
LRMS (CI, NH3), m/z (relative intensity): 488 ([M + 18]
+
, 23), 455 (7), 430 (19), 413 (29), 
273 (6), 233 (17), 181 (11), 108 (44), 91 (100). 
 IR (KBr): 3079, 2989, 2933, 2878, 1734, 1453, 1258, 1204, 1097, 850, 738, 699 cm
-1
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2,4-bis(Benzyloxy)-1,3,6,7-tetra-O-acetyl-β-L-glycero-L-allo-heptopyranose (327): 
O
BnO
OAc
OBn
OAc
OAc
AcO
327
14 : 86
O OO
H
O
OOBn OBn
(1) AcOH : H2O
 (2:1)
THF;rt; 2 hr
80 oC;3hr
326
2) NaOAc; Ac2O
Y: 77%  
To a solution of aldehyde 326 (60 mg, 0.13 mmol) in THF (2.0 mL) was added 40 % 
aqueous AcOH (2.0 mL) and the resulting mixture was stirred at ambient temperature for 2 
hr. The reaction mixture was concentrated and dried over high vacuum to yield a gummy 
crude hemiacetal product (51 mg) which was directly subjected to acetylation. Sodium 
acetate (0.13 g, 1.6 mmol) and acetic anhydride (2.0 ml) were added and the resulting 
mixture was heated to 90
 
°C for 2 hr. The reaction was quenched with ice followed by 
saturated NaHCO3 solution. The mixture was then extracted with ethyl acetate (3 x 20 mL) 
and the combined organic layers were washed with brine. The organic phase was dried 
over anhydrous Na2SO4 and concentrated to get a crude mixture of  and  anomers (14 : 
86). Further purification by silica gel simple column chromatography (25% EtOAc : 
hexanes) yielded the pure  product -327 (55 mg, 77%). 
-327: []24D = +26 (c 1.1, CHCl3) 
 
1
H NMR (CDCl3, 500 MHz): δ 7.35-7.28 (m, 10H), 5.93 (t, J = 2.8 Hz, 1H), 5.84 (d, J = 
8.4 Hz, 1H), 5.38 (ddd, J1 = 2.8 Hz, J2 = 3.2 Hz, J3 = 6.9 Hz 1H), 4.66 (dd, J1 = 12.1 Hz, J2 
= 11.1 Hz, 2H), 4.51(d, J = 12.1 Hz, 1H), 4.35 (d, J = 11.1 Hz, 1H), 4.10 (m, 2H), 4.02 
(dd, J1 = 2.8 Hz, J2 = 9.8 Hz, 1H), 3.46 (dd, J1 = 2.8 Hz, J2 = 9.8 Hz, 1H), 3.36 (dd, J1 = 2.9 
Hz, J2 = 8.2 Hz, 1H), 2.15 (s, 3H), 2.07 (s, 3H), 1.99 (s, 3H), 1.95 (s, 3H) ppm.  
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13
C NMR (CDCl3, 125 MHz): δ 170.9, 170.6, 170.3, 169.3, 137.5, 136.8, 128.8, 128.7, 
128.6, 128.4, 128.2, 127.9, 91.9, 74.7, 73.5, 73.3, 72.0, 71.4, 70.7, 65.9, 62.6, 21.2 (3xMe), 
21.0 ppm.  
HRMS (CI, NH3) exact mass calcd., for (C29H34O11+ NH4)
+
 requires 576.2445, found 
576.2460 m/z.  
LRMS (CI, NH3), m/z (relative intensity): 576 ([M + 18]
+
, 100), 499 (46), 279 (12), 224 
(10), 181 (8), 139 (11), 108 (37), 91 (93), 60 (16). 
IR (KBr): 3025, 2932, 1743, 1454, 1370, 1221, 1074, 1053, 741, 700 cm
-1
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1,2,3,4,6,7-Hexa-O-acetyl-β-D-glycero-D-allo-heptopyranose (323): 
323
O
OAc
BnO
OAc
BnO
AcO
OAc
O
OAc
AcO
OAc
AcO
AcO
OAc1) H2; Pd/C
AcOH;MeOH
2) NaOAc; Ac2O
80 oC; 2hr
322
D-glycero--D-alloheptose
[]D
25  =  + 5.0 (c 1.0, C6H6)Y: 79%
 
Solution of dibenzyl compound β-322  (0.02 g, 0.04 mmol) in MeOH (2.0 mL) was treated 
with catalytic amount of acetic acid (0.25 mL) and 10% Pd/C catalyst (5.0 mg). The 
resulting suspension was stirred under H2 (~5 psi) at ambient temperature for 12 hr. TLC 
and 
1
H NMR showed no starting material. The reaction mixture and the catalyst was 
filtered through Celite bed and evaporation of the solvent afforded the debenzylated crude 
product which was subjected to complete acetylation. Sodium acetate (45 mg, 0.54 mmol) 
and acetic anhydride (2.0 mL) were added and the resulting mixture was heated to 90
 
°C 
for 2 hr. The reaction was quenched with ice followed by saturated NaHCO3 solution. The 
mixture was then extracted with ethyl acetate (3 x 20 mL) and the combined organic layers 
were washed with brine. The organic phase was dried over anhydrous Na2SO4 and 
concentrated to afford the crude product, which, upon purification by silica-gel simple 
column chromatography (65% EtOAc: hexanes) yielded the pure product -323 (13 mg, 
79%). 
-323:  []24D = 5.1 (c 1.0, C6H6) 
 
1
H NMR (CDCl3, 500 MHz): δ 5.93 (d, J = 8.6 Hz, 1H), 5.65 (t, J = 3.0 Hz, 1H), 5.19 
(ddd, J1 = 2.8 Hz, J2 = 4.6 Hz, J3 = 7.2 Hz 1H), 5.00 (dd, J1 = 2.9 Hz, J2 = 10.4 Hz, 1H), 
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4.92 (dd, J1 = 3.0 Hz, J2 = 8.6 Hz, 1H), 4.25 (dd, J1 = 4.4 Hz, J2 = 11.8 Hz, 1H), 4.17 (dd, J1 
= 2.9 Hz, J2 = 10.4 Hz, 1H), 4.11 (dd, J1 = 7.2 Hz, J2 = 11.8 Hz, 1H), 2.14 (s, 3H), 2.09 (s, 
3H), 2.08 (s, 3H), 2.01 (s, 6H), 1.98 (s, 3H) ppm.  
13
C NMR (CDCl3, 125 MHz): δ 170.6, 170.1, 169.96, 169.3, 169.3, 169.2, 90.3, 72.5, 
69.9, 68.4, 68.1, 66.9, 61.8, 21.17, 21.14, 20.95, 20.93, 20.78, 20.75 ppm.  
HRMS (CI, NH3) exact mass calcd., for (C19H26O13+ NH4)
+
 requires 480.1717, found 
480.1715 m/z.  
LRMS (CI, NH3), m/z (relative intensity): 480 ([M + 18]
+
, 100), 403 (52), 215 (2), 152 (8), 
139 (9), 110 (8), 77 (7), 60 (41).  
IR (KBr): 3476 (w), 2965, 1749, 1433, 1370, 1216, 1048, 948, 914, 601 cm
-1
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1,2,3,4,6,7-Hexa-O-acetyl-β-L-glycero-L-allo-heptopyranose (ent-323): 
O
BnO
OAc
OBn
OAc
OAc
AcO
327
O
AcO
OAc
OAc
OAc
OAc
AcO
1) H2; Pd/C
AcOH;MeOH
(ent-323)
L-glycero--L-alloheptose
2)
80 oC;2hr
14 : 86
[]D
25  =  - 5.7 (c 1.1, C6H6)
NaOAc; Ac2O
Y: 88%
 
To the solution of compound β-327 (0.030 g, 0.054 mmol) in MeOH (2.0 mL) were added 
catalytic amounts of acetic acid (0.25 mL) and 10% Pd/C catalyst (5.0 mg). The resulting 
suspension was stirred under H2 (~5 psi) at ambient temperature for 12 hr. TLC and 
1
H 
NMR showed no starting material. The reaction mixture was filtered through Celite bed 
and evaporation of the solvent afforded the debenzylated crude product which was 
subjected to complete acetylation. Sodium acetate (67 mg, 0.81 mmol) and acetic 
anhydride (2.0 mL) and the resulting mixture was heated to 90
 
°C for 2 hr. The reaction 
was quenched with ice followed by saturated NaHCO3 solution. The mixture was then 
extracted with ethyl acetate (3 x 20 mL), the combined organic layers were washed with 
brine. The organic phase was dried over anhydrous Na2SO4 and concentrated to aford the 
crude product, which, upon purification by silica-gel simple column chromatography (60-
65% EtOAc: hexanes) yielded the pure product ent--323 (13 mg, 79%). 
-ent-323:  []24D = -5.7 (c 1.1, C6H6) 
1
H NMR (CDCl3, 500 MHz): δ 5.93 (d, J = 8.6 Hz, 1H), 5.65 (t, J = 3.0 Hz, 1H), 5.19 
(ddd, J1 = 2.8 Hz, J2 = 4.6 Hz, J3 = 7.2 Hz 1H), 5.00 (dd, J1 = 2.9 Hz, J2 = 10.4 Hz, 1H), 
4.92 (dd, J1 = 3.0 Hz, J2 = 8.6 Hz, 1H), 4.25 (dd, J1 = 4.4 Hz, J2 = 11.8 Hz, 1H), 4.17 (dd, J1 
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= 2.9 Hz, J2 = 10.4 Hz, 1H), 4.11 (dd, J1 = 7.2 Hz, J2 = 11.8 Hz, 1H), 2.14 (s, 3H), 2.09 (s, 
3H), 2.08 (s, 3H), 2.01 (s, 6H), 1.98 (s, 3H) ppm. 
13
C NMR (CDCl3, 125 MHz): δ 170.7, 
170.1, 169.96, 169.3, 169.3, 169.2, 90.3, 72.5, 69.9, 68.4, 68.1, 66.9, 61.8, 21.19, 21.15, 
20.95, 20.93, 20.79, 20.76 ppm.  
HRMS (CI, NH3) exact mass calcd., for (C19H26O13+ NH4)
+
 requires 480.1717, found 
480.1710 m/z. 
 LRMS (CI, NH3), m/z (relative intensity): 480 ([M + 18]
+
, 100), 403 (56), 215 (2), 139 
(7), 110 (7), 60 (17).  
IR (KBr): 3476 (w), 2965, 1747, 1433, 1369, 1215, 1049, 948, 914, 734, 601 cm
-1
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5 APPENDIX 
 
5.1 Appendix A: List of Stereoisomers of 1-Deoxynojirimycin 
OH
OH
(R)
(R)
(R)
(S)
N
H
OH
HO
OH
OH
(R)
(S)
(R)
(S)
N
H
OH
HO
OH
OH
(S)
(R)
(S)
(S)
N
H
OH
HO
OH
OH
(S)
(S)
(S)
(S)
N
H
OH
HO
1-Deoxynojirimycin
(1-DNJ)
1-Deoxyidonojirimycin
(ido-DNJ)
1-Deoxygulonojirimycin
(gulo-DNJ)
1-Deoxymannonojirimycin
(1-DMJ)
OH
OH
(S)
(S)
(S)
(R)
N
H
OH
HO
(L)-DNJ
OH
OH
(S)
(R)
(S)
(R)
N
H
OH
HO
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OH
OH
(R)
(S)
(R)
(R)
N
H
OH
HO
OH
OH
(R)
(R)
(R)
(R)
N
H
OH
HO
(L)-gulo-DNJ (L)-DMJ
OH
OH
(S)
(R)
(R)
(S)
N
H
OH
HO
OH
OH
(R)
(S)
(R)
(R)
N
H
OH
HO
OH
OH
(R)
(R)
(S)
(S)
N
H
OH
HO
OH
OH
(S)
(S)
(R)
(R)
N
H
OH
HO
galacto-DNJ
(L)-galacto-DNJ
allo-DNJ (L)-allo-DNJ
OH
OH
(R)
(R)
(S)
(R)
N
H
OH
HO
altro-DNJ
OH
OH
(S)
(S)
(R)
(S)
N
H
OH
HO
(L)-altro-DNJ
OH
OH
(S)
(R)
(R)
(R)
N
H
OH
HO
talo-DNJ
OH
OH
(R)
(S)
(S)
(S)
N
H
OH
HO
(L)-talo-DNJ
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5.2 Appendix B: 1H NMR Spectra for Compound 323 
 
 
 215 
 
5.3 Appendix C: 1H NMR Spectra for ent-323 
 
 216 
 
6 REFERENCES 
 
1. (a) Cornforth, J. W. “Perspectives in Organic Chemistry” Todd, A. Ed.; Wiley-
Interscience: New York, 1956; page 371.  (b) Mahrwald, R. in preview “Aldol 
Reactions” Springer: Heidelberg, 2009. (c) Mahrwald, R. “Modern Aldol 
Reactions”; Vol. 1: Enolates, Organocatalysis, Biocatalysis and Natural Product 
Synthesis. 2004. (d) Susan, A. Chemistry World, 2006, 3, (4) 58-61. 
2. (a) Calvin, M. The path of carbon in photosynthesis. Angew. Chem. Int. Ed. 1962, 
1, 65-75. (b) Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic 
Chemistry; Pergamon, Oxford, 1994, Chapter 4.  (c) Jung, S.-H.; Jeong, J.-H.; 
Miller, P.; Wong, C.-H. An efficient multigram-scale preparation of 
dihydroxyacetone phosphate. J. Org. Chem. 1994, 59, 7182-7184. 
3. (a) Heathcock, C. H. In “Comprehensive Organic Synthesis”; Trost, B. M., 
Fleming, I., Heathcock, C. H., Eds.; Pergamon Press: New York, 1991; Vol. 2, pp. 
99-319.  
4. (a) Butlerow, A. M. Bildung einer zuckerartigen substanz durch synthese. Justus 
Liebigs Ann Chem. 1861, 120, 295-298. (b) Butlerow, A. M. Formation 
synthétique d‟une substance sucrée. CR Séances Acad Sci., 1861, 53, 145-147 (c) 
Loew, O. Nachträgliche bemerkungen über formose. Ber Dtsch Chem Ges., 1889, 
22, 470-478. (d) Fischer, E.; Passmore, F. Bildung von acrose aus formaldehyde, 
Ber Dtsch Chem Ges., 1889, 22, 359-361. (e) Vogel, P. In “Glycoscience Chemistry 
and Chemical Biology”; Fraser-Reid, B. O.; Tatsuta, K.; Thiem, J.; Eds.; 2nd ed.; 
Springer: Heidelberg, 2008, chapter 4.3, pp 861-956 and references therein. 
5. Breslow, R. On the mechanism of the formose reaction. Tetrahedron Lett. 1959, 
21, 22-26. 
6. (a) de Bruyn, L. C. A.; van Ekenstein, A. W.; Cornelius, A.  Action of dilute alkalis 
on the carbohydrates.  Rec. Trav. Chim., 1895, 14,156-165. (b) Evans, L. W. M. 
Some less familiar aspects of carbohydrate chemistry. Chem. Rev. 1942, 31, 537-
559 and references therein. 
7. (a) Ricardo, A.; Carrigan, M. A.; Olcott, A. N.; Benner, A. Borate minerals 
stabilize ribose. Science, 2004, 303, 196. (b) Schwartz, A.W.; de Graaf, R. M. The 
prebiotic synthesis of carbohydrates: A reassessment J. Mol. Evol. 1993, 36, 101-
106. 
8. Markert, M.; Mahrwald, R. Total syntheses of carbohydrates: Organocatalyzed 
aldol additions of dihydroxyacetone. Chem. Eur. J. 2008, 14, 40-48.  
 217 
 
9. (a) Enders, D.; Voith, M.; Lenzen, A., The dihydroxyacetone unit: A versatile C3 
building block in organic synthesis. Angew. Chem., Int. Ed. 2005, 44, 1304-1325. 
(b) Enders, D.; Narine, A. A. Lessons from Nature: Biomimetic organocatalysis 
carbon-carbon bond formation. J. Org. Chem. 2008, 73, 7857-7870. 
10. Gleave, D. M. Ph.D. thesis. University of Saskatchewan, 1993. 
11. Nowak, P. Ph.D. thesis. University of Saskatchewan, 1998. 
12. Niewczas, I. Ph.D. thesis. University of Saskatchewan, 2008. 
13. Majewski, M.; Gleave, D. M.; Nowak, P., 1,3-Dioxan-5-ones: Synthesis, 
deprotonation, and reactions of their lithium enolates. Can. J. Chem. 1995, 73, (10), 
1616-26. 
14. Suri, J. T.; Mitsumori, S.; Albertshofer, K.; Tanaka, F.; Barbas, C. F., III, 
Dihydroxyacetone variants in the organo-catalytic construction of carbohydrates: 
mimicking tagatose and fuculose aldolases. J. Org. Chem. 2006, 71, (10), 3822-
3828. 
15. Majewski, M.; Nowak, P., Stereoselective synthesis of protected ketohexoses via 
aldol reaction of chiral dioxanone enolate. Synlett 1999, (9), 1447-1449. 
16. Majewski, M.; Nowak, P., Aldol addition of lithium and boron enolates of 1,3-
dioxan-5-ones to aldehydes. A new entry into monosaccharide derivatives. J. Org. 
Chem. 2000, 65, (17), 5152-5160. 
17. Majewski, M.; Nowak, P., Stereoselective synthesis of (+)-Frontalin. Tetrahedron: 
Asymmetry 1998, 9, 2611-2617. 
18. Niewczas, I.; Majewski, M., Building higher carbohydrates via dioxanone aldol 
chemistry: The α, α'-bisaldol approach Eur. J. Org. Chem. 2009, 33-37. 
19. Enders, D.; Grondal, C., Direct organocatalytic de novo synthesis of carbohydrates. 
Angew. Chem. Int. Ed. 2005, 44, (8), 1210-1212. 
20. Grondal, C.; Enders, D., Direct asymmetric organo-catalytic de novo synthesis of 
carbohydrates. Tetrahedron 2006, 62, (2) 329–337. 
21. Suri, J. T.; Ramachary, D. B.; Barbas, C. F., III, Mimicking dihydroxy acetone 
phosphate-utilizing aldolases through organocatalysis: A facile route to 
carbohydrates and aminosugars. Org. Lett. 2005, 7, (7), 1383-1385. 
22. Ibrahem, I.; Cordova, A., Amino acid catalyzed direct enantioselective formation of 
carbohydrates: one-step de novo synthesis of ketoses. Tetrahedron Lett. 2005, 46, 
3363–3367. 
 218 
 
23. Enders, D.; Palecek, J.; Grondal, C., A direct organocatalytic entry to sphingoids: 
asymmetric synthesis of D-arabino- and L-ribo-phytosphingosine. Chem. 
Communi. 2006, 655-657. 
24. List, B., The direct catalytic asymmetric three-component mannich reaction. J. Am. 
Chem. Soc. 2000, 122, (38), 9336-9337. 
25. Enders, D.; Grondal, C.; Vrettou, M.; Raabe, G., Asymmetric synthesis of 
selectively protected amino sugars and derivatives by a direct organo-catalytic 
Mannich reaction. Angew. Chem., Int. Ed. 2005, 44, (26), 4079-4083. 
26. Westermann, B.; Neuhaus, C., Dihydroxyacetone in amino acid catalyzed 
Mannich-type reactions. Angew. Chem., Int. Ed. 2005, 44, (26), 4077-4079. 
27. (a) Northrup, A. B.; MacMillan, D. W. C. Two step synthesis of carbohydrates by 
selective aldol reactions Science, 2004, 305, 1753-1755. (b) Storer, R.I.; 
MacMillan, D. W. C. Enantioselective organocatalytic aldehyde-aldehyde cross-
aldol couplings. The broad utility of a-thioacetal aldehydes. Tetrahedron, 2004, 60, 
7705-7714. 
28. Ibrahem, I.; Zou, W.; Xu, Y.; Cordova, A., Amino acid-catalyzed asymmetric 
carbohydrate formation: organocatalytic one-step de novo synthesis of keto and 
amino sugars. Adv. Synth. Catal. 2006, 348, 211-222. 
29. Enders, D.; Chow, S., Organocatalytic asymmetric Michael addition of 2,2-
dimethyl-1,3-dioxan-5-one to nitro alkenes employing proline-based catalysts. Eur. 
J. Org. Chem. 2006, (20), 4578-4584. 
30. Pasteur, L. Leçons de Chimie Professés en 1860 and Société Chimique de Paris: 
Paris, 1861. Translated into Researches on the Molecular Asymmetry of Natural 
Organic Products, Alembic Club Reprints, No. 14; William F. Clay: Edinburgh, 
1897.  
31. (a) Brown, C. Chirality in Drug Design and Synthesis, Smith Kline 
Pharmaceuticals, UK, Academic Press Limited, 1990. (b) Crossley, R. Chirality 
and the Biological Activity of Drugs, CRC Press, London, UK, 1995. 
32. Ojima, I. Catalytic Asymmetric Synthesis, 2ed. Wiley, New York, 2000. 
33. Comprehensive Organic Synthesis; Trost, B. M. Ed, Pergamon: Oxford, 1991, 
Vols. 1-4. 
34. Majewski, M. Advances in Asymmetric Synthesis, Vol 3.; (Ed.: Hassner, A) 
“Enantioselective Deprotonation of Cyclic Ketones”  JAI Press Inc: London, 1998, 
pp 39-76. 
 219 
 
35. Enders, D., Bockstiegel, B. Enantioselective Alkylation of 2,2-Dimethyl-1,3-
dioxan-5-one Using the SAMP-/RAMP-Hydrazone Method Synthesis 1989, 493 
36. Job, A.; Janeck, C. F.; Bettray, W.; Peters, R.; Enders, D. The SAMP-/RAMP-
hydrazone methodology in asymmetric synthesis Tetrahedron 2002, 58, 2253-
2329. 
37. Funk, R. L.; Bolton, G. L.; Metalation and alkylation of 4H-1,3-dioxin: A new 
.beta.-acyl vinyl anion equivalent J. Am. Chem. Soc. 1988, 110, 1290-1292. 
38. Funk, R. L.; Yost III, K. J. Preparation and Diels−Alder cycloaddition of 2-
acyloxyacroleins. Facile synthesis of functionalized Taxol A-ring synthons.  J. Org. 
Chem. 1996, 61, 2587-2689.  
39. Fuchs, J. R.; Funk, R. L. Intramolecular Electrophilic Aromatic Substitution 
Reactions of 2-Amidoacroleins: A New Method for the Preparation of 
Tetrahydroisoquinolines, Tetrahydro-3-benzazepines, and Hexahydro-3-
benzazocines. Org. Lett. 2001, 3, (21), 3349-3351. 
40. Maeng, J. -H.; Funk, R. L. Total Synthesis of (±)-Fasicularin via a 2-Amidoacrolein 
Cycloaddition. Org. Lett. 2002, 4, (3), 331-333. 
41. Maeng, J. -H.; Funk, R. L. Total Synthesis of the Immunosuppressant FR901483 
via an Amidoacrolein Cycloaddition. Org. Lett. 2001, 3, 1125-1128. 
42. Pracejus, E.; Matje, H. J. Prakt. Chem. Fur Reihe 1964, 24, 195. 
43. Hajos, Z. G.; Parrish, D. R. German Patatent DE 2102623. Chem. Abstr. 1972, 76, 
59072. 
44. Hajos, Z. G.; Parrish, D. R. Asymmetric synthesis of bicyclic intermediates of 
Natural product Chemistry. J. Org. Chem. 1974, 39, 1615 -1621. 
45. Eder, U.; Wiechert, R.; Sauer, G. German Patent DE 2014757. Chem. Abstr. 1972, 
76, 14180. 
46. List, B.; Lerner, R. A.; Barbas, C. F., III. Proline-Catalyzed Direct Asymmetric 
Aldol Reactions. J. Am. Chem. Soc. 2000, 122, 2395-2396. 
47. Barbas, C. F., III. Organocatalysis lost: Modern chemistry, ancient chemistry, and 
an unseen biosynthetic apparatus. Angew. Chem. Int. Ed. 2008, 47, 42-47. 
48. Dondoni, A.; Massi, A. Asymmetric organocatalyis: From infancy to adolescence. 
Angew. Chem. Int. Ed. 2008, 47, 4638-4660. 
49. Dalko, P. I.; Moisan, L. In the Golden Age of Organocatalysis. Angew. Chem. Int. 
Ed. 2004, 43, 5138-5175.  
 220 
 
50. Dalko, P. I.; Moisan, L. Enantioselective organocatalysis. Angew. Chem. Int. Ed. 
2001, 40, 3726-3748. 
51. List, B. Biocatalysis and organocatalysis: asymmetric synthesis inspired by nature. 
Asymmetric Synthesis 2007, 161-165. 
52. Seayad, J.; List, B. Asymmetric orgonocatalysis Org. Biomol. Chem. 2005, 3, 719-
724. 
53. Books: a) Berkessel, A.; Gröger, H. Asymmetric Organocatalysis: From 
Biomimetic Concepts to Applications in Asymmetric Synthesis, Wiley-VCH, 
Weinheim, 2005; (b) Enantioselective Organocatalysis (Ed.: Dalko, P. I.) Wiley-
VCH, Weinheim, 2007. 
54. Movassaghi. M.; Jacobsen, E. N. The Simplest "Enzyme" Science, 2002, 298, 
1904-1905 
55. List, B.; Hoang, L.; Martin, H. J. New mechanistic studies on the proline-catalyzed 
aldol reaction. Proc. Natl. Acad. Sci. USA. 2004, 101, 5839–5842. 
56. Ibrahem, I.; Zou, W.; Xu, Y.; Cordova, A. Amino acid-catalyzed asymmetric 
carbohydrate formation: organocatalytic one-step de novo synthesis of keto and 
amino sugars. Adv. Synth. Catal. 2006, 348, 211-222. 
57. Allemann, C.; Gordillo, R.; Clemente, F. R.; Cheong, P. H-Y.; Houk, K. N. Theory 
of asymmetric organocatalysis of aldol and related reactions: Rationalization and 
predictions. Acc. Chem. Res. 2004, 37, 558-569 and references therein. 
58. Seebach, D.; Beck, A. K.; Badine, D. M.; Limbach, M.; Eschenmoser, A.; 
Treasurywala, a. M.; Hobi, R.; Prikoszovich, W.; Linder, B. Are Oxazolidinones 
Really Unproductive, Parasitic Species in Proline Catalysis? – Thoughts and 
Experiments Pointing to an Alternative View. Helv. Chim. Acta. 2007, 90, 425-471. 
59. Bassler, B. L.; Losick, R. Cell 2006, 125, 237-246. 
60. Hopwood, D. A. Streptomyces in Nature and Medicine: The Antibiotic Makers; 
Oxford University Press: New York, 2007. 
61. Davis, J. B.; Bailey, J. D.; Sello, J. K. Biomimetic Synthesis of a New Class of 
Bacterial Signaling Molecules. Org. Lett. 2009, 11 (14), 2984-2987. 
62. (a). Martin, J. R.; De Vault, R. L.; Sinclair, A. C.; Stanaszek, R. S.; Johnson, P. A 
new occurring erythromycins: Erythromycin F. J. Antibiot. 1982, 35, 426-430. (b) 
Cevallos, A.; Guerriero, A. Isolation and Structure of a New Macrolide Antibiotic, 
Erythromycin G, and a Related Biosynthetic Intermediate from a Culture of 
Saccharopolyspora erythraea. J. Antibiot. 2003, 56, 280-288. 
 221 
 
63. Kim, H. C.; Youn, J.-H.; Kang, S. H. Synthesis of L-cladinose using 
enantioselective desymmetrization. Synlett 2008, 2526-2528. 
64. (a). Fiese, E. F.; Steffen, S. H. Comparison of the acid stability of azithromycin and 
erythromycin A. J. Antimicrob. Chemother. 1990, 25, 39-47; (b). Schonwald, S.; 
Skerk, V.; Petricevic, I.; Car, V.; Majerus-Misic, L.; Gunjaca, M. An open study to 
compare the pharmacokinetics, safety, and tolerability of a multiple-dose regimen 
of azithromycin in young and elderly volunteers. Eur. J. Clin. Microbiol. Infect. 
Dis. 1991, 10, 877-880. 
65. (a). Djokic, S.; Kobrehel, G.; Lazarevski, G.; Lopatar, N. Tamburasev, Z.; 
Kamenar, B.; Nagl, A.; Vickovic, I.; J. Chem. Soc. Perkin Trans. 1, 1986, 1881-
1990; (b) Kirst, H. A.; Recent Progress in the Chemical Synthesis of Antibiotics; 
Springer, Heidelberg, 1990, pp. 39-63; (c). Mutak, S. Azalides from Azithromycin 
to New Azalide Derivatives J. Antibiot. 2007, 60, 85-122. 
66. Kim, H. C.; Kang, S. H. Total synthesis of Azithromycin. Angew. Chem. Int. Ed. 
2009, 48, 1847-1829. 
67. Dyke, S. F.; Quessy, S. N. In The Alkaloids; Rodrigo, R. G. A., Ed.; Academic 
Press:  New York, 1981; Vol. 18, p 1. 
68. He, Y.; Funk, R. L. Total synthesis of (±)-β-erythroidine and (±)-8-oxo-β-
erythroidine by an intramolecular Diels-Alder cycloaddition of a 2-aminoacrolein. 
Org Lett. 2006, 8, (17), 3689-3692. 
69. Loder, J. W.; Nearn, R. H. Altholactone, a novel tetrahydrofuro [3,2b] pyran-5-one 
from a Polyalthia species (Annonaceae) Heterocycles 1977, 7, 113-118. 
70. Enders, D. Barbion, J. Asymmetric synthesis of (+)-Altholactone: A styryllactone 
isolated from various Goniothalamus species. Chem. Eur. J. 2008, 14, 2842-2849. 
71. (a) Nomura, M.; Shuto, S.; Tanaka, M.; Sasaki, T.; Mori, S.; Shigeta, S.; Matsuda, 
A. Synthesis and Biological Activities of 4′α-C-Branched-Chain Sugar Pyrimidine 
Nucleosides J. Med. Chem. 1999, 42, 2901-2908 (b). Waga, T.; Ohuri, H.; Meguro, 
H. Synthesis and biological evaluation of 4 -C-methyl nucleosides Nucleosides 
Nucleotides 1996, 15, 287-304. 
72. Hess, M. T.; Schwitter, U.; Petretta, M.; Giese, B.; Naegli, H. DNA synthesis arrest 
at C4'-modified deoxyribose residues Biochemistry 1997, 36, 2332-2327. 
73. Enders, D. Hieronymi, A.; Raabe, G. Asymmetric synthesis of 4'-quaternary 2'-
deoxy-3'-and-4'-epi-β-C- and -N-nucleosides Synthesis 2008, 10, 1545-1558. 
74. Enders, D.; Breuer, I.; Drosdow, E. Asymmetric synthesis of 4'-epi-Trachycladines 
A and B; Synthesis 2005, 19, 3239-3244. 
 222 
 
75. Seto, M.; Roizen, J. L.; Stoltz, B. M. Catalytic enantioselective alkylation of 
substituted dioxanone enol ethers: Ready acess to C(α)-tetrasubstituted 
hydroxyketones, acids and esters Angew. Chem. Int. Ed. 2008, 47, 6873-6876. 
76. Bulugahapithiya, V.; Rapado, L. P.; Synthesis of non-racemic 1-
hydroxycycloalkene-1-carboxylic-acid derivatives by metathesis of alpha,alpha-
dialkylated glycolate derivatives  Helv. Chim. Acta 2000, 83, 1625-1632. 
77. Garg, N. K.; Caspi, D. D.; Stoltz, B. M. The Total synthesis of (+)-Dragmacidin F 
J. Am. Chem. Soc. 2004, 126, 9552-9553. (b) Garg, N. K.; Caspi, D. D.; Stoltz, B. 
M. The utility of the classical and oxidative Heck reactions in natural product 
synthesis: studies directed toward the total synthesis of dragmacidin  Synlett 2006, 
3081-3087. 
78. Suzuki, S.; Isono, K.; Mizutani, T.; Kawashima, Y.; Mizuno, T. A new antibiotic, 
polyoxin A. J. Antibiot. 1965,   A18, 131-134. (b) Isono, K. Asahi, K.; Suzuki, S. 
The structure of polyoxins J. Am. Chem. Soc. 1969, 91, 7490-7505. 
79. Shenbagamurthi, P.; Smith, H. A.; Becker, J. M.; Steinfeld, A.; Naider, F. Design 
of anticandidal agents: synthesis and biological properties of analogues of polyoxin 
L  J. Med. Chem. 1983, 26, 1518-1522. 
80. Falentin, C.; Daniel Beaupe`re, Demailly, G.; Imane Stasik, I. New approach to 
(―)-polyoxamic acid and 3,4-diepipolyoxamic acid from D-lyxono-1,4-lactone. 
Tetrahedron 2008, 64, 9989-9991. 
81. Enders, D.; Vrettou, M. Asymmetric Synthesis of (+)-Polyoxamic acid via an 
Efficient Organocatalytic Mannich Reaction as the Key Step. Synthesis 2006, 13, 
2155-2158. 
82. Kuroda, I.; Musman, M.; Ohtani, I. I.; Ichba, T.; Tanaka, J.; Garcia-Gravalos, D.; 
Higa, T. Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine 
sponge, Pachastrissa sp. J. Nat. Prod. 2002, 65, 1505-1506. 
83. Ledroit, V.; Debitus, C.; Lavaud, C.; Massiot, G. Jaspines A and B: two new 
cytotoxic sphingosine derivatives from the marine sponge Jaspis sp. Tetrahedron 
Lett. 2003, 44, 225-228. 
84. Enders, D.; Terteryan, V.; Paleček, J.; Asymmetric synthesis of Jaspine B 
(Pachastrissamine) via an organocatalytic aldol reaction as key step. Synthesis 
2008, 14, 2278-2282. 
85. Nomenclature of carbohydrates, Pure & Appl. Chem., 1996, 68, (10), 1919-2008.  
86. Inouye, S.; Tsuruoka, T.; Niida, T. The structure of nojirimycin, a piperidinose 
sugar antibiotic. J. Antibiot. 1966, 19, 288-292.   
 223 
 
87.  Legler. G.  Glycoside Hydrolases: Mechanistic Information from Studies with 
Reversible and Irreversible Inhibitors. Adv. Carbohydr. Chem.1990, 48, 319-384. 
88. Lees, W. J.; Whitesides, G. M. The enzymatic synthesis of 1,5-dideoxy-1,5-
diimino--talitol and 1-deoxygalactostatin using fuculose-1-phosphate aldolase, 
Bioorganic Chemistry 1992, 20, 173-179 and references therein. 
89.  Pearson, M. S. M.; Mathé-Allainmat, M.; Fargeas, V.; Lebreton, J. Recent 
advances in the total synthesis of piperidine azasugars. Eur. J. Org. Chem. 2005, 
2159-2191. 
90. Nash, R. J.; Bell, E. A.; Fleet, G. W. J.; Jones, R. H.; Williams, J. M. The 
identification of a hydroxylated pyrrolidine derivative from Castanospermum 
australe J. Chem. Soc., Chem. Commun., 1985, 738-740. 
91. (a) Nash, R. J.; Fellows, L. E.; Dring, J. V.;  Fleet G. W. J.; Derome, A. E.;  
Hamor, T. A.;  Scofield, A. M.; Watkin, D. J. Tetrahedron Lett. 1988, 29, 2487 -
2490. (b)  Colegate, S. M; Dorling, P. R.; Huxtable, C. R.  Aust. J. Chem. 1979, 32, 
2257 -2264. (c) Asano, N.; Kato, A.; Miyauchi, M.; Kizu, H.; Tomimori, T.;  
Matsui, K.;Nash, R. J.; Molyneux, R. J. Eur. J. Biochem. 1997, 248, 296 -303. 
92. Hughes, A. B.; Rudge, A. J. Deoxynojirimycin: Synthesis and biological activity. 
Natural Product Reports, 1994, 135-162. 
93. (a) Winchester, B.; Fleet, G. W. J. Glycobiology, 1992, 2, 199-210. (b) Asano, N.; 
Nash, R. J.; Molyneux, R. J.;  Fleet, G. W. J. Tetrahedron: Asymmetry, 2000, 11, 
1645-1680. 
94. Tyler, P. C.; Winchester, B. G. Iminosugars as Glycosidase Inhibitors; Stuetz, A. 
E., Ed.; Wiley-VCH Verlag GmbH: Weinheim, Germany, 1999; pp 125−156. 
95. Jacob, G. S. Glycosylation inhibitors in biology and medicine. Current Opinions in 
Structural Biology, 1995, 5, 605-611. 
96. Matos, C. R. R.; Lopes, R. S. C.; Lopes, C. C. Synthesis of 1-deoxynojirimycin and 
N-butyl-1-deoxynojirimycin. Synthesis 1999, 4, 571-573. 
97. Wong, C. -H.; Ichikawa, Y.; Kajimoto, T.; Liu, K. -C.; Shen, G. -J.; Lin, C. -H.; 
Dumas, D. P.; Wang, R.; Look. G. C. Practical synthesis of carbohydrates based on 
aldolases and glycosyl transfereses. Pure & Appl. Chem. 1993, 65, 803-808. 
98. Kinast, G.; Schedel, M.; A four-step synthesis of 1-deoxynojirimycin etc. Angew. 
Chem. Int. Ed. Engl. 1981, 20, 805-806. (b) Osten, C. H.; Sinskey, A. J.; Barbas, C. 
F.; Pederson, R. L.; Wang Y. F. Wong, C.-H.; Use of a recombinant Bacterial 
Fructose-1,6-diphosphate aldose in aldol reaction: Preparative synthesis of 1-
 224 
 
deoxynojirimycin, 1-deoxymannojirimycin, 1,4-dideoxy-1,4-imino-D-arabinitol 
and fagomine. J. Am. Chem. Soc. 1989, 111, 3924-3927. 
99. (a) Calderon, F.; Doyaguez, E. G.; Cheong, P, H.; Fernandez-Mayoralas, A.; Houk, 
K. N. Origins of the double asymmetric induction on proline-catalyzed aldol 
reactions. J. Org. Chem. 2008, 73, 7916-7920.  (b) Calderon, F.; Doyaguez, E. G.; 
Fernandez-Mayoralas, A. Synthesis of azasugars through a proline-catalyzed 
reaction. J. Org. Chem. 2006, 71, 6258-6261. (c) Calderon, F.; Doyaguez, E. G.; 
Fernandez-Mayoralas, A. Asymmetric aldol reaction using immobilized proline on 
mesoporous support. Adv. Synth. Catal. 2005, 347, 1395-1403. (d) Calderon, F.; 
Doyaguez, E. G.; Fernandez-Mayoralas, A. Asymmetric aldol reaction catalyzed by 
a heterogenized proline on mesoporous support. The role of the nature of solvents. 
J. Org. Chem. 2007, 72, 9353-9356. 
100. (a) Levy, D. E.; Fugedi, P. The Organic Chemistry of Sugars. CRC Press, Boca 
Raton, 2006; (b) Secrist, J. A., III; Barnes, K. D.; Wu, S. R. Trends in Synthetic 
Cabohydrate Chemistry; Horton, D.; McGarvey, G. J., Eds.; ACS Symp. Ser. 1989, 
386, Chapter 5. 
101. For reviews of higher monosaccharides see (a) Danishefsky, S. J.; DeNinno, M. P. 
Angew. Chem. Int. Ed. Engl. 1987, 26, 15-23; (b) Jarosz, S.; J. Carbohydr. Chem. 
2001, 20, 93-107; (c) J. S. Brimacombe, Studies in Natural Products Chemistry, ed. 
Atta-ur-Rahman, Elsevier, Amsterdam, 1989, vol. 4, 157–193; (d)  Zamoski, A.; 
Jarosz, S. Pol. J. Chem., 1992, 66, 525; (e) Casiraghi, G.; Rassu, G. in Studies in 
Natural Products Chemistry, ed. Atta-ur-Rahman, Elsevier, Amsterdam, 1992, vol. 
11, 429–480; (f) Hemeon, I.; Bennet, A. J, Synthesis 2007, 13, 1899-1926. 
102. (a) Vuilhorgne, M.; Ennifar, S.; Das, B. C.; Paschal, J. W.; Nagarajan, R.; 
Hagaman, E. W.; Wenkert, E. J. Org. Chem. 1977, 42, 3289; (b) Uchida, K.; Wolf, 
H,  J. Antibiot. 1974, 27, 783; (c) Furstner, A.; Wuchrer, M, Chem. Eur. J. 2006, 
12, 76-89. 
103. (a) Fraser-Reid, B. O.; Tatsuta, K.; Thiem, J. Glycoscience Chemistry and 
Chemical Biology; 2
nd
 Ed. Springer Berlin Heidelberg, Germany, 2008, chapter 4.3, 
pp 861-956. (b) Collins, P. M.; Ferrier, R. J. Monosaccharides: their chemistry and 
their roles in natural products; John Wiley & Sons Ltd.; Chichester, New York, 
1995. (c) Teuber, M.; Bevill, R. D.; Osborn, M. J. Biochemistry, 1968, 7, 3303. (d) 
Zamyatina, A.; Gronow, S.; Puchberger, M.; Graziani, A.; Hofinger, A.; Kosma, P. 
Carbohydr. Res. 2003, 338, 2571. (e) Adams, G. A.; Quadling, C.; Perry, M. B. 
Canadian Journal of Microbiology, 1967, 13, 1605. 
 225 
 
104. (a) Davies, D. A. L. Nature, 1957, 180, 1129. (b) Davies, D. A. L. Biochem. J., 
1957, 67, 253. (c) MacLennan, A. P.; Davies, D. A. L. Bulletin de la Societe de 
Chimie Biologique, 1960, 42, 1373. 
105. Raetz, C. R. H.; Ulevirch, R. J.; Wright, S. D.; Sibley, C. H.; Ding, A.; Nathan, C. 
F. Gram-negative endotoxin: An extraordinary lipid with profound effects on 
ekaryotic signal transduction.  FASEB. J. 1991, 5, 2652-2660. 
106. Slein, M. W.; Schnell, G. W. Proc. Soc. Exp. Biol. 1953, 82, 734. 
107. Heptoses reviews: (a) Kosma, P. Curr. Org. Chem., 2008, 12, 1021-1039. (b) 
Hansson, J.; Oscarson, S. Curr. Org. Chem., 2000, 4, 535. (c)  Oscarson, S. Topics 
Curr. Chem., 1997, 186,172 (d) Eidels, L.; Osborn, M. J. Proc. Nat.  Acad. Sci. 
USA, 1971, 68, 1673 and reference therein. 
108. Heptoses synthesis: (a) Jaipuri, F. A.; Collet, B. Y. M.; Pohl, N. L. Angew. Chem., 
Int. Ed.  2008, 47, 1707. (b) Prenner, R. H.; Binder, W. H.; Schmid, W. Liebigs 
Annalen der Chemie. 1994, 1, 73. (c) Okuda, T.; Saito, S.; Watanabe, K. 
Carbohydrate Res. 1978, 65, 183. (d) Guezlek, H.; Graziani, A.; Kosma, P. 
Carbohydrate Res. 2005, 340, 2808. (e) Brimacombe, J, S.; Kabir, A.  K. M. S. 
Carbohydrate Res. 1986, 152, 329-34.; Carbohydrate Res., 1986, 150, 35-51. (f) 
Kim, M.; Grzeszczyk, B.; Zamojski, A. Tetrahedron, 2000, 56. 9319. (g) Deferrari, 
Jorge O.; De Lederkremer, Rosa M. Carbohydrate Res. 1967, 4, 365. (h) Dmitriev, 
B. A.; Chernyak, Y.; Chizhov, O. S.; Kochetkov, N. K. Russian Chemical Bulletin, 
1972, 21, 2230. (i) Hricoviniova, Z. Tetrahedron: Asymmetry, 2002, 13, 1567. (j) 
Hulyalkar, R. K.; Jones, J. K. N.; Perry, M. B. Can. J. Chem. 1963, 41, 1490. (k) 
Khare, N. K.; Sood, R. K.; Aspinall, G. O. Canadian Journal of Chemistry, 1994, 
72, 237. 
109. Magerlein, B. J.; Pearlman, D, (Ed.): Structure Actiuity Relationships among the 
Semisynthetic Antibiotics. Academic Press, New York, 1977, 601-650. 
110. Unger, F. M.  Advu. Carbohydr. Chem. Biochem. 1981, 38, 323. 
111. Barker, S. A.; Fish, F. P.; Prchal, J. J.Biochem.Biophys.Res.Commun. 1983, 116, 
988. 
112. (a) Azuma, T.; Isono, K. Transglycosylation: An improved method for 
tansglycosylation from pyrimidines to purines. Chem. Pharm. Bull. 1977, 25, 3347-
3353. (b) Kozaki, S.;  Sakanaka, O.; Yasuda, T.; Shimizu, T.; Ogawa, S.; Suami. T. 
Alternative total synthetic approach toward octosyl acid A. J. Org. Chem. 1988 53, 
281-286  
113. (a) Nadano, D.; Iwasaki, M.; Endo, S.; Kitajima, K.; Inove, S.; Inove, Y. A 
naturally occurring deaminated neuraminic acid, 3-deoxy-D-glycero-D-galacto-
 226 
 
nonulosonic acid (KDN). Its unique occurrence at the nonreducing ends of 
oligosialyl chains in polysialoglycoprotein of rainbow trout eggs. J. Biol. Chem. 
1986, 261, 11550-11557. (b) Angata, T.; Varki, A. Chem. Rev. 2002, 102, 439 and 
references therein; (c) Kiefel, M. J.; Itzstein, V. M. Chem. Rev. 2002, 102, 471 and 
references therein. 
114. De Rosa, M.; De Rosa, S.; Gambacorta, A.; Bulock, J. O.  Structure of calditol, a 
new branched-chain nonitol, and of the derived tetraetherlipids in thermoacidophile 
archaebacteria of the Caldariella group. Phytochemistry 1980, 19, 249-254. (b) 
Goro. T.; Toya, Y.; Ohgi, T.; Kondto, T. Structure of amipurimycin, a nucleoside 
antibiotic having a novel branched sugar moiety. Tetrahedron Lett. 1982, 23, 1271-
1274. 
115. (a) Vuilhorgne, M.; Ennifar, S.; Das, B. C.; Paschal, J. W.; Nagarajan, R.; 
Hagaman, E. W.; Wenkert, E. Carbon-13 nuclear magnetic resonance spectroscopy 
of naturally occurring substances. Structure analysis of the nucleoside disaccharide 
antibiotic anthelmycin by carbon-13 nuclear magnetic resonance spectroscopy. A 
structural revision of hikizimycin and its identity with anthelmycin J. Org. Chem. 
1977, 42, 3289-3292; (b) Uchida, K.; Wolf, H,   Inhibition of ribosomal peptidyl 
transferase by hikizimycin, a nucleoside antibiotic J. Antibiot. 1974, 27, 783-787; 
(c) Furstner, A.; Wuchrer, M, Concise Approach to the “Higher Sugar” Core of the. 
Nucleoside Antibiotic Hikizimycin Chem. Eur. J. 2006, 12, 76-89. (d) Magerlein, 
B. J.; Pearlman, D, (Ed.): Structure Activity Relationships among the Semisynthetic 
Antibiotics. Academic Press, New York, 1977, 601-650. 
116. Takatsuka, A.; Arimak, T.; Tamura, G. Isolation and characterization of 
tunicamycin. J. Antibiot. 1971, 24, 215-223. 
117. (a) Lonngren, J. Pure & Appl. Chem., 1989, 61, 1313-1314; (b) Dwek, R. A. Chem. 
Rev. 1996, 96, 683-720. 
118. (a) Brimacombe, J. S.; Kabir, A. K. Carbohydr. Res. 1986, 152, 335-338; (b) 
Ohlsson, J. Carbohydr. Res. 2002, 331, 91-94; (c) Marshall, J. A.; Beaudoin, S. J. 
Org. Chem. 1994, 59, 6614-6619; (d) Jorgensen, M.; Iversen, E. H.; Madsen, R. J. 
Org. Chem. 2001, 66, 4625-4629 and references therein. 
119. (a) Brimacombe, J. S.; Kabir, A. B. K. M. S. Carbohydr. Res. 1986, 152, 329 and 
references therein. (b) Boons, G. J. P. H.; van der Marel, G. A.; van Boom, J. H. 
Tetrahedron Lett. 1989, 30, 229. (c) Jørgensen, M.; Iversen, E. H.; Madsen, R. J. 
Org. Chem. 2001, 66, 4625 and references therein. (d) Read, J. A.; Ahmed, R. A.; 
Morrison, J. P.; Coleman, W. G., Jr.; Tanner, M. E. J. Am. Chem. Soc. 2004, 126, 
8878-8879 and references therein. 
 227 
 
120. (a) Kiliani, H. Ber. Dtsch. Chem. Ges. 1885, 18, 3066. (b) Fisher, E. Dtsch. Chem. 
Ges. 1889, 22, 2204. (c) Hudson, C. S. The Fischer cyanohydrin synthesis and the 
configurations of higher-carbon sugars and alcohols Advances Carbohydr. Chem. 
1945, 1, 1-36. 
121. (a) Aoyagi, S.; Fujimaki, S.; Kibayashi, C. Total synthesis of (+)-α-
Homonojirimycin J.Chem. Soc. Chem. Comm. 1990, 1457–1459 (b) Iida, H.; 
Yamazaki, N.; Kibayashi, C., Total synthesis of (+)-Nojirimycin and (+)-1-
Deoxynojirimycin.  J. Org. Chem. 1987, 52 3337–3342. 
122. Secrist, J. A.; III; Barnes, K. D. Synthesis of methyl peracetyl α-hikosaminide, the 
undecose portion of the nucleoside antibiotic Hikizimycin. J. Org, Chem. 1980, 45, 
4526–4528. 
123. Miljkovic, M.; Habash-Marino, M. Synthesis of higher sugars as precursors for the 
synthesisof chiral polyhydroxylated macrocyclic lactones. J. Serb. Chem. Soc. 
2000, 65, 497–505. 
124. Jarosz, S.; Fraser-Reid, B. Synthesis of a higher carbon sugar via directed aldol 
condensation. Tetrahedron Lett. 1989, 30, 2359–2362. 
125. (a) Esswein, A.; Betz, R.; Schmidt, R. R. Synthesis of 3-deoxy-D-manno-2-
octulosonic acid (KDO) and derivatives. Helv. Chim. Acta. 1989, 72, 213-223. (b) 
Schmidt, R. R.; Preuss, R. Synthesis of lacto-neo-tetraosyl ceramide Tetrahedron 
Lett. 1989, 30, 3409-3412. 
126. (a) Danishefsky, S. J.; Hungate, R. The total synthesis of octosyl acid A: a new 
departure in organostannylene chemistry J. Am. Chem. Soc. 1986, 108, 2486–2487 
(b) Danishefsky, S. J.; Barbachyn, M. A fully synthetic route to tunicaminyluracil.  
J. Am. Chem. Soc. 1985, 107, 7761–7762 (c) Danishefsky, S. J.; Maring, C., A 
fully synthetic route to hikosamine. J. Am. Chem. Soc. 1985, 107, 7762–7764. (d) 
Danishefsky, S. J.; De Ninno, M. P.; Chen, S. “Stereoselective Total Synthesis of 
the Naturally occurring Enantiomers of N-Acetylneuraminic Acid and 3-Deoxy-D- 
manno-2-octulosonic acid. A new and stereospecific approach to sialo and 2- 
deoxy-D-manno-octulosonic acid conjugates J. Am. Chem. Soc. 1988, 110, 3929–
3940. 
127. Dodoni, A.; Fantin, G.; Fogagnolo, M.; Medici, A. Synthesis of long chain sugars 
by iterative, diastereoselective homologation of 2,3-O-Isopropylidene-D-
glyceraldehyde with 2-Trimethylsilylthiazole Angew. Chem. Int. Ed. Engl. 1986, 
25, 835-837. 
128. (a) Hanessian, S. The Total Synthesis of Natural Products. the Chiron Approach., 
Pergamon Press, New York, 1983. (b) Hanessian, S.; Murray, P. J. Sahoo. S. P. 
Tetrahedron Lett. 1985, 26, 5623-5634. (c) Hanessian, S. Design and 
 228 
 
implementation of tactically novel strategies for stereochemical control using the 
chiron approach. Aldrichimica Acta. 1989, 22, 3-14 and references cited there. 
129. (a) Jefford, C.W.; Jaggi, D.; Sledeski, A.W.; Boukouvalas, J. New methodology for 
the synthesis of biologically active lactones in Studies in Natural Products 
Chemistry, Vol 3, Part B, Attaur-Rahman (Ed.), Elsevier, Amsterdam, 1989, p. 
157–171. (b) Jefford, C. W.; Jaggi, D.; Bernardinelli, G.; Boukouvalas, J. The 
synthesis of (±)- cavernosine. Tetrahedron Lett. 1987, 28, 4041–4044 
130. Casiraghi, G.; Colombo, L.; Rassu, G.; Spanu, P. Highly stereocontrolled total 
synthesis of 6-deoxy-6-aminoheptopyranuronic acid derivatives J. Chem. Soc., 
Chem. Commun. 1991, 603-604. 
131. Hanessian, S. Total Synthesis of Natural Products: The “Chiron” Approach; 
Pergamon Press: Oxford UK, 1983. 
132. (a) Majewski, M.; Niewczas, I.; Palyam, N. Acids as proline co-catalysts in the 
aldol reaction of 1,3-dioxan-5-ones. Synlett 2006, (15), 2387-2390. (b) Majewski, 
M.; Lazny, R.; Nowak, P. Effect of lithium salts on enantioselective deprotonation 
of cyclic ketones. Tetrahedron Letters 1995, 36, (31), 5465-5468. 
133. Evans, D. A. In Asymmetric Synthesis; Morrison, J. D. Ed.; Academic Press: 
Toronto, 1984; Vol.3, Pg 1. 
134. Seebach, D.; Boes, M.; Naef, R.; Schweizer, W. B. Alkylation of amino acids 
without loss of the optical activity: preparation of α-substituted proline derivatives. 
A case of self-reproduction of chirality J. Am. Chem. Soc. 1983, 105, 5390-5398. 
135. Pihko, P. M.; Laurikainen, K. M.; Usano, A.; Nyberg, A. I.; Kaavi, J. A., Effect of 
additives on the proline-catalyzed ketone–aldehyde aldol reactions. Tetrahedron. 
2006, 62, 317–328. 
136. Palyam, N.; Majewski, M. Organocatalytic syn-aldol reactions of dioxanones with 
(S)-isoserinalhydrate: Synthesis of L-deoxymannojirimycin and L-deoxyido-
nojirimycin J. Org. Chem. 2009, 74, (11), 4390-4392. 
137. Saito, S.; Yamamoto, H. Design of acid-base catalysis for thr asymmetric direct 
aldol reaction. Acc. Chem. Res. 2004, 37, 570-579. 
138. Torii, H.; Nakadai, M.; Ishihara, K.; Saito. S.; Yamamoto, H. Asymmetric direct 
aldol reaction assisted by water and a proline-derived tetrazole catalyst. Angew. 
Chem.Int. Ed. 2004, 43, 1983-1986. 
 
139. Niewczas, I.; Majewski, M., Building higher carbohydrates via dioxanone aldol 
chemistry: The α, α'-bisaldol approach. Eur. J. Org. Chem. 2009, 3, 33-37. 
 229 
 
140. Kato, A.; Kato, N.; Kano, E.; Adachi, I.; Ikeda, K.; Yu, L.; Okamoto, T.; Banba, 
Y.; Ouchi, H.; Takahata, H.; Asano, N. Biological properties of D- and L-1-
deoxyazasugars.  J. Med. Chem. 2005, 48, 2036-2044. 
141.  Asano, N.; Yamauchi, T.; Kagamifuchi, K.; Shimizu, N.; Takahashi, S.; 
Takatsuka, H.; Ikeda, K.; Kizu, H.; Chuakul, W.; Kettawan, A.; Okamoto, T. 
Iminosugar-producing Thai medicinal plants. J. Nat. Prod. 2005, 68, 1238-1242. 
142. Corey, E. J.; Cheng, X, -M. The Logic of Chemical Synthesis; Wiley: New York, 
1995. 
143. Milewska, M.; Polonski, T. A facile synthesis of (S)-isoserine from (S)-malic acid 
Synthesis, 1988, 6, 475. 
144. Schmidt, U.; Meyer, R.; Leitenberger, V.; Stabler, F.; Lieberknecht, A. Total 
synthesis of the biphenomycins; Synthesis of protected (2S,4R)-4-
hydroxyornithines. Synthesis 1991, 5, 409-413.  
145. Schmidt, U.; Meyer, R.; Leitenberger, V.; Lieberknecht, A.; Griesser, H.; The 
synthesis of the biphenomycin B. Chem. Commun., 1991, 275-277. 
146. Falb, E.; Bechor, Y.; Nudelman, A.; Hassner, A.; Albeck, A.; Gottlieb, H. E. IOOC 
Route to substituted chiral pyrrolidines. Potential glycosidase inhibitors. J. Org. 
Chem. 1999, 64, 498-506. 
147. References for 1-deoxyidonojirimycin: (a) Fowler, P. A.; Haines, A. H.; Taylor, R. 
J. K.; Chrystal, E. J. T.; Gravestock, M. B. Synthesis and activity towards yeast α-
glucosidase of 1,5-dideoxy-1,5-imino-L-iditol (1-deoxy-L-idonojirimycin). 
Carbohydr. Res., 1993, 246, 377-381.(b) Ruiz, M.; Ruanova, T. M.; Blanco, O.; 
Nunez, F.; Pato, C.; Ojea, V. Diatereoselective synthesis of piperidine iminosugars 
using aldol additions of methal bislactim ethers to threose and erythrose acetonides 
J. Org. Chem., 2008, 73, 2240-2255 and the references there in (c) Schaller, C.; 
Vogel, P.; Jager, V. Total synthesis of (+)- and (-)-1-deoxynojirimycin and of (+)- 
and (-)- 1-deoxyidonojirimycin via furoisoxazoline-3-aldehydes. Carbohydr. Res., 
1998, 314, 25-35. (d) Lee, B. W.;  Jeong, I.-Y.; Yang, M. S.; Choi, S. U.; Park, K. 
H. A short and efficient synthesis of 2R,3R,4R-3,4-dihydroxyproline, 1,4-dideoxy-
1,4-imino-L-xylitol, 2R,3R,4R,5S-3,4,5-trihydroxypipecolic acid, and 1,5-dideoxy-
1,5-imino-L-iditol  Synthesis 2000, 9, 1305-1309.  
148. Baxter, E. Reitz, A. B. Expedious synthesis of azasugars by the double reductive 
amination of dicarbonyl sugars. J. Org. Chem. 1994, 59, 3175-3185. 
149. (a) Fellows, L. E.; Bell, E. A.; Lynn, D. G.; Pilkiewicz, F. Miura, I. Nakanishi, K. 
L. Isolation and structure of an unusual cyclic amino alditol from a legume J. 
Chem. Soc., Chem. Commun. 1979, 977-978. (b) Kinast, G. Schedel, M. A four-
 230 
 
step synthesis of 1-deoxynojirimycin with a biotransformation as cardinal reaction 
step Angew. Chem. Int. Ed. Engl. 1981, 20, 805-806. 
150. References for 1-deoxymannojirimycin: (a) Singh, O. V.; Han, H. A general 
methodology for the asymmetric synthesis of 1-deoxyiminosugars. Tetrahedron 
Lett., 2003, 44, 2387-2391. (b) Fleet, G. W. J.; Ramsden, N. G.; Witty, D. R. 
Practical synthesis of deoxymannojirimycin and mannolactam from L-
gulonolactone. Synthesis of L-deoxymannojirimycin and L-mannolactam from D-
gulonolactone. Tetrahedron, 1988, 45, 319-326. Proc. Nat. Acad. Sci, U.S.A., 
1988, 85, 9229-9233. (c) Hardick, D.J.; Hutchinson, D.W.; Trew, S. J.; Wellington, 
E. M. H.; Tetrahedron, 1992, 48, 6285-6296.  (d)  Haukaas, M. H.; O‟Doherty, G. 
A. Synthesis of D- and L-deoxymannojirimycin via an asymmetric 
aminohydroxylation of vinylfuran. Org. Lett., 2001, 3, 401-404. (e) Boglio, C.; 
Stahlke, S.; Thorimbert, S.; Malacria, M. A stereoselective route towards 
polyhydoxylated piperidines. A total synthesis of (±)-deoxymannojirimycin Org. 
Lett., 2005, 7, 4851-4854 and the references there in.  
151. Haustveit, G.; Wold, K. J. Higher-carbon sugars of opium poppy (Papaver 
somniferum) Acta. Chem. Scand. 1970, 24, 3059-3061. 
152. Brimacombe, J. S.; Kabir, A. K. Higher-carbon sugars.  Part 4.  A synthesis of L-
galacto-D-galacto-decose Carbohydr. Res. 1986, 152, 335-338; (b) Ohlsson, J. 
Carbohydr. Res. 2002, 331, 91-94; (c) Marshall, J. A.; Beaudoin, S. Stereoselective 
synthesis of higher sugars by homologation of carbohydrate-derived enals with 
nonracemic γ -(silyloxy) allylic stannanes and substrate-directed hydroxylation J. 
Org. Chem. 1994, 59, 6614-6619; (d) Jorgensen, M.; Iversen, E. H.; Madsen, R. A 
convenient route to higher sugars by two-carbon chain elongation using 
Wittig/dihydroxylation reactions. J. Org. Chem. 2001, 66, 4625-4629 and 
references therein. 
153. Dondoni, A.; Merino, P. Org. Synth., 1993, 72, 21-28. 
154. (a) Jarosz, S.; Zamojski, A. Carbohydrate derivatives containing the carbon-lithium 
and carbon-tin bonds. Current Organic Chemistry, 2003, 7, 13-33. (b) Jarosz, S. 
Synthesis of higher carbon sugars via coupling of simple monosaccharides-Wittig, 
Horner-Emmons, and related methods. J. Carbohydrate Chem. 2001, 20, 93-107. 
155. Palyam, N.; Niewczas, I.; Majewski, M., Building carbohydrates on the dioxanone 
scaffold: Stereoselective synthesis of D-glycero-D-manno-2-octulose. Tetrahedron 
Lett. 2007, 48, (52), 9195-9198. 
156. Mangion, I. K.; Nothrup, A.B.; MacMillan, D. W. C. Importance of iminium 
geometry control in enamine catalysis: identification of a new catalyst architecture 
for aldehyde-aldehyde couplings. Angew. Chem. Int. Ed. 2004, 43, 6722-6724. (e). 
 231 
 
(f). Paras, N. A.; MacMillan, D. W. C. new strategies in organic catalysis:  the first 
enantioselective organocatalytic Friedel−Crafts alkylation J. Am. Chem. Soc. 2001, 
123, 4370-4371. 
157. Corey, E. J.; Erickson. B. W. Oxidative hydrolysis of 1,3-dithiane derivatives to 
carbonyl compounds using N-halosuccinimide reagents. J. Org. Chem. 1971, 36, 
3553-3560. 
158. (a) Chérest, M.; Hugh Felkin, H.; Prudent, N. Torsional strain involving partial 
bonds. The stereochemistry of the lithium aluminium hydride reduction of some 
simple open-chain ketones. Tetrahedron Lett. 1968, 9, 2199-2204 (b) Anh, N. T.; 
Eisenstein, O.; Lefour, J. M.; Dau, M. E. Orbital factors and asymmetric induction 
J. Am. Chem. Soc. 1973, 95, 6146-6147. 
159. Palyam, N.; Niewczas, I.; Majewski. M. Building carbohydrates on dioxanone 
scaffold: Stereodivergent synthesis of DD- and LL- glycero-β-alloheptoses; under 
review 
160. Missale, G.; Colajacomo, A.; Bologna, I. Further research on the possible presence 
of an aldoheptose in the protein fraction of liver tissue Bollettino - Societa Italiana 
di Biologia Sperimentale, 1960, 36, 1885-1887. 
161. Pratt, J. W.; Richtmyer, N. K. D-glycero-D-allo-Heptose, L-allo-Heptulose, D-
talo-Heptulose and related substances derived from the addition of cyanide to D-
allose J. Am. Chem. Soc. 1955, 77, 6326-6328. 
162. Evans, D. A.; Chapman, K. T.; Carreira, E. M. Directed reduction of α-hydroxy 
ketones employing tetramethylammonium triacetoxyborohydride. J. Am. Chem. 
Soc. 1988, 110, 3560-3578. 
163. Vogel, A. I.; Furniss, B. S.; Hannaford, A. J.; Smith, P. W. G.; Tatchell, A. R. 
“Vogel’s Textbook of Practical Organic Chemistry” 1989, 5th Ed., Pearson 
Education Ltd., Essex, UK. 
164. Harwood, L. M.; Moody, C. J. “Experimental Organic chemistry” 1989, Blackwell 
Scientific Publications, Oxford, UK.  
165. Burfield, D. R.; Smithers, R. H. Desiccant efficiency in solvent drying. Dipolar 
aprotic solvents. J. Org. Chem. 1978, 43, (20), 3966-3968. 
166. Armarego, W. L. F.; Chai, C. L. L. “Purification of Laboratory Chemicals” 2003, 
5th Edition,  ed. by Butterworth-Heinemann, London. 
167. Winkle, M. R.; Lansinger, J. M.; Ronald. R. C. 2,5-Dimethoxybenzyl alcohol: a 
convenient self-indicating standard for the determination of organolithium reagents 
 J. Chem. Soc., Chem. Commun. 1980, 87-88. 
168. Still, W. C.; Kahn, M.; Mitra, A. Rapid chromatographic technique for preparative 
separations with moderate resolution. J. Org. Chem. 1978, 43, 2923-2925. 
 232 
 
169. Harwood, L. M. 'Dry column' flash chomatography. Aldrichimica Acta 1985, 18, 
25. 
170. Budavari, S.; O‟Neil, M. J.; Smith, A.; Heckelman, P. E. “The Merck Index, an 
Encyclopedia of Chemicals, Drugs, and Biologicals” 1989, 11th Ed, Merck Co., 
Inc. Rahway, New Jersey. 
171. Bax, A.; Summers, M. F. Proton and carbon-13 assignments from sensitivity-
enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple 
quantum NMR. J. Am. Chem. Soc. 1986, 108, 2093-2094. 
172. Heathcock, C. H., In Asymmetric Synthesis; Morrison, J. D., ed.; Academic Press: 
Toronto, 1984; Vol. 3, p 111-212. 
173. Mander, L. N.; Sethi, S. P. Synthesis of tert-butyldimethylsilyl enol ethers from 
sterically hindered ketones. Tetrahedron Lett. 1984, 25, (51), 5953-5956.  
174. Evans, D. A.; Chapman, K. T.; Carreira, E. M., Directed reduction of β-hydroxy 
ketones employing tetramethylammonium triacetoxyborohydride. J. Am. Chem. 
Soc. 1988, 110, (11), 3560-3578. 
175. Hoppe, D.; Schmincke, H.; Kleeman, H. W. Studies toward the total synthesis of 1-
oxacephalosporins.  1.  3-Amino-4-thio-2-azetidinones with protected γ,γ'-
dihydroxyalkenoate side chain. Tetrahedron 1989, 45, 687-694. 
176. Meyers, A. I.; Strickland, R. C. The synthesis and properties of 2-(2-
cyanoethylidiene)-1,3-dithiane and its isomeric ketene thioacetal. J.Org. Chem. 
1972, 37, (16), 2579-2583. 
177. Schmid, C. R.; Bryant, J. D. (R)-Glyceraldehyde acetonide. Organic Syntheses 
1995, 72, 6-13. 
178. Denmark, S. E.; Yang, S. -M. Total synthesis of (+)-Brasilenyne. Application of an 
intramolecular silicon-assisted cross-coupling reaction J. Am. Chem. Soc., 2004, 
126, 12432-12440 
179. (a) Aldrich Chemistry: Handbook of Fine Chemicals 2009                                     
(b) http://www.omicronbio.com/Pdf/D-ribosenmr.pdf 
180. Li, N. -S.; Lu, J.; Piccirilli, J. A. Efficient synthesis of methyl 3,5-di-O-benzyl-α-d-
ribofuranoside and application to the synthesis of 2„-C-β-alkoxymethyluridines 
Org. Lett. 2007, 9, 3009-3012. 
 
 
